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Abstract
Majority of biological processes can not be described deterministically. Multple
levels of regulation contribute to the noise in the observable properties of the cells:
fluctuations are ubiquitous in biological networks and in their spatial organization. In this
thesis we consider several examples from three broad categories. Firstly, we study two
problems that highlight connection between network topologies and manifestations of
stochastic fluctuation in networks of chemical reactions that are meant to represent
biological networks in the coarse-grained way. We show that specific network structure
can have profound consequences on the steady-state probability distribution function of
corresponding chemical system. Secondly, we study effects of spatial organization of the
proteins on the membrane surface of T-cells on the initialization of signal propagation.
We show that coordinated diffusion of proteins is critical for signal-enhancing properties
of co-receptors CD4 and CD8. In third part of the thesis we attempt to reconstruct
network topology based on incomplete information about specific interactions between
the network nodes and some information about "macroscopic" behavior of the system
governed by the network in question. The matter of the Part III, however, is one scale
larger than the corresponding objects considered in Part II and I. Specifically, we
consider transformations of cells between different cell types and molecular origins that
underlie cell transformations (such as differentiation/de-differentiation). Our model
suggests specific structure of the master-regulatory network of genes and makes testable
predictions.
Thesis Supervisor: Arup K. Chakraborty
Title: Professor of Biological Engineering
Robert T. Haslam Professor of Chemical Engineering
Professor of Chemistry
6
Acknowledgements
This work was only possible due to constant support and encouragement of my
beloved wife Yulia. Although completion of thesis writing is a remarkable source of joy,
I consider my greatest achievement this year (and my life so far) to be my son Luki
coming to the world on Oct 10, 2009.
This dissertation is devoted to Yulia and Luki; they make my life meaningful.
Support of my family throughout these years far away from the Motherland was
central for my ability to focus on the scientific problems. My mother Olena, father
Nikolai and brother Nikita are filling my heart with the happiness and calm even while
being an ocean away.
I would like to thank my Thesis Supervisor Arup K. Charkaborty for two things
above all. Firstly, for introducing me into thriving field of biological sciences while
maintaining a deep anchor in physical sciences. Secondly, for gathering a group of
intelligent and devoted people from whom I learned a great deal of "skill in the trade".
Although the list is bound to be incomplete, I would like to give my thanks to Jayajit Das,
Bo Jin, Jason Locasale and Abhishek Jha.
My great thanks are for the experimentalists who patiently responded to my often
silly questions and, thus, taught me a great deal of understanding about experimental
immunology: Herman Eisen, Jennifer Stone, David Kranz, Saso Cemerski.
I would like to take this opportunity to thank people who have affected my
scientific thinking in the most vivid way (in chronological order): persistent interactions
with Anatoly Kolomeisky allowed me to get infected with his passion for puzzles and for
science as a perpetual source of puzzles; the scientific and personal style of Karl Freed
will always be one of the most important guide-marks in my professional life; lastly, I
would like to join the crowd of the admirers of statistical mechanics class taught by
Mehran Kardar at MIT, this class laid the deep appreciation of the way physical sciences
should be done into my uninitiated mind.
I am grateful to my friends from Chemistry Department Steve Presse and
Maksym Kryvohuz (cc-Max): many scientific and not so scientific discussions have
created special atmosphere of camaraderie in a "Zoo".
Last but not least, I would like to mention with the deepest warmth my friends
from "Chicago cohort", who have now spread all over US (pending the further spread all
over the globe): Joji (Hayashida), Mridu (Saikia), Praket (Jha), Abhishek (Jha), thanks for
being there!
8
Table of Content
A cknowledgem ents .................................................................................................... 7
Chapter 1
Introduction...................................................................................-- ........... ..------ 11
1.1 Background.............................................................................................................. 11
1.2 Thesis outline........................................................................................................--- 14
1.3 References to published work and work outside the thesis scope .......................... 19
1.4 Bibliography............................................................................................................. 20
1.5 Figures for Chapter 1 .......................................................................................... 23
PART I
Chapter 2
Purely stochastic binary decisions in cell signaling models without underlying
determ inistic bistabilities ............................................................................................. 25
2.1 Introduction............................................................................................................ 25
2.2 Signaling m odel ....................................................................................................... 27
2.3 Results ..................................................................................................................... 28
2.4 D iscussion................................................................................................................ 37
2.5 Appendix to Chapter 2......................................................................................... 38
2.6 Bibliography............................................................................................................. 49
2.7 Figures for Chapter 2 ........................................................................................... 52
Chapter 3
Stochastic bimodalities in deterministically mono-stable reversible chemical networks
due to network topology reduction............................................................................. 65
3.1 Introduction............................................................................................................. 65
3.2 M odel developm ent ............................................................................................. 67
3.3 Solution of Fokker-Planck Equation .................................................................... 71
3.4 D iscussion................................................................................................................ 72
3.5 Bibliography............................................................................................................. 73
3.6 Figures for Chapter 3 ........................................................................................... 75
PART II
Chapter 4
Introduction into SSC: algorithm, units conversion and examples .......................... 79
4.1 G eneral description of the algorithm .................................................................... 79
4.2 Rate constant unit conversion .............................................................................. 81
4.3 Appendix 1 to Chapter 4: BioInformatics Paper Describing SSC .......................... 84
4.4 Appendix 2 to Chapter 4:...........................................87
4.5 Bibliography............................................................................................................. 98
Chapter 5
Dissecting the role of CD4 and CD8 co-receptors in T cell signaling: A puzzle
resolved ........................................................................................................... 99
5.1 Introduction.............................................................................................. 99
5.2 Sim ulation results................................................................................................... 100
5.3 Appendix to Chapter 5........................................105
5.4 Bibliography .. ..... ......................................... ............................................. 110
5 .5 g p ............................................................................................. 1 13
Chapter 6
Mechanisms of signal enhancement by non-cognate peptides in CD4 /8 T-cells.... 121
6.1 Introduction........................................................................................................... 121
6.2 M odel 1 of self-peptide enhancem ent..................................................................... 125
6.3 M odel 2 of self-peptide enhancem ent..................................................................... 130
6.4 M odel 3 of self-peptide enhancem ent..................................................................... 133
6.5 D iscussion.............................................................................................................. 134
6.6 Appendix p ........................................................................................... 137
6.7 Bibliography........................................................................................................... 141
6.8 Figures for Chapter 6............................................................................................. 144
PART III
Chapter 7
A model for genetic and epigenetic regulatory networks identifies rare pathways for
transcription factor induced pluripotency .............................. 157
7.1 Iy................................................................157
7.1 Introduction ........................................................................................................... 157
7.2 M odel Developm ent.............................................................................................. 158
7.3 Results: D ifferentiation.......................................................................................... 163
7.4 Results: Reprogramming........................................................................................ 164
7.5 D iscussion.............................................................................................................. 170
7.6 Sim ulation M ethods............................................................................................... 173
7.6 Appendix to Chapter 7........................................................................................... 178
7.7 Bibliography ........................................................................................................... 186
7.8 Figures for Chapter 7 ............................................................................................. 201
Chapter 8
Concluding rem arks......................................................................................................215
10
Chapter 1
Introduction
1.1 Background
Several levels of regulation govern life of biological cells. Signals from the
environment are received and processed by networks of proteins that undergo different
post-translational modifications, such as phosphorylation, dephosphorylation,
ubiquitination etc. Appropriately processed signals activate and induce translocation of
transcription factors into the nucleus, and promote the action of factors (e.g. chromatin
modifying factors) that could cause proliferation and differentiation. The resulting
alterations of the transcriptional program of the cell enable it to properly respond to the
external stimuli. Often, response involves significant changes in cell appearance,
function, and cell numbers.
Enormous numbers of proteins and nucleic acids regulate every aspect of cellular
existence. This complexity is accentuated by noise that is present at all levels of
regulation. Protein numbers differ from cell to cell and they fluctuate with time in a
single cell. Proteins are not distributed homogeneously or in any particular order inside
the cell, and are subject to stochastic forces and diffusive transport. Also, often very
small numbers of proteins or chemicals are involved in intracellular biochemical
reactions. For example, the typical acidity (pH=1) inside the phagosome of macrophages
implies that there are only 50 protons present in this closed space. This generates a source
of extrinsic noise because, when there are small numbers of reactant molecules, one must
account for the intrinsic stochasticity of chemical reactions (McQuarrie, 1967) that is
often neglected in classical chemical kinetics.
A biologically relevant situation where stochasticity of biochemical reactions
plays a critical role is recognition of ligands by cell surface receptors when stimulatory
ligands are limiting. One very important example of this situation is T-cell signaling. T-
cells are one of the most numerous cell types in an organism. T-cells represent 1 to 5 %
of all cells in humans, which reflects their importance as orchestrators of adaptive the
immune response to infectious pathogens that have evaded the defense mechanisms of
the innate immune system. Multiple cell surface molecules mediate T-cell interactions
with the environment in order to ensure appropriate responses and prevent spurious
responses to proteins of the host (which would lead to autoimmunity) (Janeway et al.,
2008).
T cells have evolved to combat pathogens that have invaded host cells. Proteins
transcribed by these intracellular pathogens (bacteria or viruses) are chopped up in to
short peptide fragments. These peptide fragments are then loaded on to proteins coded
for by the major histocompatibility (MHC) gene complex. These peptide-MHC
complexes are transported to the cell surface, and serve as molecular flags of the
pathogen. The most important interactions of a T-cell with its surroundings take place
through engagement of the T-cell receptor with these peptide-MHC molecules, which are
most prominently displayed on the surface of antigen-presenting cells (typically
macrophages, B-cells or dendritic cells). Outcome of such an engagement is critically
dependent on the pathogen-derived peptide.
In the healthy state of the organism, only peptides derived from the self-proteins
are presented to the T-cells for there are only self-proteins present in the system. Naive T-
cells are generally unresponsive to the self-antigens (due to thymic selection), thus,
avoiding autoimmune responses. When organism gets infected with a microbe or virus,
non-self proteins start circulating in the system. Pathogen-derived proteins give rise to
peptides that are different from the self-derived peptides and T-cell receptors sense this
difference which sometime can be as small as single aminoacid substitution (Fig. 1.1).
From the point of view of biophysical characterization, interactions between
ligand and receptors are described by an association-dissociation reaction. Sufficiently
strong binding is known to result in biochemical transformations of a myriad proteins
inside the T cell (signaling). These downstream events are represented by a chemical
network, either detailed or coarse-grained. Thus, understanding the influence of topology
of chemical networks on the signal processing properties of T cells is an important
research frontier. Part I of this thesis is devoted to the study of two coarse-grained models
of signaling networks (inspired by T cell biology) where topological effects enable
peculiar deviations from the mean-field behavior predicted by classical chemical kinetics.
Ligand quality (i.e. whether it is stimulating or non-stimulating ligand) is
typically reflected by the affinity (dissociation constant, Keq) and/or lifetime in the
bound state (dissociation rate, koff). In terms of T-cell ligands there is no clear
understanding as to which one is the critical parameter distinguishing between the antigen
and non-antigen. In our work we are using fixed kon since it has less variablility and vary
koff values, thus, making no distinction between Keq and koff.
T-cell sensory apparatus must be able to distinguish ligands with rather small
differences in k-off. Three major membrane proteins play important roles in this
discrimination: T-cell receptor (TCR), coreceptor (CD4 or CD8) on the T-cell surface
and peptide-MHC complex on the surface of antigen-presenting cell.
At the level of the membrane proximal events, stimulatory ligand sensing should
be translated into increased phosphorylation of intracellular part of TCR, which is then
used to propagate the signal further. This phosphorylation is carried out by Lck,
membrane associated kinase. Lck is present at the inner membrane in two forms: as a free
protein or as a coreceptor-bound form. Upon TCR-peptide-MHC engagement, Lck
phosphorylates intracellular domains of TCR thus mediating the signal input into the cell.
Coreceptor aids the phosphorylation process because it spans the membrane and is
capable of binding MHC with its extracellular part while being constitutively associated
with Lck inside the T-cell (Fig.1.2). Part II of this thesis presents detailed studies of the
earliest signaling events during T-cell activation. A new computational method for
efficient simulation of cell signaling processes is described, and some results that may
alter the textbook descriptions of coreceptor function are highlighted.
The complexity and robustness of post-translational modifications plays essential
role in propagating the signal down to the nuclei where it starts transcriptional programs.
The latter can change the cell in the most dramatic ways. For example, it can force the
cell to change its identity through differentiation. Although controlled by mechanisms of
colossal size and complexity, cell identity (T-cell, B-cell, red blood cell etc) is reasonably
stable and well-defined. Yet, it is far from being a deterministic concept. Cell
differentiation is viewed as probabilistic event, in that a progenitor can differentiate into
progeny 1 with some probability and into progeny 2 with some other probability.
Celular differentiation is usually encountered in the forward direction. For
example, an embryonic stem cell differentiates in to a hematopoietic stem which, upon
the receipt of appropriate cues, differentiates in to blood cells (e.g., T cells), etc..
Interestingly, current experiments (Jaenisch and Young, 2008) showed that cells can
change their identities in the opposite direction too, albeit with very low probabilities.
Although some information is available with respect to genes that maintain cellular
identities and mechanisms of transition between the cell states, our knowledge is far from
complete at this moment. Part III of this thesis focuses on understanding the general
topology of the network of interacting master regulatory genes that is compatible with
data on both cellular differentiation and de-differentiation. Specifically, the first theory
describing exciting new developments in reprogramming of differentiated cells to a
pluripotent state that can be used for patient-specific therapy is presented.
I would like to conclude this introductory chapter by noting that biology offers a
broad spectrum of problems ranging from fundamental studies of the stochastic behavior
of chemical networks important for signal processing all the way to the application of
coarse-grained statistical mechanical models for phenomenological description of cellular
behavior. Examples of such problems that span a spectrum of scales and levels of
theoretical description have been explored in this thesis.
1.2 Thesis outline
The thesis consists of three major parts which encompass, although not
exhaustively, the extent of my work as a graduate student in the Department of Chemistry
at MIT.
In Part I we study the appearance of bimodal steady-state probability distribution
in two non-typical model networks of chemical reactions. It is customary to observe
bimodal steady-state probability distribution in the situations when underlying system has
two stable fixed points. In these settings, and in the presence of noise, transitions between
stable states occur, and complete probability distribution has two peaks (or more, in the
case of multistability). In Chapters 2 and 3 we have considered situations when the
systems in question do not have any underlying multistabilities and, thus, are not
expected to exhibit multipeaked probability distribution. We show that in the regime
where intrinsic stochasticity of chemical networks must be taken into account bimodal
distribution can emerge as a consequence of combination of stochastic fluctuations in
numbers of particles and particular network topologies.
We have studied conditions on network topologies and kinetic parameters of the
networks that enable this effect in two classes of systems. Firstly, Chapter 2 illustrates
how a strong feedback loop can lead to the appearance of bimodal distribution in
irreversible systems. Secondly, Chapter 3 reports a novel mechanism, termed network
topology reduction, that leads to appearance of bimodality in monostable reversible
systems. In fact, biologically relevant systems discussed in the literature (Miller and
Beard, 2008; Samoilov et al., 2005a) exhibit bimodality due to network topology
reduction, which was not recognized previously.
Although material of Part I was motivated by biological systems, Chapters 2 and
3 do not address directly important biological questions. They consider general properties
of networks emerging in the biological applications. Part II, however, focuses on
biological problem where underlying stochasticity plays critical role.
T-cell signaling networks are the main subject of interest in Part II. Early
signaling events that take place in the membrane proximal region during the T-cell
activation serve as unique filtering module discriminating between noise and signal. By
natural design of the human (or mouse, as these are main objects of study in clinical
immunology) body, T-cell receptors are constantly interacting with multiple non-
stimulating ligands derived from self-proteins of the organism (i.e. self-peptides
presented in context of MHC complexes). Yet T-cell receptors have to be able to deliver
activation signal in rare cases when pathogenic-derived, stimulating ligand is presented to
them. T-cell machinery can distinguish these two classes of ligands, although they are
often very similar, sometimes differing by a single aminoacid substitution.
This remarkable resolution of T-cell sensory apparatus leads to the following
general question: what are the principles guiding the topology of signaling networks in T-
cell that allow it to achieve such discriminatory capabilities? In this thesis we only
consider a very limited part of T-cell signaling pathway which, nonetheless, amounts to
approximately 1,000 reaction chemical network. (Even though the number of interacting
proteins that we consider is less than ten, see below about the combinatorial expansion.)
The general idea that we adhere to in Part II is to deduce the topology of the molecular
network based on "microscopic" information about protein-protein interactions and
"macroscopic" information about T-cell response to different perturbations.
We face two major obstacles when studying realistic problems in signal
propagation. The most commonly recognized one is combinatorial expansion of number
of reactions and reactants in the typical biological systems. Unlike ordinary chemicals,
proteins that participate in signaling network do not loose their identity as a result of
reaction. Rather, they are modified in some way; for example, phosphorylated,
dephosphorylated, ubiquitinated etc. The origin of the combinatorial expansion problem
lies in the multi-domain structure of the proteins. One recognizes that the same protein
can have multiple modification states. Thus, presense of just two phosphorylation sites
implies that there are 4 different states this protein can be at. In the very direct manner
this also affects the number of chemical reactions in the network under consideration: one
has to consider four explicit binding reaction if two reacting proteins have one
phosphorylation site each. This problem has been recognized previously and several
solutions have been proposed, most notably based on rule-based modeling or K-
calculus.(Danos and Laneve, 2004; Faeder et al., 2009).
Second major problem has to do with spatial organization of the proteins
participating in the signaling network. Although this aspect is often neglected when
considering intracellular signaling cascades that take place in cytoplasm, it is critical to
consider interplay between the interactions and spatial motion of proteins when action the
interactions take place in two-dimensions, e.g. in cell membrane. The reaction-diffusion
view is especially appropriate in the problem of T-cell membrane-proximal signaling
because timescales of chemical reactions and diffusion processes of proteins in the
membrane are very similar, as will become apparent in Chapter 5. However, by the year
2009, there was only one simulation software that allow spatially resolved simulation of
stochastic chemical networks (MesoRD) that was created by Johan Elf and collaborators
(Hattne et al., 2005).
However, there was no computational solution that would provide the capabilities
to address both of the aforementioned problems. We were able to address this question
through the collaboration with Mieszko Lis, graduate student at MIT Computer Science
Department. He created the software (Lis et al., 2009), named SSC for Stochastic
Simulation Compiler, that combined the rule-based approach to solving the problem of
combinatorial expansion of chemical network and next-subvolume algorithm (Hattne et
al., 2005) for simulating spatial motion of particles. Appendix to Chapter 4, which is due
to Mieszko Lis and is not a part of my thesis, describes the details of the SSC software
and provides the basic examples of its use. Chapters 5 and 6 make extensive use of SSC
software and, thus, I feel that inclusion of rather large Appendix to Chapter 4 is justified.
Having clarified our simulation methods in Chapter 4 we move on to consider the
question of the coreceptor involvement in T-cell early signaling in Chapter 5. We find
that observed experimental characteristics of coreceptor-MHC interactions are
inconsistent with one of the commonly accepted (even in the textbooks) mechanisms of
coreceptor-mediated signal enhancement. By carrying out explicit molecular simulations
with the help of SSC software we were able to accurately describe the origins of the
positive effect of coreceptor involvement in signal initiation.
Next chapter, Chapter 6, deals with fascinating phenomenon of synergy between
two classes of TCR ligands. It was found relatively recently (Krogsgaard et al., 2007a)
that peptides derived from self-proteins can enhance the signal that originates from
stimulation with pathogenic peptides (Fig. 1.3), even though self-peptides do not deliver
any activation signal by themselves. Although conceptual models treating involvement of
self-peptides have been already published (Li et al., 2004b; Wylie et al., 2007b), coherent
description that would employ all of the available biophysical information in a consistent
manner has been lacking. In Chapter 6 we describe three explicit molecular models that
are compatible with current biological knowledge about protein-protein interactions and
corresponding biophysical parameters. This explicit description allows us to address an
important debate about origins of difference of self-peptide involvement in CD4 and CD8
systems (Ebert et al., 2009; Lo et al., 2009; Yachi et al., 2007). All the different models
that we consider point to the importance of the positive selection threshold for
identification of range of co-enhancing self-peptides. Our conclusions are corroborated
by recently published results in CD4 systems where only positively selecting peptides
were capable of synergizing the antigen-derived signal (Ebert et al., 2009; Lo et al., 2009;
Yachi et al., 2007).
Part III of this thesis is in line with general philosophy of Part II. Here too, we
attempt to reconstruct network topology based on incomplete information about specific
interactions between the network nodes and some information about "macroscopic"
behavior of the system governed by the network in question. The matter of the Part III,
however, is one scale larger than the corresponding objects considered in Part II.
Specifically, we consider transformations of cells between different cell types and
molecular origins that underlie cell transformations (such as differentiation/de-
differentiation).
Cell differentiation is ubiquitous phenomenon when different kinds of cells are
arising upon division of the older cells. One of the classical examples of differentiation is
formation of an organism starting from a single fertilized egg. It is commonly recognized
that all cells in an organism have the same DNA (in fact, only majority of cells have the
same DNA). Yet, the cells often appear as differently as red blood cells and T-cells and
skin cells. They express different proteins and carry out different functions. This is
because of epigenetic differences; i.e., DNA in different cell types is packaged distinctly,
making it hard to express certain genes while facilitating the expression of others. This
additional above-(epi)-genetic level of regulations insures that diverse cell types can arise
based on the exact same DNA sequence. During development, upon receipt of
appropriate cues, pluripotent embryonic stem cells differentiate in to diverse cell types
that make up the organism (e.g., a human). There has long been an effort to make this
process go backward - i.e., reprogram a differentiated cell (e.g., a skin cell) to pluripotent
status. Recently, this has been achieved by transfecting certain transcription factors in to
differentiated cells (Jaenisch and Young, 2008). This method does not use embryonic
material and promises the development of patient-specific regenerative medicine, but it is
inefficient. The mechanisms that make reprogramming rare, or even possible, are poorly
understood. In Chapter 7 we report the first computational model of transcription factor-
induced reprogramming. Results obtained from the model are consistent with diverse
observations, and identify the rare pathways that allow reprogramming to occur. If
validated by further experiments, our model could be further developed to design optimal
strategies for reprogramming and shed light on basic questions in biology.
1.3 References to published work and work outside the thesis scope
The work presented in Chapter 2 has been published in Proceedings of the
National Academy of Sciences (Artyomov et al., 2007a) and was featured in Physics
Today (Fleming and Ratner, 2008). The work described in Chapter 3 is currently in press
at Journal of Chemical Physics. Collaborative work on creation of SSC software that is
described in Chapter 4 has been published in BioInformatics (Lis et al., 2009). The
materials of Chapters 5 and 6 are in the final stages of preparation for submission.
Chapter 7 is currently under review in the PLoS Computational Biology.
Although the Chapters of the thesis correspond to the most important research
projects of my PhD career, there have been many others that came along due to
discussions with experimental and theoretical scientists.
I was a part of three major experimental collaborative efforts during my PhD
career: the most current collaboration with Michel Nussenzweig lab at Rockefeller
University; collaboration with David Kranz and Jennifer Stone at UIUC; and
collaboration with Uli von Andrian lab from Harvard Medical School (HMS). In the first
(Rockefeller) project we were lucky to have contributed to understanding the
phenomenon of heteroligation of antibodies on the viral particles (one paper submitted to
Nature, and the other in final stages of preparation for submission to Journal of
Immunological Methods). As a result of this collaboration two manuscripts are now in
preparation. In the second (UIUC) project, we had a fascinating opportunity to dwell
deeper into the details and caveats of famous MHC tetramer assay. I believe that our
findings will improve the level of understanding of this widespread experimental tool.
The manuscript that reports the details of our work is currently in preparation. In the last
(HMS) project we were able to reconcile dynamics of peptides dissociation off the MHC
complexes of dendritic cells in vivo and in vitro, which appeared to be inconsistent on a
first glance. This work has been published in Nature Immunology (Henrickson et al.,
2008). In all of these collaborative projects, I want to be very clear about it, the most
difficult scientific work was done by our experimental colleagues; but I would like to
believe that we, too, contributed critical pieces of understanding.
During my MIT years I have been fortunate to continue interactions with
Professor Anatoly Kolomeisky from Rice University. Multiple discussions with him have
yielded interesting and analytically tractable questions in the theory of molecular motors.
We have addressed these questions in several publications (Artyomov, 2009; Artyomov
et al., 2008; Artyomov et al., 2007b; Morozov et al., 2007) with some containing exact
analytical results for burnt-bridge model of motor proteins (Artyomov et al., 2007b).
Please note that I use different spelling of my name in my publications. This
originates from the conflict between direct official transliteration of my family name
from Cyrillic to Latin alphabet (Maksym Artomov) versus the spelling that most
appropriately corresponds to phonetic pronunciation of my last name (Maxim N.
Artyomov).
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1.5 Figures for Chapter 1
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Fig.1.1. Schematic representation of MHC loading with foreign derived peptide. After
MHC has been loaded with peptide, it is targeted to the cell surface where it presents
peptide to the T-cell.
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Fig.1.2. Schematic representation of coreceptor (CD4 in this case) involvement into
TCR-pepMHC interactions.
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Fig.1.3. Biological manifestation of the self-peptide enhancement phenomenon. Self-
peptides (designated null-peptides on the picture) do not stimulate T-cell activation and
proliferation (yellow curve on the right panel). However, when mixed with stimulatory
peptides (designated agonist on the picture), it provokes higher degree of activation as
measured by proliferation or, for instance, cytokine production.
PART I
Chapter 2
Purely stochastic binary decisions in cell signaling
models without underlying deterministic bistabilities
2.1 Introduction
The detection of external stimuli by receptors on a cell membrane followed by
intracellular signaling, gene transcription, and effector functions is ubiquitous, and
necessary for life. The regulatory processes involved in gene transcription are often
mediated by small numbers of molecules. This makes stochastic effects important and, in
recent years, many interesting consequences of such fluctuations have been elucidated
theoretically and observed in experiments (e.g., (Acar et al., 2005; Elowitz et al., 2002;
McAdams and Arkin, 1997; Weinberger et al., 2005)). The importance of stochastic
effects on enzymatic reactions in the zero order ultrasensitivity regime has also been
described (Berg et al., 2000; Samoilov et al., 2005a). Less attention has been devoted to
the effects of stochastic fluctuations on cell signaling dynamics. Yet, many such
processes involve small numbers of molecules. One important example is provided by T
lymphocytes (T cells), the orchestrators of the adaptive immune response. T cell
signaling and activation can be stimulated by as few as 3 molecules that represent
signatures of pathogens (called agonists) (Brower et al., 1994; Davis et al., 2007; Irvine et
al., 2002; Li et al., 2004a; Purbhoo et al., 2004; Sykulev et al., 1996). The small numbers
of molecules involved can make stochastic effects important for membrane-proximal
signaling in T cells. Here, we study simple and general models inspired by recent
descriptions of membrane-proximal signaling in T cells, and find an interesting
consequence of stochastic fluctuations. An essential feature of the model, dueling
positive and negative feedback loops, is ubiquitous, and so our findings may be of broad
relevance in cell biology.
Many examples (particularly models of gene regulation) have been studied
previously wherein a deterministic treatment of the kinetic scheme describing the
relevant processes has two stable steady states in a certain parameter regime (Acar et al.,
2005; Elowitz et al., 2002; Karmakar and Bose, 2007; Kepler and Elston, 2001b;
McAdams and Arkin, 1997). In such systems, stochastic effects can lead to bimodality
(e.g., populated "on" and "off' states) in the parameter range where bistability is
predicted by the deterministic equations as well as outside this range where there is a
single stable steady state (Acar et al., 2005; Elowitz et al., 2002; Karmakar and Bose,
2007; Kepler and Elston, 2001b; McAdams and Arkin, 1997). The latter phenomenon is
a consequence of stochastic fluctuations enabling the system to sample parameters (e.g.,
rate constants) that effectively fall within the range where two deterministically stable
fixed points are present. In these examples, the existence of bistability in the
deterministic analysis in some parameter range underlies the observation of bimodal
behavior in the stochastic treatment.
The model we study exhibits a different feature. The deterministic dynamical
equations yield a single steady state in all parameter ranges; i.e., there is no bistability.
Yet, stochastic fluctuations result in a bimodal long-time response with neither mode
corresponding to the steady state obtained deterministically. Upon increasing the copy
numbers of molecules, the stochastic description ultimately converges to the
deterministic behavior. Thus, we find a purely stochastically driven instability when
none exists in the deterministic treatment in any parameter range. When fluctuations are
important, we find that average quantities scale with parameters "anomalously"
compared to the corresponding mean-field behavior. Our analyses suggest that the
necessary and sufficient conditions for this phenomenon to occur are quite common.
2.2 Signaling model
Our simple ("toy") model is inspired by ideas proposed recently to describe T cell
responses to diverse stimuli (Altan-Bonnet and Germain, 2005; Davis et al., 2007; Irvine
et al., 2002; Li et al., 2004a; Stefanova et al., 2003; Wylie et al., 2007a). T cell receptor
(TCR) molecules expressed on the surface of T cells can bind complexes of peptides (p)
bound to major histocompatibility (MHC) proteins on the surface of antigen presenting
cells (APCs). TCR can potentially bind strongly to pMHC molecules where the peptide
is derived from a pathogen's proteins (agonists). In contrast, thymic selection ensures that
TCR bind weakly to "self' or endogenous pMHC molecules that are also expressed on
APCs (Starr et al., 2003). The binding of TCRs to pMHC molecules can initiate
signaling cascades that result in T cell activation and an immune response. T cells are as
good a sensory apparatus as any in biology, and can detect as few as three agonists in a
sea of tens of thousands of endogenous pMHC molecules, and it has been suggested that
this extraordinary sensitivity is mediated by cooperative interactions between self pMHC
and agonists(Davis et al., 2007; Irvine et al., 2002; Li et al., 2004a; Purbhoo et al., 2004;
Yachi et al., 2005b).
Another interesting response of T cells to pMHC molecules is called antagonism
(Evavold et al., 1994; Stefanova et al., 2003). Antagonists are pMHC molecules obtained
by mutating agonist peptide residues. When present on APC surfaces in sufficient
numbers, they can shut down intracellular signaling stimulated in response to agonists.
Recent experimental results (Stefanova et al., 2003) have suggested that this phenomenon
may be mediated by dueling positive and negative feedback loops (Fig. 2.1). One of the
earliest steps in downstream signaling initiated by the binding of the TCR to pMHC
molecules is the phosphorylation of cytoplasmic domains of the TCR complex by a
kinase called Lck. It has been proposed that Lck also activates its own inhibitor, a
phosphatase called Shp (negative feedback). This inhibitory interaction is prevented by a
product (ERK) of signaling downstream of phosphorylation of the TCR complex that
protects Lck by phosphorylating one of its sites (positive feedback). It has been
proposed, and detailed calculations support this (Altan-Bonnet and Germain, 2005; Wylie
et al., 2007a), that the positive feedback is dominant when T cells are stimulated by
agonists (and synergistic endogenous ligands), and negative feedback shuts down
signaling when sufficient numbers of antagonists are present.
While the specific molecular identity of positive and negative regulators involved
in T cell signaling is still debated (Li et al., 2007), the idea that dueling positive and
negative feedback loops play a role in determining whether signaling is shut off
(antagonism) or sustained/amplified (agonism) is of general significance to cellular
decisions that lead to distinct outcomes. Furthermore, such processes are often mediated
by small numbers of molecules. Therefore, we set out to study the effects of stochastic
fluctuations on the following simple and general model with dueling positive and
negative feedback regulation:
Al k, > E + Al (1); A2  k2 > S+A2 (2)
E+A k3 >E+APROT (3); APROT k4 >E+APROT (4)
S +A A, *4 S +A AINACTIV (5); S kD > p, E kD 0 (6
While this model is general, seeing how it relates to T cell signaling makes clear that it is
relevant to situations where cells make distinct decisions (e.g., agonism and antagonism
in Fig. 2.1). The first reaction mimics the production of the positive regulator ERK (E)
upon agonist (A1) binding to TCR. Thus, it subsumes a large number of steps in the
actual signaling cascade into one. Of course, agonists also lead to production of the
negative regulator Shp (S), but this is ignored in this general model. Similarly, some
production of E by antagonist (A2) binding to the receptor is ignored, and reaction 2
mimics the production of the negative regulator. Reaction 3 represents positive feedback
and mimics protection of Lck from the action of Shp, in that the interaction of E with Ai
protects it (by forming A1 PROT) from the inhibitory action of S (reaction 5). Protected A
species can generate positive regulators E (reaction 4), and both positive and negative
regulators can be inactivated (reaction 6).
2.3 Results
The mean-field deterministic equations corresponding to the model described by
Eqs. 1-6 can be written down following mass action kinetics (web supplement), and yield
the following solution for the steady state:
-S)k kA(ss) = 0 A PROT (SS) A(ss) = AiPROTtSS) is-SS APROT(SS) Siss) - A 2  (7)
1,NCI D kD
At steady state, the number of A1 molecules equals zero, the number of S
molecules is a function of the number of A2 molecules, the number of E molecules
depends upon the number of protected Ai molecules, and all solutions which satisfy the
constraint that the sum of the number of APROT species and AINACT species sum to the
initial number of A I are allowed. Thus, unique steady states cannot be obtained from Eqs.
7 without knowledge of the initial conditions. Rather, there is a line of possible steady
states. Stability analysis shows that all, but one, eigenvalues of the Jacobian matrix are
negative. The only non-negative eigenvalue is zero, and corresponds to sliding along the
line of possible steady states, A[PROT (SS) + A(,)4CTIV = initiai , with corresponding change
in the steady-state value of E. Solving the dynamical equations with specific initial
conditions and taking the long-time limit obtains a unique point on this fixed line. Thus,
the deterministic solutions of the model are a set of unique steady-states for all parameter
values.
While we have studied different parameter ranges for a stochastic description of
this model (web supplement), let us first consider situations that are inspired by T cell
signaling. Reactions (1), (2), and (4) represent multi-step processes (Lin and Weiss,
2001). Reactions (3) and (5), the dueling feedback loops, are thought to represent one
step phosphorylation or deactivation steps (Stefanova et al., 2003). So, we study
situations where k3 and k5 are much larger than ki, k2 and k4; i.e., both positive and
negative feedback loops are strong. Recent studies (Li et al., 2004a; Wylie et al., 2007a)
with detailed models of membrane-proximal signaling in T cells suggests that k4 could be
larger than k1, but we have taken them to be equal (k4 > ki is considered in the web
supplement). Changing the relative values of ki and k2 would simply modify the specific
value of the ratio of initial numbers of A1 and A2 molecules that would result in a
transition from "agonism" to "antagonism".
Fig. 2.2 shows results of spatially homogeneous stochastic simulations with
discrete number of molecules (using the Gillespie algorithm (Gillespie, 1977)) of the
model represented by Eqs. 1-6. When there are only a few molecules of A1 and A2,
essentially all the stochastic trajectories commit to one of two final states: all the A1
molecules are converted to the protected species, APROT , or are annihilated and signaling
stops. This bimodality is in striking contrast to the mean-field solution that does not
exhibit bistability for any parameter values. The qualitative phenomenon of finding a
bimodal stochastic solution when the deterministic solution is unique for all parameter
values is preserved as long as the positive and negative feedback loops are sufficiently
strong (web supplement).
The mechanism underlying this result is as follows. The species A, is converted to
either AIPROT or A INACT. The effective rates of production of these species can be
obtained from the deterministic equations. Both rates equal zero initially and at long
times, and exhibit a maximum (Fig. S2.4). The initial rise and amplitudes of the maxima
depend upon the values of the initial number of A1 and A2 molecules, and are very
different if one of these quantities is much larger than the other. In these circumstances,
either agonism or antagonism dominates in the deterministic and stochastic solutions.
The more interesting cases are ones where the generation of positive and negative
regulations is roughly balanced (Fig. 2.2) as it could result in a transition from agonism to
antagonism. Now, the rates at short times and amplitudes of the maxima for the
production of A1 PROT and A1 INACT are comparable in the mean-field sense, and the
deterministic equations yield a single steady state solution with an intermediate value of
PROTAP . However, stochastically, one of two reactions (1) and (2) occurs first. There is a
stochastic delay, t, before the other reaction occurs, and for this duration, the reaction
propensities are effectively as in cases where A1>>A 2, or vice versa. For small numbers
of A1 and A2 molecules, -c can be long. If - is longer than the intrinsic time scale
associated with the feedback reaction corresponding to the reaction that occurred first
(e.g., reaction (3) if (1) occurred first), then the small number of A1 molecules will all be
converted to either A PROT or be annihilated, depending upon whether reaction (1) or (2)
occurred first. So, the stochastic trajectories partition into two classes (those that end
with all A1 molecules annihilated or protected), and the stochastic solution is bimodal.
The time delay (,r) becomes smaller as the number of molecules of AI and A2
increases. This suggests that, for a sufficiently large number of particles, it will not be
longer than the intrinsic time scale associated with the feedback loops and the stochastic
solution will not be bimodal. Rather, it will be distributed around the mean-field solution.
Fig. 2.3 shows results of simulations that demonstrate this unequivocally. Thus, for the
same parameter values, as the number of molecules decreases past a threshold, the
stochastic solution exhibits an instability from one solution to bimodality. This transition
from unimodal to bimodal solutions is driven by stochastic effects, and occurs in the
absence of any underlying deterministic bistability.
The qualitative differences between the stochastic and deterministic descriptions
due to the dominance of fluctuation effects suggests that the manner in which the
response scales with different control parameters may be different. For example, we
expect the steady state amount of APROT to scale with k2A2 for the stochastic
k2 2
simulations. This is because the probability of conversion to AROT is essentially equal to
k A
the probability that reaction (1) occurs first, which is given by .1 Conversely,k1A1 + k2 A2
k A
probability of annihilating all A1 molecules is equal to 2 2 (equal to probabilityk1A1 +k 2A2
that reaction (2) occurs first). Both expressions depend only on the combination ki A
k2A2
This implies, for example, that the amount of A PROT scales linearly with ki (a measure of
how effective the agonist is in stimulating signaling). The deterministic solution, on the
other hand, is not expected to obey this linear scaling. Indeed, numerical solutions
support these expectations (Fig. S2.3).
The complexity of the model described by Eqs. 1-6, however, makes it difficult to
explore these differences in scaling behavior precisely. The complexity also prevents us
from analyzing the necessary and sufficient conditions for purely stochastic instabilities
(results in Figs. 2.2, 2.3) in cell signaling dynamics. Therefore, we formulated a simpler
model that enabled exploration of these issues.
This minimal model, which can be solved exactly, includes the following features:
irreversibility, branching, and feedback. The model is described in terms of the three
coupled reactions shown below:
Z+Y 1 >X+Y Z+X+Y 2 2X+Y, Y k3 >0 (8)
The deterministic equations corresponding to these reactions can be written down (web
supplement) following the mass action kinetics. Let us denote the numbers of x, y and z
species at time t by Nx(t), N(t) and N(t), respectively. At t = 0, only Z and Y species are
present; i.e., Nx(O) = 0, Ny(O) = N, and NM(O) = M. As for the more complex model, the
steady state values of the numbers of each species cannot be determined by setting the
right sides of the above rate equations to zero; i.e., only a line of possible steady states
can be obtained. Linear stability analysis of the steady state solutions shows that there is a
neutral mode (with an eigenvalue 0) corresponding to sliding along the line of possible
steady states, and stable modes along the directions N, + (k2N + kj)(M-N')/k3 6N, and
dN, respectively, which span the plane of the steady states. It is easy to solve the time
dependent equations and take the t -+ oo limit to obtain the unique steady-state solution
for given initial conditions. The time-dependent solution to the deterministic equations
describing system (8) is:
Nx t (F()-1 , N, (t) = Ne-k, ', N, (t) = M-_N, (t) (9)Mk2 + kF(t)
where F(t) = exp{(M2+ k})Nl - e .j* At long times (t >>kV), the steady state particle
_ k3-
numbers are,
N,(t -* oo)= N'= k1M(exp[N(Mk2 + kj)/k 3 ]-1) (10)Mk2 + k, exp[N(Mk2 + kj)/k 3]
N, (t ->0=N,' = 0, N,(t -+0o) = Nzs = M - N,(t -> oo). (11)
Given initial conditions, these equations determine a unique steady state, a
behavior identical to that exhibited by the model described by Eqs. 1-6. Unlike the more
complex model, the deterministic scaling behavior can be determined, and is given by,
Ns (k,k 2 ,k,N,M)= Mf(Mk 2k~ , Nk k~1).
The following Master Equation describes the stochastic time evolution of the
reactions shown in (8):
P(nXnn) =[k2(nx 
-1)n,(n +1)+ k1n,(n, +1)]P(nx -1,n,,n, +1,t) (12)
+ k3(n , I)Py ,,n, + nz,t) -(k2nxnynz + kjn~nZ + kan,)P(n,,n,,nz,t)
P(n,,n,,nzt) denotes the probability of having nx,n, and nz particles at time t. The
probability distribution at t = 0 is given byP(nx,n,,nz,t = 0) ='5 on ,NnzM. Note that at
steady state (or in the limit, t -+ oo) there will be no y species present, and therefore,
P(nX,n,,nz,t -> oo) = #(nx,nz)g 0. However, any form of $(n,,nz) will make the right
hand side of Eq. 12 vanish. Therefore, as for the deterministic equations, irreversibility
makes it necessary to solve the time dependent Master equation for a particular initial
condition in order to obtain the steady state solution.
Using the method of generating functions (Gardiner, 2004), Eq. 12 can be solved
exactly (web supplement) to obtain:
P(nnnz0= p+, M Pnr NCnF (1- exp(-(Ar + k3)t exp(-ny(Ar +
(13)
F(M+ k/k 2 +1-r)F(M+ ki/k 2 -nj)
where Ar = r((M- r)k 2 + k1) and pnr =rCn (-1)nz F(M + k 1k2 +1-r)F(M+k1k 2 )TF(M+ k 1k2+ 1- nz-r)F(M+k 4k2)
{A ,} are determined from the equations:
M
I A'rPnr = 0  for n < M (14)
r= n
=1 for n=M
At long times (t -+ oo), the above probability distribution takes the form,
M
P , t - = , , krP n3 (15)P~n~n~z t ->00)= 'n +nz Mgny10 A~nzr r(M - r) k2 + rk + k3_r-n 3
Note that this solution to the Master equation indicates the appearance of a spectrum of
time scales (indexed by r and ny), which is presumably related to stochastic delays.
Eq. 15 results in a steady state probability distribution that is bimodal for small
numbers of molecules (Fig. S2.5a) when the deterministic solution does not exhibit
bistability in any parameter range. In the more complex model that we studied (Eqs. 1-
6), mean-field behavior was obtained as the numbers of A1 and A2 molecules increased
past a threshold value even though their relative numbers were kept constant. The
corresponding limit for the minimal model is k3 -+ oo,N -* , with the ratio N/k 3 (or the
dimensionless, Nki/k 3) remaining constant. This is because a large value of N
corresponds to a large amount of the source of a positive regulator (A1 in Eqs. 1-6) and a
large value of k3 corresponds to greater annihilation or a big source (A2 in Eqs. 1-6) of
negative regulation. Fig. S2.5b shows that, like the more complex model, there is a purely
stochastic transition as the stochastic solution is unimodal and distributed around the
deterministic solution above a threshold value of N and k3. So, these results establish that
the sufficient conditions for the phenomena we report are: irreversibility, branching, and
feedback loops. But, are these also necessary conditions?
The possibility of two different outcomes is obviously necessary, and branching is
ubiquitous in cell signaling processes that lead to functional decisions. We have also
found that removing irreversibility abolishes the phenomenon (data not shown).
Ultimately, all reactions are, in principle, reversible. However, in the time scales of
interest to signal propagation in cells, many steps are effectively irreversible.
Feedback regulation is also necessary as the bimodal stochastic solution does not
exist if k2 in the minimal model tends to zero (Fig. S2.9). Insight into the kind of
feedback regulation that is necessary can be obtained by contrasting our studies of
dueling feedback loops in cell signaling to a model for binary drift in population genetics
(Gillespie, 2004; Rice, 2004). Consider a population of heterozygote individuals with two
forms, B1 and B2, for a particular allele. In the absence of mutations, the number of each
type of allele can change from generation to generation, even in a population of fixed
size, due to mating. The effects of binary selection on the numbers of B1 and B2 forms
can be roughly represented as follows (Gillespie, 2004; Rice, 2004):
BI + B2 k >, B, + B1, B, + B2 k' > B2 + B2 (16)
with k and k' related to the relative fitness of each phenotype.
The model described by Eq. 16 also contains branching and irreversibility. There
is also an effective feedback, but unlike Eqs. 1-6 or Eq. 8, there is no separate intrinsic
time scale associated with the feedback loops. A special case of this model (with no
selection), k = k', shares some features with the systems we are considering. The
deterministic changes in this limit are trivially zero, and any initial condition (along the
fixed line of B1+B2 = population size) remains fixed. These deterministic steady states
are unique, but the stochastic solutions yield a bimodal distribution. This is because the
stochastic trajectories are divided into two classes: ones which terminate when the
number of B1 particles vanishes and those which terminate when the number of B2
reaches zero.
There is an important difference, however, between the model for binary drift
with k = k' and the class of cell signaling models we have been considering. The
stochastic solution of the model represented by Eq. 16 does not converge to the
deterministic solution when the number of particles becomes large. The stochastic
solution at t -> oo is always bimodal! The stochastic trajectories cease to evolve when
either B1 or B2 become zero because only then is the effective rate of conversion between
these species equal to zero. The deterministic rates of formation of B1 and B2 equal the
same constant for all times. Increasing the numbers of molecules does not eliminate this
difference between the deterministic and stochastic cases. As the number of particles
increases, the stochastically determined time (t') required for B1 or B2 to equal zero
increases, but ultimately it always happens. There is no separate intrinsic time scale that
can compete with increasing values of t' as the number of particles increases and prevent
this from happening (i.e., a bimodal solution). Recall that, for the signaling models that
we focused on, the relative values of the stochastic delay, t, and the separate time scale
associated with feedback loops determined the stochastically driven transition when the
number of molecules was lowered (Figs. 2.3 and S2.5b). The absence of such an
interplay prevents a purely stochastic instability in the binary drift model as the number
of particles decreases. Correspondingly, if the rate coefficients in the model represented
by Eq. 16 were time dependent with an intrinsic time scale, the phenomenon of a purely
stochastic instability would be recovered.
The analyses presented above suggest that the necessary and sufficient conditions
for a purely stochastic bimodality in the absence of any deterministic bistabilities are: 1]
irreversibility 2] branching and 3] feedback regulation with an associated distinct and fast
time scale.
The analytical solution for the probability distribution (Eq. 15) obtained for the
minimal model of cell signaling that satisfies these conditions enables us to calculate
average properties, such as the average number of molecules of the product, <x>. This
allows us to examine whether <x> scales with parameter values in the same way as Nx
determined from the mean-field equations (see above). The average value, <x>, is:
(x) = I arpnr(M kj (17)
n=Or=n M r)k2 + k)+3
So, in general, there is no simple scaling law, such as Nx scaling with Nki/k3 , as in the
deterministic limit. Does this "anomalous" scaling, originating from the importance of
stochastic fluctuations, revert to mean-field scaling behavior in the limit corresponding to
a large numbers of particles?
In order to answer this question, as shown above, we need to consider the value of
<x> in the limit of large values of N, M, and k3. Consider first the limit of large values of
N and k3 for a fixed value of Nki/k 3. Simple algebra yields the value of <x> in this limit
to be:
M M
LtN- (x)= arnr(M- n)ep(-r((M- r)k2 /k +1)Nk /k 3). (18)
k3 __>00n=0Or=n
k3 IN fixed
So, the deterministic scaling with Nki/k 3 (Eq. 10) is recovered in the appropriate limit.
Similarly, mean-field scaling is recovered in the limit of large values of N and M (web
supplement).
The general solution (Eq. 18) for <x> does not allow us to explicate the non-
mean-field scaling when fluctuations are important. This can be obtained analytically
only in special limits. For example, consider the limit of infinitely strong feedback
(k 2 -> oo). In this limit, (x) takes the following form (web supplement):
i / N
(x)= M(1 k 3  = M(1 - e-Nln(1+M kI k3 (19)
MAk + kd
Fig. 2.4 shows that (x) obtained from numerical solutions of the Master equation (Eq. 8)
for different values of N and k3 collapse to one master curve when scaled according to
Eq. 19, a scaling that is distinctly different from the mean-field scaling with Nki/k3. We
have not been able to determine whether these specific differences in scaling laws
between the deterministic and biologically relevant stochastic solutions are universal to
all models which satisfy the necessary and sufficient conditions (identified earlier) for a
purely stochastic instability.
2.4 Discussion
Dueling positive and negative feedback loops are ubiquitous in biology. In many
instances, these processes involve small numbers of the pertinent molecules, and hence
stochastic fluctuations can be important. We report a striking result for such systems.
The models we have studied correspond to unique deterministic steady states for all
parameter values, and do not exhibit bistability. Yet, when there are a small number of
molecules, stochastic effects result in a bimodal solution with neither solution
corresponding to the mean-field result. Our analyses suggest that the necessary and
sufficient conditions for this phenomenon are irreversibility, branching, and the existence
of an intrinsic and relatively fast time scale associated with feedback regulation. Our
studies show that for specific examples of such systems, near the transition from one
phenotype to another (e.g., agonism to antagonism), mean-field scaling does not apply to
the stochastic solutions. Whether or not the specific differences in scaling between
mean-field and stochastic solutions that we report are universal for the class of models
which exhibit the phenomenon revealed by our studies remains an open question.
There is a key difference between models of gene regulation and cell signaling
where bimodality has been observed in stochastic limits under conditions where the
deterministic equations yield monostable solutions and our results. In the former
examples (double negative feedback, dimer mediated gene regulation, etc. e.g. (Allen et
al., 2006; Bhalla et al., 2002; Lai et al., 2004; McAdams and Arkin, 1997; Ozbudak et al.,
2004; Sasai and Wolynes, 2003; Xiong and Ferrell, 2003)), bistable deterministic
solutions exist in some other parameter regime. Stochastic bimodality displayed by
binary drift models in population genetics are also different from the phenomena we
report in that the stochastic solutions are always bimodal, regardless of the number of
particles; i.e., there is no stochastically driven transition from a single solution to bistable
solutions.
The necessary and sufficient conditions for the phenomenon that we report
(branching, irreversibility, and feedback loops with distinct time scales) are quite
common in cell biology. Our results suggest that these features, when combined with
stochastic fluctuations, can enable cells to make binary decisions while this would not be
possible in a deterministic world. For instance, if gene transcription and effector function
required greater than a threshold value of a downstream signaling product, in a mean-
field world, cells would be unable to make decisions with a distinct functional outcome
(Fig. 2.5). Under the same conditions, stochastic effects would result in cells being either
"on") or "off' (Fig. 2.5), as observed in experimental studies in diverse contexts.
For example, a recent study of HIV latency by Weinberger et al (Weinberger et
al., 2005) showed a 'temporary' bimodal cell population in a time window when there is
no instability in the set of rate equations used to describe the signaling events. The main
difference between this study and the results we have discussed is that in (Weinberger et
al., 2005) the observed bimodality disappears at long times. Another example is provided
by T cell signaling. It has been proposed that dueling feedback regulation could underlie
how antagonists shut off signaling in T cells. Experiments show a bimodal response for a
downstream signaling product (Erk), with the proportion of "off' cells increasing as the
number of antagonists becomes larger (Altan-Bonnet and Germain, 2005; Stefanova et
al., 2003). Stochastic simulations of a model of the T cell signaling network are in
accord with these experimental observations (web supplement); i.e., bimodal
distributions are the norm because of fluctuations, while the deterministic equations do
not exhibit bistability in any parameter regime. We emphasize, however, that a bimodal
or "digital" ERK response in T cells could also result from important contributions from
other molecular mechanisms (Roose et al., 2007).
We hope that the possibility of purely stochastic instabilities which lead to distinct
cellular decisions will be broadly explored in the context of cell signaling processes by
carrying out single cell assays for systems where the necessary and sufficient conditions
we have described are naturally present or are engineered.
2.5 Appendix to Chapter 2
1. Deterministic Equations for model described in section 2
dA1  -A -AL A = -k3A,E -k AS
dt
dAPROT1 = k3 A1 E
dt
dEk A +k APROT 
~D E
dt 11 41
dS
-=k 2A2 -kDSdt
2. Exploring different ranges of parameters for model described in section 2
Our computational studies show that any combination of parameters that
preserves strong feedbacks leads to a stochastic bimodal response. In addition to the case
discussed in the text, bimodal behavior is observed when k4, k 5>> ki, k2, k3. Biologically,
this can correspond to a situation where upon action of the positive regulator E, A] gets
further activated or it could result from cooperativity (Li et al., 2004a) with other
molecules, resulting in faster rate of production of the positive regulator. Figures S2.1
and S2.2 are drawn in complete analogy to Fig. 2.2 and 2.3 of the main text of the
Chapter and show stochastic bistability. This "all-or-none" behavior is explained by
exactly the same arguments as those described in the text.
3. Stochastic and mean-field scaling in the model described in section 2
To illustrate the differences in scaling behavior between the stochastic and
deterministic descriptions of the system, we calculated the amount of protected Al as a
function of the rate constant k for fixed values of k2 and the amount of Al. This could be
considered to be analogous to computing the cellular response as the nature of agonist is
changed. In Fig. S2.3, stochastic and deterministic dose response curves for the system
with 10 initial Ai molecules are plotted. The stochastic behavior (Fig. S2.3a) is
manifested in linear scaling of the amount of AfPROT with k, (agonist quality): all curves
coincide when the amount of A PROT in the steady state is plotted against 2 , which
k A
represents the scaling variable I1 (see main text) with k2 and A1 fixed. As can be seenk2 A2
in Fig. S2.3b, the deterministic solution does not obey this linear scaling. Moreover, the
value of k4 naturally affects the deterministic steady state value of A['ROT, while it does
not have any influence in the stochastic c4se, since feedback regulation occurs before
reaction 4.
4. Rates of protection and inactivation as functions of time
On fig. S2.4, the time dependence of the rate of production of APROT (red curve)
and of A] INACT (blue curve) are shown for excess of antagonist (S2.4a) and equal amounts
of agonist and antagonist (S2.4b). The parameters of the model are the same as those
used in th Figs 2 and 3 in the main text: k=1, k2 =1, k3 =100, k4 =1, k5 =100, kD =1
5. Mathematical Details of Solutions to the simpler model (eq 12 of the main text of
this chapter).
This section is due to Jayajit Das
5a. Solution of the Meanfield Rate Equations
Here we describe the details of the calculations for the meanfield rate equations shown in
Eqs. 13-15 in the main text.
The mean field equations are,
dN~
= k2NNN,+ kNN, (A1)
dt
d =-k2NNN, - kNN, (A2)
dN
t=-kN, (A3)dt
and the initial conditions are, N(O) = 0,N,(O) = N and N,(O) = M. Since the total
number of x and z species are conserved at all times, we need to solve only two
equations,
dN~ dN
= k2NN,(M-N,)+k,(M-N,)N, and, y=-kN,.dt dt
The equation for Ny can be readily solved to get N,(t) = Ne-k3'. Substituting this form of
Ny(t) in the equation for Nx we get,
dN- = (k 2 N, + kj)(M - N, )Ne-3''
dt
dN' 
= N-k3tdt
(k2N + k)(M - N +)
1 k 2dNx dN = Ne-k'
Mk2 + k, (k2N,+k) (M-Nx)]
k]M(F(t) -1)
Mk2 +k1F(t)
where, F(t) = exp (Mk2 + ki)-N (1 -ek3tl[ k3 j
Therefore, the solutions to Eq. (Al -A3) are,
Nx(t)= k M(F(t) -1) (A4)Mk2 + kF(t)
N,(t) = Ne-ks' (A5)
N,(t) = M - N,(t) (A6)
Fig. S2.6 shows the variation of the steady state value of Nx with k3 for various initial
numbers of the y species. The number of x species produced at the steady state decreases
exponentially as k3 > N(Mk 2 + kj).
5b. Large particle number limit (M -> oo and N -> oo) from the mean-field solution
F M (eNk (Mk2 /k, +1)k 1) A ( - eNNk1 (Mk2  ki +1)kcAsFrom Eq. A4, N (t) = k±Nc(/2/±)c'-1±(k k~Nc(/2/l1)/ . As,
Mk2 Ik,+e Nk, (Mk2 / k, +1)k3'- ( k2 1 -Nki (Mk2/kj +1 )k3~
M -> oo and N -> oo, Nkj(Mk 2 /k +1)/k 3 >>1, therefore,
Lt Nx (t) = M(1 - O(e-Nk, (Mk 2 /k, +1)kil)) (A7)N -)o
In the next section, we will show how the average particle number of species x,
calculated from the stochastic solution of the Master Equation corresponds to Eq. A7 in
large particle number limit.
5c. Exact Solution of the Master Equation
We describe the details of calculations for the solution of the Master Equation in Eq. 19.
The Master Equation is given by,
o'P(n,,n,,nz, t) =[k 2 (nx -1)n,(nz + 1)+ kln,(nz +1)]P(nx 
-1,n,,nz +1,t)+ k3(ny + l)P(nM,n, + I,nz,t)
(k2nxnyn,+ klnyn, + kan~y n,n,,nz,)
(B 1)
M N M
We define a generating function, G(s,,s 2,s3 ,t) = I s s2 sYP(n,,n,,n)
n,= On, Onz 0
(Gardiner, 2004). The time evolution of the generating function determined by the above
Master Equation is given by,
__ = k2siS2(si -Ss, aG+ ks(s, S3) ,2 ,G-k3(S2 -1)s2G (B2)
At t = 0, G(s,s 2 ,s3,t =0)= sNsM , in addition to that, it should satisfy G(,1,1,t) = 1 at all
times, which is a condition for the conservation of the sum of the probabilities for all
possible particle configurations.
If we look for a solution in terms of the reduced variables, si, s2 and =(sI -s 3 )/s1 then
G(s,,s 2, ,t) satisfies the following equation:
= -k 2ss 2  - k2 --1)s 2 s G + (k2 - kl)s 2%92 i3 G - k (s2 -1)s2.G (B3)
We define, G(s1,s 2,, t) = s"'G'(s2 ,0,t),
= -- k2 s2 g(1 - )5 G' - (k2a, - k2 + k)s 2 5 16s2G' - k3(s2 -1)JsG' (B4)
If, G'(s2 , , t)= eEt (s2,), then,
E,= -k 2s2 (1- l #-(k 2a1 - k2 +k)s 2  d 0 - k3(s2 -l)ds2# (B5)
Introducing a separation of variables, #(s2,) = S(s2)E( ), Eq. B5 becomes,
k2 (1- ) d2E dS (k2a, -k 2 + k,) dE dS k3 (s2 -1) dS E,+ + + =m0 (B6)SE d2 ds2  SE d ds2  s2S ds2 s2
The above equation will be satisfied if,
k2 (1- ) d2E dS 4(k 2a, -k2 + k) dE dS = f(s 2) (B7)
SE d 2 ds2  SE dg ds2  f
and,
k3(s2 -1) dS E
s2  ~2+ ' Af(s2). (B8)s2S ds2 s2
However, from Eq. (B7) we get,
1 dS
S ds2  (B9)
Therefore, in order to make Eq. B8 consistent with Eq. B9 we have to choose the
following form forf(s2 ): f(s 2) =- Em(k3 +An )s2 -1k3
Using the above form we get the solution for S(s2) as,
kdk k3 +^,,S(s2)= S2- d
3 +n
E( ) satisfies the equation below,
k2 2(- E) + g(k2 a, - k2 + k1) ~- AE 0, By changing 4 to r7=1- = s3 sI, we get,
kl-))d772-y -) dq n (B 10)
where, A= k2ca1 - k2 + kj
This equation has the form of the ODE which yields hypergeometric functions (Bateman
Manuscript Project. et al., 1953) as its solutions. The following ODE has hypergeometric
functions as its solutions.
d2u du
z(l-z) 2 +(c -(a+ b+1)z) d- abu=0 (B11)
dz2 dz
The hypergeometric function is defined as,
2F (a,b,c;z)= (a)n(b)n zn (B12)
nO (c)
where, (a)n = F(a .n) The series in Eq. B12 is convergent for a positive c and Iz<1. If
1(a)
a is a negative integer, i.e., a = -n, the series terminates after z". Comparing Eq. B 10, to
Eq. B11 we get, if, c -+-a,+l- -, and a=-n, then b=-a+n--k . In that
k2 k2 k2
case, An = n(-a + n)k 2-
k2
Therefore, the general solution to Eq. B2 is,
E 
MG(s2,s 0 
- k3 '", k3e_ Et a,b,c; . (B13)
m= I=0 n=0 3)1
The constants are chosen in such a way that the solution satisfies the initial condition and
also the sum of the probabilities is conserved at all times.
At t = 0, Eq.B13 takes the form,
00 00 00Em
G(s,s 2 ,s,t=0)= a'A,si"' 2 - kF (B 14)
m=01=0 n=O n Sl
NFk 3_ ( kYF Nk ( _ _Now, s2N k3 L3 k1N2 3 N k] ( k3 -m2 3 i , therefore,
A2 +k ,+k ,o + kS2 An + kN
if we choose,
kN-m
Em = -m(k 3 + An) and iZlmn=Nc Al J n for m : N
=0 form>N
Then Eq. B 14 satisfies the initial condition for S2. If we choose,
am = M and Aln = (5mAn then Eq.B14 assumes the form below,
=0)= s2N MIn 2F a,b,c;s_3
n= 0 
S1/
o nr
=sN ILn p rn (L
n = 0 
r 0 
S 1 )
M M n
=s2 M ,PnrH
n=O r=n 1
M ~n
n=0 
( 1I
where, P,.n = (an)r(bn )r(cn )rr!
cn =-M+1 1 If " 0k2kc2  =1
G(s,s 2,s ,t =)= s2N M
M
q= I 2 rPnr and
for n < M
for n = M
an =-n, bn=-M + n I
k2
and
then, Eq.B 14 satisfies the initial condition,
Therefore, the time dependent generating function is given by,
M M
G(s,,s 2,s3, t)= =n S2, 3
n= 0 rn
+ N
+ (s2- k3 -(3 +A,>'t and
M
I Zrpn,= 0 for n<M
r- n
AMpMm =1 forn=M
It is straightforward to show, G(s, =i,s 2 =1,s3 =1,t)=1 for
coefficients. The proof follows below. From Eq. B 15,
(B 16)
the above choices of the
M M M M
G(s, =1,s 2 =1,s 3 =1,)0 = I Arpnrf(r,s2 -1, t) = Anprf(ln,S2 =1, -
n= 0 r= n n=0 r=0
.G(1,1,1, t)=1, if, Ip,.n =0 for n > 0 and AO =1. This is because, f(0,1,t) =1 and p0 0 =1.
r=0
n
Proof: ILPrn = 0, when, n >0.
r=0
G(s1,s2,s3,t
where, f(s2,r, t) Ar+k 3
(B15)
In
F(M+ k /k 2 +1-n) "nCr(_1)r F(M+ kj/k 2 -r)
F(M+k,1 k2 ) Lr=0 F(M+ kI k2 +1-n-r)_
F(M+ k 1k2 ±1-n)Kn n-1
F(M+ k/k 2  ) Cr(1)' SP (a- r)l where,a=M+ k/k 2 -12) _r= p=O
J(M + k 1k2 + 1-n) S1P ( C a -q r "C,.( -)
F(M+k k2 ) _- I nnr-0)r1J1
In the above, expressions, S,'") denotes the Stirling number of the first kind (Gradshtein et
al., 2000).
n
" 0C,(-1)r =
r= 0
However, therefore,
=0, hence,. For, 0 5 q s n -1,
n
Prn =0.
r=O
Proof: AO =1
Using, Eq. B 16,
M M M n M n
I I A.pnr = 1, :>1A2nPn = 1, ->20pOO + Z1 AnPrn = 1.
n=0 r=n n=Or=0
n
Since, 1pr =0 forn>0 and poo =1; AO =1.
r=O
Therefore, G(1,1,1, t) =1. QED.
n=1 r=O
Expanding the polynomials one can easily get the probability distribution
M~-n,
P(nn,nynzt) = 8n MI AXrp NMn ,- - exp(-(Ar ex
n,+Ir-n, z r nYLAr~k (1k3t
x=1
(-fy(Ar +
(B17)
where, Ar = r((M- r)k 2 + kI) andpn rCnz (-1)n F(M+ k 1k2 I1- r)F(M± k 1k2 - nz)F(M+ k /k 2 +1-n --r)(M+ k 1 k2)
{A ,.} are determined from the equations,
M
I ArPnr = 0 for n < M
=1 for n=M
At large times, t->oo,
~N
fAs2,r,t)= k3,
A,.+k3_
Ar = r((M- r)k2 + k) >0 for r M. Therefore, the generating function at the steady
state has the following form,
M M n N
G(s , t = kSM 3 s3"
n=0 r=n 3 r)
(B18)
n
IPn
r-0o
because,
(1- x)"n = n r "C(-1)'r rx',
x q 1-x"
Hence, the probability distribution function at t -> oo is given by,
P(n,,n,, n, t -> co)= , n,,o a rpnrM k3 . (B19)X5 Y5(5n,+n,,M g t- A,_ (r(M - r) k2 + rk)+ k3-
For fixed ki, k2, and kd , the factor u(r)= kd 1 is peaked at r = 0 and r
(r(M- r)k + rk2)+ kd
= M which corresponds to the cases at n, = M and n, =0 respectively. The values of the
1N
peaks are u(r = 0) =1 and u(r = M)= .Therefore, the peak at r = M, will
(Mk /k3 + 1
have significant contribution when, k3 >> Mk, i.e., the y particles decay at a much faster
rate than it generates particles of the x species. Furthermore, if the initial number of the y
particles increases, the value of the peak at r = M goes down. Therefore, we can expect to
see a bimodal behavior in the distribution function for k3 >> Mk, and small N. Fig. S2.7
displays the above characteristics in the distribution function.
5d Calculation of the average particle number
The average particle number of any species can be easily calculated from the generating
function, G(s,s 2 ,s3 , t). For example, the average number of x species is given by,
M M
(x(t)) = i, G(s,s 2,s 3 ,t) ,=i =1 = Z12rpnrf(r,s2 = 1, t)(M- n) (B20)
n=Or=n
At, t -+ oo, the above average takes the following form,
(x(t ->00))= r( (,.pn k3 (M- n) (B21)
=o I rnr r((M- r)k2 + k)+ k3
5e. Limit of large N and large k1/k3, keeping the ratio Nki/k3 fixed:
Let us, write,
NN
k3
r((M-r)k2 + k)+ k3 J 4 aIN+ JN, where, a = r((M- r)k2 /k, + 1)Nk 1 /k3 .
Therefore, in the limit, N - oo and Nk/k3 = const,
N 1/y
LtN--o I = Lt,,o = g(a/N +1 1 ay+1)
when y =1/N.
Now, ln(g)= -l/y ln(ay +1) -*-a+ O(y) as y --+0.
.- LtN 4  j= exp(-a)
Thus,
M M
LtN- (x) = arpnr(M - n)exp(-r((M - r)k 2 1k + )Nk /k 3). (B22)
k3 -Nfxe n=O r=nk3 /Nfixed
5f Large M limit:
Rewriting, Eq. B22 as,
M n
LtN (x) an pn(M - r) exp(-n((M - n)k 2/k +1)Nk /k 3 )
k3 
__W n=0 r=0
k3 IN fixed (1323)
M n
= M- Za exp(-n((M- n)k 2 /k + 1)Nk /k 3 ) rpm
n=1 r= 0
In the limit, M -+ oo, each term in the sums of Eq. B23 decay exponentially with M, thus,
we can write, LtN-+w (x) = M(l O(e-Nk /k3 (Mk2 /kl+1))).
k3 IN fixedM -+a>
This form is consistent with the large particle limit of the solutions of the meanfield rate
equations in Eq. A7.
5g. Strong feedback limit (k 2 -> oo and k 1/k2 = ' -+0)
In this limit, k2 -+ o and ki /k2 =e-*0.
Particle distribution function
The probability of having no x species in the steady state is given by,
P(n =0,n, =0,nZ = M)=AMPMM 3 _ j ( 3 , because, AmpAf = 1 fromMkj + k) Mkj + k3)
Eq.B 16. Note, the distribution does not depend on k2 and this form of the distribution
function holds good for any value of k2.
Now, in the limit, k /k2 =, s- 0,
PMM=M CM ( 1)" =F(l)F(C) -1, using (Abramowitz and Stegun, 1972),F(-M+1 + c)F(M)
F(-n + s)= - y as c -+0. (B22)
n! X C J
where, y ~ 0.5772 is the Euler Mascheroni constant.
We need to evaluate, other p, for r = n .... M (0 n M) and j..... Am in order to
compute the probability distribution function for all particle numbers. Now,
pnr =Cn()n F(M+ s+1- r)F(M+ - n) -+ 0 for n+r > M+1 andnwr. ForF(M+ +- n - r)F(M+,)
n+r >M+l andn=r; pn, =-1. Therefore, Ar=O forM/2 ! r<M which can be
easily shown from Eq. B16. For, n+r<M+1pnr>rCn( 1)"lF(M+I-r)F(M-n)F(M+1-n -r)F(M)'
however, from Eq. B16 it can be shown that, A = 0 for 0 <r < M/2 and AO = 1.
Therefore, the probability distribution is,N / N
P(nn, =0,n,)= k3 g n,n + 1 _ k3 (5n X 4,O (B23)X5 Y(AMk, + k3) Mkj + k3-
Note, that the distribution is strictly bimodlal with peaks at n, =0 and n, = M. The
magnitudes of the peaks depend on Mki, N and k3. The probability of having no particles
of x species is easy to guess from following observation: Starting with N particles of y
species at t 0, the probability of having N successive y annihilation events is
k , which is also the probability of having no particles of x species in the
Mkj /k3 +1
steady state. Now intuitively on can think that when a single reaction for the creation of
the x species occurs, the strong positive feedback will convert all the z species into the x
species. Fig. S2.8 shows the comparison of Eq. B23 with the Gillespie simulation with a
very large positive feedback.
5h. Calculation of the average particle number
Using the same properties of the coefficients, {Ar} and {Pnr} it can be shown that,
(x(t -> oo)) = AOM+ AM 3  = M 1- k3 (B24)
k 3 + Mkik3+ M
5i. No Feedback Limit (k2 -> 0)
The limit, k2 - 0, is tricky to take directly from Eq. 20 because k2 multiplies the highest
derivative in Eq. B3, therefore, analyzing the limit k2 -+0 becomes a case of singular
perturbation theory. A simpler approach would be to analyze the case with k2 = 0 from
the Master Equation and solve it directly. In that case, the Master Equation will be given
by,
P(nxnYnZt) = kIn,(nz +1)P(nx 
-1,nyn. + 1,t)+ k3(ny +1)P(n,n, +1,nZ, t) B25)
-(k,nn+ k3n)P(nx,n,nz')
The equation followed by the generating function,
M N M
G(s1,s2,s3 ,t)= I sxs"-s"P(n,,n,,nz,t) is,
n,=On= Onz=O
= ks 2(s1 -s 3 )d d G-k 3(s2 -1)i 2G (B26)
This equation can be solved in a similar way by changing to variables,
s1, s2 and = (s, - s3)/s, and performing separation of variable on the ensuing equation.
The general solution of Eq. B26 is
t)= sCnNN rn 3r 2 M 3 m( 3e p -,N sll nj NnJ exp(-m(k3  nk)t)
(B27)
In the steady state (t -> oo), the probability distribution can be easily obtained from Eq.
B27, which is given by,
M N
x t ->y0) (n,+, nv,0 M r r nz _,r+nz k3 .(B28)P ~ n x n y l n + M(5 1 r k I + k y
This form always gives a unimodal distribution (Fig. S2.9, also see Fig. S2.8(b)).
Therefore, the nonlinear feedback is essential in order to realize a bimodal distribution.
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2.7 Figures for Chapter 2
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Figure 2.1 A schematic representation of dueling positive and negative feedback loops
stimulated upon receptor binding to stimulatory or inhibitory ligands. The negative
regulator can shut off signaling by inactivating the receptor-associated signaling complex
(negative feedback), while the positive regulator could prevent this inhibitory interaction
and increase or continue production of downstream signaling products (positive
feedback).
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Figure 2.2 Bimodal stochastic solutions distinct from the unique deterministic solution.
Histogram showing the bimodal distribution of the protected agonists at steady state (red)
for a situation when there are 10 agonist (Al) and 10 antagonists (A2). The
corresponding single steady state solution of the deterministic ODEs (blue) is also shown.
The other parameter values are: kl =1, k2 =1, k3 =100, k4 =1, k5 =100, kD =1 (all s-1),
and statistics were collected over 5000 trajectories obtained using the Gillespie algorithm.
The result is robust to variations in the parameter values as long as there is strong
feedback.
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Figure 2.3 A purely stochastically driven transition. Histograms showing the
distribution of the protected agonists at steady state (red) and corresponding steady state
solution of deterministic ODEs (blue) for different amounts of agonist and antagonist.
All other parameters are identical to that in Fig. 2.
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Figure 2.4 Results from the Minimal Model. Non meanfield scaling in the limit of large
positive feedback (k2 + o'):The average values of X species, <x>, at steady state
obtained from Gillespie simulations scale with(/log(1 + M/q /k3))/N instead of the mean
field scaling variable Nk/k3. The values of the parameter k2 is 100 s-1 (i.e. a large
value). kl=0.0012 s-1 and M=20 are held fixed as k3 and N are varied. The solid line is a
plot of the scaling function shown in Eq. 19.
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Figure 2.5 Stochastic fluctuations can enable cellular decisions. Schematic
representation showing that irreversibility, branching, and dueling feedback loops
associated with intrinsic time scales, when combined with stochastic effects, can result in
distinct functional decisions for each cell. A deterministic treatment would mask this
ability of cells to make decisions.
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Fig. S2.1: Bimodal stochastic solutions distinct from the monostable deterministic
solution. Histogram showing the bimodal distribution of the protected agonists at steady
state (red) for a situation when there are 10 agonist (A1) and 10 antagonists (A2). The
corresponding single steady state solution of the deterministic ODEs (blue) is also shown.
The other parameter values are: kz =3, k2 =0.7, k3=1, k4 =1000, k5 =50, kD=l, and statistics
were collected over 5000 trajectories obtained using the Gillespie algorithm. The
robustness of this result to variations in the parameter values is discussed in the main text
and section 1 of the web supplement.
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2.2: A purely stochastic instability.
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Histograms showing the distribution of the
protected agonists at steady state (red) and corresponding steady state solution of
deterministic ODEs (blue) for different amounts of A1 and A2 molecules. All other
parameters are identical to that in Fig. Si.
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Fig. S2.3: The variation of the average number of AROT species as a function of the
number of A2 molecules and the parameter k, (which could be considered to reflect the
quality of the agonist).
a) Results of the stochastic simulations collapse to one master curve when
scaled with A2
k,
b) The deterministic results do not follow this scaling. All results are for
cases where k3, k5 >> ki, k2, k4.
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Fig. S2.4: Time dependence of the deterministic rate of production of protected species
(red) and inactivated species (blue) as a function of time.
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b) For 10 molecules A, and 10 molecules A2
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Fig. S2.5: Results from the Minimal Model. (a) Exact solution of the Master Equation:
The exact solution (Eq. 20) shows a bimodal distribution for low values of initial
numbers of Y (N=2) and Z (M=20) species. The reaction rates are taken to be, ki=0.0012
s-1 , k2 = 0.0010 s , and k3 =0.0125 s~1 (b) Minimal model captures the essential
characteristics of the larger model: Distribution of the number of X species at steady
state is calculated from Gillespie simulations as both N (related to agonist number) and k3
(related to antagonist number) are increased keeping the ratio N/k3 fixed. All the other
parameters, as well as the ratio, N/k3, are the same as in (a). The distribution is markedly
bimodal for a low value (shown in red) of N = 2. The distribution becomes unimodal
(shown in blue), peaked at the mean field value (shown with the black bar) as both N and
k3 are increased 1000 fold keeping all other parameters unchanged. We use Gillespie
simulations instead of the exact solution (Eq. 20) for the above cases because numerical
evaluation of the Gamma functions for large arguments (required to evaluate Eq. 20) is
computationally more expensive than carrying out Gillespie simulations. The Gillespie
simulations agree with the exact solution.
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Fig. S2.6: The steady values of the number (N. ) of the x species as the decay rate of
the y species (k3) is varied. Three cases, corresponding to different values of the initial
numbers (N) of species Z are shown.
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Fig. S2.7 The distribution of the number of x particles at the steady state. Results
obtained from the analytic solutions (given by Eq. 20) are compared with the results
from Gillespie simulations. All the cases have a fixed k2=0.001 s-, and are started with
the same number (M = 20) of particles for the Z species. (a) A bimodal distribution is
obtained for ki=0.0005 s-, k3=0.06 s-1 and N= 15, where N is the number of Y species at
t=0. (b) The bimodal distribution in (a) turns in a unimodal distribution as k3 is inceased
to 0.5 keeping other parameters fixed. (c) The distribution becomes unimodal when ki is
increased to 0.005 s-1. (d) The bimodal distribution in (a) becomes sharper as N is
reduced to 5 with other parameters held fixed.
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Fig S2.8 The particle number distribution function for the x species at the steady state for
(a) a very strong positive feedback, k2 = 2s-1 and (b) for a very weak positive feedback
k2=10- s '. The values of the other parameters are,
k =0.0005s-',k 3 =0.2§-1,M=20 andN=15, where, M and N are the numbers of
particles at t=0 for the Z and Y species respectively. The solid line and the red points are
obtained from the analytical solution and the Gillespie simulation respectively.
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Fig. S2.9 Particle distribution functions for the X species do not show any bimodality
when there is no positive feedback, i.e., k2=0. The plots show cases for (a) M=25, N=5,
ki=0.005s~1 and k3=0.1 s-1, (b) M=25, N=100, ki=0.005s~1 and k3=0.8 s~1. The Gillespie
solution is compared with the exact solution in Eq. B28.
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Chapter 3
Stochastic bimodalities in deterministically mono-
stable reversible chemical networks due to network
topology reduction
3.1 Introduction
Diverse cellular functions are mediated by signal transduction and subsequent
gene transcription events. The dynamical behavior of chemical reaction networks control
and regulate these processes. The dynamics of spatially-homogeneous chemical
reactions are often described by deterministic ordinary differential equations in terms of
classical chemical kinetics (CCK) (Goldbeter and Koshland, 1981; Gomez-Uribe et al.,
2007; Lai et al., 2004; Markevich et al., 2004). The mean-field character of such a
treatment is exemplified by considering the following deterministic ordinary differential
equation describing the dynamics of second order reactions such as A + B * AB.
Sd(A = kA -B) ~ k(A)(B) (1)
where k is the rate coefficient. In writing Eq. 1, the number of molecules of each species
is described by an average concentration (<A> or <B>) and the average of the product of
the number of A and B molecules is replaced by the product of the average
concentrations. In other words, stochastic and discrete features of the underlying
molecular number levels, including fluctuations and associated correlations are ignored.
Cell signaling and gene transcription often involve small copy numbers of the
pertinent molecules. Therefore, many important examples of stochastic fluctuations in
determining cellular response have been reported (Artyomov et al., 2007a; Berg et al.,
2000; Kepler and Elston, 2001a; Levine et al., 2007). Accurate analysis of these and other
chemical processes - for which the underlying discrete molecular states or random nature
of individual interactions become important - requires methods able to capture such
features. This is frequently done in via the chemical master equation (CME) (McQuarrie,
1967).
For example, when a continuous-deterministic CCK description of the dynamics
of chemical reactions yields multiple steady states in some parameter range, the
corresponding discrete-stochastic CME descriptions will generally produce a multimodal
distribution of responses. This is because CCK closely follows modes of the underlying
CME distribution, so presence of multiple steady states under the same set of parameters
broadly indicates existence of multiple distribution modes (Samoilov and Arkin, 2006).
Notably, CME distributions with this type of multimodality, e.g. bimodality with cells
being either "on" or "off", can be realized for parameter ranges where a deterministic
multi/bistability is predicted as well as outside of these regimes. The latter phenomenon
results from stochastic sampling of parameters or dynamic states in the deterministically
bistable regime, which is enabled by the fluctuations inherent in CME system trajectories
that are not available under CCK.
A more intriguing class of phenomena is comprised of studies showing the
existence of bimodal stochastic responses for systems whose deterministic description
yields monostable solutions for all parameter ranges. Two types of reaction networks in
this class have been reported. One is comprised of systems with absorbing states (i.e.,
systems comprised of irreversible chemical reactions). We have recently demonstrated
that the necessary and sufficient conditions for such a system to exhibit purely stochastic
bimodal responses are the existence of more than one absorbing state and feedback loops
characterized by distinct time scales (Artyomov et al., 2007a). The focus of this paper is
on chemical reaction networks without absorbing states, e.g. networks comprised of
reversible chemical reactions, that exhibit bimodal stochastic responses when a
deterministic treatment is devoid of instabilities in any parameter range.
An example of such a system is obtained by considering the following simple
birth-death process for a species X (Lipshtat et al., 2006; Loinger et al., 2007):
kx
$ 7;-> X (2)
k-x
The rate constants in Eq. 2 can be chosen such that at steady state there are only few
molecules of X present. This reaction can then be coupled to a fast "indicator" reaction
as shown below:
X k X + y; y 1 # (3)
Species X gives birth to species Y with rate ky, and Y can be degraded with the rate ky.
If the rate constants ky and k.y are chosen to be much larger than kx and kx, an adiabatic
concentration of Y is established corresponding to the particular value of X being
sampled stochastically. When a small number of X molecules is present, on average, one
can see the signature of the discreteness of X in multiple peaks appearing in the steady-
state probability distribution of Y (see Fig. 3.1, simulations carried out with standard
Gillespie algorithm(Gillespie, 1977)), provided that the rates of the reactions (3) are fast
enough that peaks in the steady-state distribution of Y are resolved. The "indicator
reaction" effectively amplifies the discrete nature of the molecules of X which is why this
scenario can be called the "discreteness amplification" scenario for obtaining multi-
peaked distributions for deterministically monostable systems. A particular example of
this scenario that was presented in Ref ((Lipshtat et al., 2006)) can be obtained from the
reaction scheme (2-3) by restricting possible numbers of X molecules to zero or one.
Referring to the state with X = 0 as the inactive state of a gene and X = 1 as the active
state, a bimodal distribution of cellular response is obtained for conditions where the
adiabatic limit is approached (see above).
Our focus is on a different class of chemical reaction networks without absorbing
states that can exhibit purely stochastic bimodalities. Kinetic schemes in this class have
been described previously (Samoilov et al., 2005b), but the underlying reason for a
bimodal stochastic response in the absence of any deterministic instabilities remained
unclear. Here, we show that a previously unreported phenomenon, network topology
reduction, is one of the mechanisms that could result in this unusual behavior.
3.2 Model development
We start by considering the following simple chemical reaction network:
ki k3
N+N # A+N, N 7 A, (4)
k2 k4
k5
A B (5)
The deterministic kinetic equations for this system are
dN NkNkk
=N-kiN 2 + k2 N A-k3 N+k4 A
dt
dA
-=kN 2 - k2 NA+k 3N-k A-k 5 A+k 6 B (6)dt
dB
= kA -k 6Bdt
Eq. 6 makes clear that the quadratic equation obtained for steady-state concentrations of
A (or B) can only result in a single stable fixed point for all possible values of rate
parameters. Stochastic simulation of this reaction network for some choices of parameter
values, however, yields a bimodal response for the number of B molecules (Fig. 3.2).
This phenomenon cannot be explained by the arguments described above in the
"amplification of discreteness" scenario.
One of the peaks in the bimodal distribution in Fig. 3.2 corresponds to the
monostable deterministic steady state solution of Eq. 6, but the other is different. The
explanation for this unexpected stochastic bimodality can be found by considering the
time courses of the concentrations of N and B simultaneously (Fig. 3.2, inset). One
notices that values of B corresponding to the peak that is not centered around the
deterministic solution (i.e., B~27) are sampled when the number of molecules of N in the
system accidentally, by way of stochastic fluctuations, becomes zero. In this situation,
the reaction network effectively reduces in size because all reactions where N is among
the reactants cannot occur, which leads to certain kinetic degrees of freedom otherwise
available to the system to be temporarily "frozen out", subsequently constraining it onto a
smaller dynamical manifold. The latter may potentially display different temporal or
stationary features, thus contributing another behavioral mode to discrete-stochastic
reaction network properties that may then be reflected in the overall species state
distribution.
While a general analytical investigation of specific CME mechanisms underlying
such phenomena is substantially outside the scope of this work and would need to be
further addressed/discussed elsewhere, the described mechanism provides a compelling
example of how this type of deviant chemical and biochemical dynamics can arise even
in seemingly simple reaction mechanisms, making them relevant for in vivo and in vitro
applications. For example, of the six reactions in the scheme described by Eqs. 4-5 only
three are still possible if N is eliminated. If parameters are chosen appropriately, this
reduced network may be realized for a sufficient amount of time to allow sampling of its
steady state, with the second peak in the bimodal response shown in Fig. 3.2
corresponding to it. The only way for the system to escape from being "trapped" or
"frozen" in the reduced network is thorugh the occurrence of a reaction that produces N,
i.e. the one that converts A to N here.
This type of behavior was, in fact, observed by Samoilov et al(Samoilov et al.,
2005b)and it was attributed to the non-linearity of the noise appearing in the system
coupled to the "noise generator" of reactions of type (4) (or reaction 9 below). These
authors considered (Samoilov et al., 2005b) the much-studied and biochemically
ubiquitous futile cycle (Berg et al., 2000; Goldbeter and Koshland, 1981; Gomez-Uribe et
al., 2007; Levine et al., 2007), which interconverts X and X* with the help of enzymes E+
and E. according to the standard Michaelis-Menten mechanism, with E+ subject to noise
(9):
k+1 k.3
X + E+4 X-E±-> X* + E+ (7)
k+2
k.1 k-3
X* + E.4X*-E.-> X + E. (8)
k-2
In (Samoilov et al., 2005b), the peculiar bimodal steady-state distribution of species X
has been attributed to a sufficiently non-linear yet monomodal external noise
distributions imposed on the forward enzyme E+ in the Michaelis-Menten reaction
network. The specific example considered in (Samoilov et al., 2005b) achieved the
required non-linearity of noise appearing in the system reactions (7-8) by having it
coupled to a "noise generator" reaction mechanism of type (4) (or reaction 9 below).
k21  k22
N+N # E4+N N g E, (9)
k-21 k-22
The deterministic steady-state equations for the reaction system (7-9) are
polynomials of up to 6th order and it is not straightforward to show that there is no
bistability for all possible sets of rate constants. This can be circumvented by using the
topological rules described by Feinberg and coworkers (Craciun et al., 2006), which
allow us to conclude that the system can not admit more than one positive steady-state,
regardless of parameter values. However, a bimodal steady-state distribution of X (and
X*) was found in(Samoilov et al., 2005b) for a fully discrete-stochastic description of
this chemical network in a narrow range of parameters (Fig. 3.3). Just like in the simple
example considered previously, the behavior of the generator reaction (9) may be viewed
as having two network topologies. For non-zero values of N, the complete network (7-9)
is explored and a peak around its steady state solution emerges. But when the number of
molecules of N stochastically becomes zero - the effective topology is reduced similar to
that of mechanism 4-5 (see Fig. 3.3).
The necessary conditions for observing bimodality due to network topology
reduction is that the steady-states for complete and reduced topologies are sufficiently
different so that two distinct peaks can be resolved. The other necessary condition is that
system stays "arrested" in the reduced topology for a time scale sufficient for sampling its
steady state. Samoilov et al.(Samoilov et al., 2005b) actually achieved this for the driver
reaction (9) by "kinetically" arresting the system in the reduced topology by setting k-22
(9) to be smaller than reaction rates pertinent for the reduced network (7-8). Since
reaction k-22 is the only possible way to return from the reduced topology to the complete
network, this kinetic restriction fulfils the second necessary requirement.
The transient nature of the bimodality observed by Samoilov et al (Samoilov et
al., 2005b) is related to the violation of the second necessary condition above, which
requires that the system be able to spend sufficient time in the N = 0 state and that is
possible only for a relatively small number of N molecules in the steady-state. Therefore,
the observed bimodality disappears in Samoilov et al (Samoilov et al., 2005b) when
increasing the number of molecules of N participating in the reaction. For N + E+ = 40,
the peak around X= 790 corresponding to reduced topology becomes very small
compared to the situation when N + E+ = 35 (Fig. 3.3). In spite of the fact that peaks are
well separated, the reduced topology is rarely sampled because fluctuations leading to
N=0 are rare and the time spent in this state is short when Nit, is large.
When decreasing the number of molecules of N in the system, steady-state
concentrations for complete and reduced topologies are very close to each other, and can
not be resolved in the simulation. For N + E+ = 35, one sees two distinct peaks
corresponding to X = 1455 (complete system) and X = 1120 (reduced topology).
However, for N + E+ = 30, steady-states for the full and reduced topologies are X = 1766
and X=1639, respectively. These peaks can not be resolved completely due to intrinsic
noise of the level ± 70 molecules at steady-state conditions (Fig.3.3). With the further
decrease of concentration, the two peaks merge in to one.
3.3 Solution of Fokker-Planck Equation
We next turn to the possibility of treating systems of this type with continuous
approximation methods, particularly the Fokker-Planck equation. The interest is
stimulated by the fact that bimodality in this class of systems occurs due to special
behavior at the single point where N=0. Is N=0 still a special point when N can take on
non-integer values in a continuous approximation (Gardiner, 2004). For arbitrary small
N, as long as it is not exactly 0, the effective topology is still the complete topology of the
network, and the effect of the second attractor is not obvious.
Consider again the simplest kinetic scheme (4,5) featuring the network-topology
reduction induced bimodality. The corresponding master-equation
dP tn,a,b () = -{kn(n -1) + k2na +k 3n +k 4a k5a +k 6b Pna,b ( ±
dt
+ kin(n+ l)In+la-lb (t) + k2 (a + 1)(n - 1)Pn-,a+,b (t) + k3 (n+ ')+,a-1,b (t) (10)
+ k4 (a + 1)P-1,a+1,b (0 + k5 (a + 1)Pn,a+1,b-1 (0 + k6 (b + 1)Pn,a-1,b+1 (0
can be transformed into a Fokker-Planck equation according to standard rules (Gardiner,
2004), and after taking care of conservation of mass law n + a + b = T becomes
aP(n,a,t) a a 1 a2
ata2= an [(n, a)P(n, a,t)] + [f 2(n, a)P(n, a, t)]+ 2 2 [f 3 (n, a)P(n, a, t)] +
aI ia2
+ [f 4 (n, a)P(n, a, t)] + - [f5 (n, a)P(n, a, t)]
aaan 2 aa
with
f = kjn2 - k2na + kan - ka
f = -kn 2 + k2na - k3n+k 4a+k 5a -k 6 (T -a -n)
f = k1n2 + k2na+k 3n+k 4a (12)
f = -k 1n 2 - k 2na - k3n - ka
f5 = kn 2 + k2na+k 3n+k 4a + ka + k 6(T -a -n)
The time dependent partial differential equation (10) was solved numerically with
reflecting boundary conditions and the steady state distribution was determined in the
very long time limit. In Fig. 3.4 the numerical solution of the Fokker-Planck equation is
shown along with the steady-state distribution obtained from the stochastic simulations.
One can see immediately that continuous approximation correctly reproduces network
topology reduction effects. An analogy can be drawn with diffusion on a surface where
there is a point-like sink to understand why the Fokker Planck equation reproduces
behavior that appears to arise from discreteness. Even if the surface is curved such that
the mass is concentrated well away from the sink, in the very-long time limit the mass
will escape through the sink due to negligible, but still non-zero, diffusive motion. The
described Fokker-Planck equation has the character of diffusion in a potential well with
an additional "finite" point-like sink at the boundary.
3.4 Discussion
Finally, it can be argued that the fact that both systems (4-5) and (7-9) are
"closed" systems strictly obeying conservation of mass introduces additional non-
linearity at the boundary that is necessary to observe the mechanism of network topology
reduction. In order to address this point we have constructed "open" system exhibiting
the stochastically bimodal distribution due to topology reduction:
k, k3 k
N + N B + N, N A, N -><(13)
k2 k4
k7 ks k8
A > , A -B, #-+ B (14)
k6
As one can see from the Fig. 3.5, two peaks are observed in the steady-state
histogram of B molecules. First peak at B~37 molecules correspond to the complete
network when both eqns (13) and (14) are dictating steady-state of the network. The
second peak at B-91 molecule correspond to the steady-state of the reduced network
which consists only of equations (14). The second peak is observed when number of
molecules of N stochastically goes to zero (see inset of Fig. 3.5).
In this work we have identified the mechanism that allows multipeaked steady-
state distributions for the systems without absorbing states characterized by a single
deterministic attractor (e.g. chemical networks consisting of purely reversible chemical
reactions that have single stable solution for their ODE chemical equations). This
mechanism can be realized in both closed, mass-conserving, system and in open, steady-
state systems. The network topology reduction relies on the stochastic fluctuations in the
particular network architectures that allows effective reduction in the number of possible
reactions due to exhaust of one of the components. The validity of continuous (Fokker-
Planck) description of this mechanism was also studied.
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3.6 Figures for Chapter 3
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Figure 3.1: Stochastic simulations for network (1-2)
X=0.01, kY= 300, k-Y = 10. Steady-state distribution of
with parameters kX =0.01, k-
molecules Y is shown.
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Figure 3.2: Stochastic Simulations of the network (3-4) with parameters kl=0.1; k2=10;
k3=13; k4=0.03; k5=100; k6=10; N+A+B=30. Steady-state distribution of molecules B
is shown. Peak at B-27 corresponds to steady-state of reduced network, while peak at
B-15 corresponds to steady state of the complete network. Inset: time course of
simulations shown for N (red) and B (black) species.
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Figure 3.3: Steady-state probability distribution, for the reaction network (7-9) with
parameters kl=40; k2=104; k3=104; k-1=200; k-2=100; k-3=5000; k2l=10; k-21=5;
k22=10; k-22=0.2; X+X*=2000; E- = 50 (same as (Samoilov et al., 2005b)) and E+ + N
= 30 (red), E+ + N = 35 (black), E+ + N = 40 (blue);.
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Figure 3.4: Numerical solution of the Fokker-Planck eqn (10) at infinite time, coinciding
with results of stochastic simulations for network (6-8) with the same parameters as fig.3
and E++ N = 30.
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Figure 3.5: Stochastic Simulations of the network (13-14) with parameters kl=1; k2=10;
k3=13; k4=0.01; k5=100; k6=10; k7=1; k8=9; k9=0.4; Steady-state distribution of
molecules B is shown. Inset: time course of simulations shown for N (red) and B (black)
species.
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PART II
Chapter 4
Introduction into SSC: algorithm, units conversion
and examples
4.1 General description of the algorithm
In this chapter we briefly describe the simulation algorithm used for modeling
reaction-diffusion processes. More general and thorough descriptions of the simulation
algorithms can be found elsewhere (Lis et al., 2009). All the simulations presented in Part
II were carried out with the help of SSC software ((Lis et al., 2009), see also Appendix to
this Chapter) which performs spatially-resolved stochastic chemical master-equation
simulations and allows efficient treatment of the combinatorial expansion problem in the
size of simulation network.
Discretization is used for treatment of spatial components: space is discretized
into subvolumes and all the particles withtin subvolume are assumed to be well mixed. In
our simulations typical subvolume size is determined by the interaction length of
proteins. We will illustrate the mechanics of SSC by example of T-cell surface proteins
interacting with proteins on the surface of antigen presenting cell.
According to the experimental data interface between T-cell and APC is of the
order of 1 ptm 2 (Grakoui et al., 1999). In our simulation it is represented by a square of
dimensions 1 pim x 1 pim (although SSC provides capabilities to explore other
geometries). Simulation surface is divided into square chambers (subvolumes) of the
length L=100 angstrom (0.01 tm), which implies that we simulate a "chessboard" of
100 x 100 chambers. The dimensions of the individual chamber are chosen to correspond
to the range of attractive interactions between T-cell membrane proteins (Yachi et al.,
2006).
At any moment of time there might very well be more than one protein in each
chamber. We are ignoring internal degrees of freedom and specific positions of proteins
inside the chamber saying that proteins can react with each other provided that both are in
the same chamber (i.e. they are within the range of interactions). Reactions between the
species in different cells are not permitted. Diffusion of proteins is considered as a first
order chemical reaction and is represented by protein hopping from one chamber to the
neighboring chamber with corresponding rate constant.
The simulation consists of very large number of repetitions of two basic
operations (which is very similar to original algorithm(Gillespie, 1977)):
1. Choosing subvolume where reactions take place
2. Choosing next process happening (might be reaction or diffusion - they are on
the same footing)
3. Choosing the time when next process happens
And, after updating concentrations and positions, these steps are repeated all over again.
In first step, probability to choose specific subvolume is determined by a relative
reaction flux in this subvolume compared to total reaction flux in all subvolumes.
We illustrate the procedure behind second step by considering the molecule A
which can either diffuse to the neighboring chamber with rate constant kmotion or
transform into molecule B (as in A->B) with rate constant kA-B. Probability that
diffusion will occur is found with:
P(diffusion) - kmotion (1)
k,- ion +k A- B
P(reaction) _ kAB = I - P(diffusion) (2)
kmotion +k A-*B
We throw a random number within 0 to 1 interval, and if it turns out to be smaller than
P(diffusion) then we make a diffusion move, otherwise we substitute one molecule of A
with B.
The time when the process determined by above procedure occurs is defined by
picking a random number from an exponential distribution eX with parameter
A = kmotion kA-B. This implies that after throwing another random number from 0 to 1
(rand) we employ the formula:
t =in( (3)
k,,oti + k A -B rand
It is important to note, once again, that diffusive motion and chemical reactions -
both first and second order, are treated on the same footing which differs from the usual
way they are described in experiments: diffusion by the diffusion constant D (cm 2/s), first
order reactions by rate constant ki (s-1), second order reactions by rate constant k2 (M- s- 1)
etc.. In a following section, we describe in detail how we shift to description where all
the parameters have the same units and, thus can be compared to each other.
4.2 Rate constant unit conversion
The processes are characterized by the rate constants, but it is propensity of the
reaction rather than its rate constant that enters into expression for relative probabilities.
Propensity is defined as reaction flux in a given volume, i.e. number of reactions taking
place every second. Thus, for
* first order reaction A->B
aAB =kA-B x (# of molecules A per chamber), (4a)
which for the case of the single molecule coincides with rate constant aAMB= kAaB*
This is why expressions (1) and (2) have rate constants in them.
0 second order reactions A+B->C
aA+B-C =kA+B-C x (# of molecules A per chamber) x (# of molecules B per chamber) (4b)
e diffusion of molecules A out of the particular chamber
adif A = kd if x (# of molecules A in chamber) (4c)
Note, that all propensities must have the same units, namely, 
1
s x chamber area
i.e. the physical meaning of propensity is the reaction flux in a individual chamber on the
surface. Unit consistency in equation (4) requires the rate constants to have the different
units:
k
chamber area
molecules x s
kdiff A :
(5a)
(5b)
(5c)
One can see immediately, that units of (5b) are very different from the ones used
in bulk measurements for k2, namely M~'s. 1
L
mole x s
. Below we show how to
transform experimental value k2 in units M-'s- to the computational parameter kA+B-C in
units chamber area
molecules x s
k2  L = k 103 m
3
mole x s 6 23 molecules x s
k2 * i-3 10'%upx pm2
6 .1023 molecules x s
k2 *10- 3 .1018
6 .1023
i10 chambers k2 -10-3 .1018 -104
molecules x s 6 .1023
chamber
,um Xmolecules 
x s
(6)
where we have used the fact that our contact area of 1 ptm 2 consists of 104 chambers.
The last step is to convert three dimensional value of k2 into the 2-dimensional kA+BC.,C
To do that, we have to know a characteristic length, corresponding to the confinement of
the proteins to 2-dimensional membrane. Usually, we assume that membrane proteins can
move in direction perpendicular to membrane within the distance of approximately d= 10
Angstrom=10-3 pim. Thus:
k2 -10-3 .1018 .104
6 -1023
chambers 1
pmx xmolecules xs 10- pm
k2 -10- 3 -. 1018 -104kA+B-C 6 .1023 1-3
where k2 is in units M' s-1 and kA+B->C is in units chamberarea
molecules x s
Note, that for each
particular choice of the individual chamber size (which is determined by the range of
chambers
molecules x s (7)
(8)
interactions), one should recalculate the value of kA+B-c accordingly, while experimental
value, naturally, does not change.
Rate of the diffusion process is estimated from the diffusion rate constant D,
which is usually measured in units pm2/s. Here, we can simply multiply by the number of
chambers in 1 pm 2, which is 104 in this particular case:
1
kd=Dx 104 - (9)
S
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ABSTRACT
We present the Stochastic Simulator Compiler (SSC). a tool for exact
stochastic simulations of well-mixed and spatially heterogeneous
systems. SSC is the first tod to allow a readable high-level
deseription with spatially heterogeneous simulaion slgorithms and
complex geometries; this permts large systems to be expressed
concisely. Meenwhile, direct native-code complation allows S8 to
generate very fast simiations,
Aveleblty: SW curently runs on ,nux and Mac OS X and is freely
available at http:/veb.mit.edusrc/ssc/
Contact: mieszko@csail.mit.edu
supplementary Information: Supplementary data are available at
Bioinformatics orine.
I BACKGROUND
Cells interact with their environment via receptors that bind
to extracellular molecules: these events are then translated into
functions by biochemical signaling networks. Non-linearities arising
from the complex topology of such networks often make it difficult
tointuit qualitative behavior of signaling modules. Moreover. recent
imaging experiments have revealed that signaling components are
organized into spatial patterns that modulate signaling (Grakoui
el al., 1999; Lee ei at., 2003). Finally, extrinsic and intrinsic
stochastic effects. which make each cell's response unique, can
be important when small numbers of signaling molecules are
involved (Artyomov ei al., 2007). As computational studies
are increasingly becoming necessary complements to genetic.
biochemical and imaging experiments in unraveling this non-
intuitive behavior of cell signaling networks, efficient and easy to
use tools that can carry out stochastic simulations of biochemical
networks, both in well-mixed and spatially inhomogeneous
approximations, have become key technologies.
Since the original stochastic simulation algorithm (Gillespie.
1977), basic computer science techniques have reduced the rate
at which the per-step computation time grows with the number of
possible reactaons to loganthmtic growth (Gibson and Bruck. 2000;
Li and Petzold. 2006; Wylie el al. 2006). or optimized perfornance
by noting that a few reactions account for most events (Cao et al.,
2004; McCollum et al, 2006); moe recently, Slepoy el al. (2008)
*To whom conmspondence should be addmsed.
have reduced per-step computation to expected constant time via an
elegant composition-rejection algorithm. Similar techniques have
been applied to reduce spatially heterogeneous simulation time to
logarithmic (Elf and Ehrenberg, 2004). The combinatorial growth
of the instantiated reaction network size, another limiting factor for
complex systems, has been addressed either by generating species
and reactions on the fly (Faeder ei al., 2005; Lok and Brent,
2005) daring a Gillespie-based simulation, by representing each
molecule separately (Morton-Firth and Bray, 1998), or ingeniously
do away with explicit counts altogether by adjusting the sampling
distribution (Danos et a.., 2007; Yang et a. 2008).
Efficient formulation of such simulations in a general
programming language like C or FORTRAN, however, is not a
trivial task; while simulating a few reactions is fast even with a
simple implementation, a system with thousndIs of reactions and
subvolumes demands more complex algorithms which are much
more tricky to code. The programming burden has been reduced
by libraries (e.g. Li et al., 2008) as well as by simulators for
well-mixed (e.g. Gillespi et a., 2006 Mauch, 2009) and spatially
inhomogeneous (e.g. Hatine eta)., 2005; Meier-Schellersheim ri a.,
2006) models. File formats like SBML (Hucka el al., 2008),
developed to express biochemical models, can be read by several
simulators.
The modeling task is further complicated by the explosion
in combinatorial complexity which arises when modeling post-
translational modification or reactions local to one molecule in a
complex (Ilavacek et al, 2006): in SBML (and, indeed, in most
simulators) all possible species and each combination of every
possible reacting complex must be written out as a separate reaction,
which renders expressing even modestly complex reaction networks
impractical. To mitigate these limitations, BioNetGen (Paeder er a.,
2009) and & (Danos and Laneve, 2004) have proposed higher
level specifications where the reactants in each reaction are written
as panerns covering many possible species; such descriptions not
only naturally correspond to the intuitive concept of a biochemical
reaction, but are significandy smaller and therefore more readable
as well as much less error-prone.
The main contribution of the Stochastic Simulation Compiler
(SSC) that we present here lies in combining a higher level
specification required for modeling larger systems with the ability to
model spatially heterogeneous systems It differs from BioNetGen
and x because their syntax and expansion algorithms offer no
o 2009 The AuxWo(s)
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support for spatially inhomogeneous containers, wille SSC supports
multiple regions with arbitrarily comnplex shapes specified using
Constructive Solid Geometrv (CSG; meanwhile, while MesoRD
allows such regions and geomretries, it suffers front the combinatorial
complexity Imitations described above. In addition, SSC produces
fast simulations (cf Supplementary Material) by directly generating
iachine code tailored to a specific architecture.
2 IMPLEMENTATION
2.1 Tool flow
The tool fow resetmbles a progratuning language conpiler. The
user writes a high-level description of the reaction system (see
Supplementary Material for examplest, using patterns to select
and change specific parts of cotpounds (sitilar to how a cell
biologist would describe a kiown or hypothesized cell signaling
network). Regions are specified using CSG a technique thal emiploys
simple operations (e.g. union, intersection, difference atid scale) on
basic shapes (such as spheres, cubes, cylinders, etc.) to describe
arbitrarily complex geometries and widely used in solid modeling
and computer graphics (see,e.g. Requicha and Vocleker, 1977 Any
reaction can be restricted to a subset of regions, and diffusions
within and among the regions are written using the same high-
level pattent syntax as reactions. The compiler then expands the
model starting with initial species aid reaction patterns. creating
the recessary instances with specific properties and connections as
well as specific reactions operating on each of those compounds
in each region; meanwhile, the regions are discretized into cubic
subvolunes. [his intermediate representation is used to produce a
simulator executable, which, in turn, simulates the itiodel signaling
pathway.
2.2 Reaction expansion
Most biologically relevant signaling reactions are conceptually
local, that is, they 'sce' only a part of a larger nolecule or conmplex
(say, a single phosphorylation site( Therefore, we write reactions
and diffusions locally, using pattern matching to recognize and
nxify parts of complexes, and rely on the compiler to derive all
the possible cases in all regions. Similarly, only initially present
compounds are specified; the compiler generates the rest from the
initial set and the reactions.
Formally, the reactions and diftusion form a graph term-rewriting
system, which is fully evaluated to generate the simulator. Briefly,
cacti expansion step considers a rule in the system, finding all
cotibinations of substrates inl the relevant region that matchI tIh
rule. The rule is then applied to cacti match, possibly resulting in
new compounds. and a compound-specific reaction is created for the
specific substrate combination. Any new compourds rot excluded
by predefined limits (used to prevent intinite expansion) are added to
the region where the reaction took place and any regions reachable
by following the given diffusion patterns; the cycle then repeats until
no more new compounds have been created (See Supplenentary
Material for details of the expansion prc-ss).
2.3 Direct code generation
We obtain the efficiency of hand-optinized code by directly
generating assemibly code fromi tie fully expanded set of reachable
species and reactions. his allows us to avoid the interpretive
overhead of consultmg dependency graphs to detennine which copy
counts and propensities must be recomputed.
The generated code is also tailored for model complexity and
processor architecture. For most sizes, the compiler creates a
separate. straight-line segment of code for each possible reaction
in a region; each segment is parameteried only on the subvolume
for. in the case of diffusion, two subvoluracs), and directly updates
and propagates the affected propensities (se Section 2.4). This
avoids pipeline stalls and cache flushes caused by mispredicted
branches, and reduces the number of data memory reads and writes
(which are the performance bottleneck) to the absolute minimum.
(See Supplenentary Material for a detailed description of the code
generation method).
2.4 Reaction-diffusion simulation algorithm
The simulation algorithm is similar to the logarithtmic-time versions
of the direct stochastic simulation algorithm (Li and Petzold. 2006.
Wylie et aL., 2006). The simulation-time representation details may
be found in the Supplementary Material; briefly, the reactions
in each subvolutne (or on each boundary between subvolumes
are arranged in an n-ary heap with the leaves corresponding
to individual reaction propeisities atid each node carrying the
combied propensty of the reactions underneath the topaost node
for each subvolume is, then, the propensity of any reaction taking
place within. The subvolume and boundary reaction propensities
are, in turn. themselves arranged in a heap where each leaf is either
a subvolume or a boundary propensity; the topmost node is the
propensity of any reaction in the system taking place (and, lhence,
the range frotn which the random number should be selected).
Simulation proceeds as follows: a random number r is selected
firomi range ,0.R) where R is the propensity of any reaction taking
place; then the subvolume and reaction corresponding to r is selected
by n-ary search in the heap. Next, the reaction is 'executed, that is,
the copy nunbers of the affected species are adjusted as the reaction
dictates. Finally, the propensity of each reaction whose substrate
copy counts were altered is recomputed, and the partial propensities
are propagated up the propensity heap until the new R is recomputed
and the cycle can be repeated.
Since the propensity heap in each subvolume (or boundary) has
height logarithic in the number of reactions witlin, and the heap
above is logarithmic in the number of subvolumes and boundaries,
the total tree depth scales roughly logarithmically in the number of
reactions in the systetm. Both the reaction selection/search atid copy
number/propensity update step. therefore. run in time logarithmic in
the number of reactions.
3 PERFORMANCE
A cotnparedspatiallyhomogetnous SSCagainst fBioNeiCeti 2.0.46
(Faeder el at. 2009o (since, like SSC, it builds reaction networks
from pattern-matching rules), and against simulators built with the
SiochlKit library OLt et al., 2X8); because of the complexity of
the larger nxxels, we had SSC automatically geerate the required
StochKit C++ configurations. To test real-world performance, we
selected two toy systems and two more realistic systems with
various reaction counts: a diner decay model (Gillespie, 2001)
with four reactions, a sitplified EGFR signaling modcl (Blinov
et al,. 2006) with 64 reactions, a tnodel for the earliest events in
2290
Efficient stocheec simuation of rewttin-dtuson proceme
T-cell ignaing tWylie et al., 2006) with 1120 reactions. and an
enhanced version of the same with 2422 reactions. To test spatially
heteroetous models, we compared with the latest developntent
revision of MesoRL) (Hattne et at, 2005o SVN r559; we used
tie T-cell, signaling model above where single molecules ibut not
conpounds i were permitted to diffuse around a memibrane interface,
which was divided into 100, 10000, and 50000 subvolutes.
All situlations produced the s.nte results irnodulo random seed
variaion and precision loss during floating point arithnetic, To
focus on measuring only the sinaulation tilm, we disabled all output
except the final species counts. and repeated each expetiment 5-fold
to account for initial random seed variation and possible effects of
other procsses executing ont the systent.
We foutxi that SSC consistently outperfortmed the faster of the two
spatially totogeneous simulators we tested by 2 to 6 , with the
advantage growing with the size of the model 'see Supplementary
Fig,. . For spatially heterogeneous simulation, we found that SSC
was 50 y faster than MesoRD. although both scaled very well
with the number of subvolunes see Supplementary Fig. 4 .
4 CONCLUSIONS
We have described the SSC, a new tool for exact stochastic
simulations of biochetical reaction networks. SSC is, to our
knowledge, the first ool to combine a succinct high-level description
twhich avoids combinatorial complexity explosion) with spatially
resolved simulation where species and reactiots tay be restricted
to specific regions of arbitrarily complex shapes, atid unique in
emnployitg direct natinve tachine code generatiot to produce fast
sitnulators.
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4.4 Appendix 2 to Chapter 4: Examples of SSC codes
This appendix is a result of work of summer research student Mykyta Artomov, who was
testing SSC under my supervision.
The reaction networks treated in this appendix are exactly same networks initially
simulated in famous Gillespie 1977 paper (Gillespie, 1977).
1. Isomerisation reaction
Consider the following reaction:
Si - + Z with reaction rate c
la. Parameter set 1: c = 0.5, SI = 1000, time step = 0.1
Create a file isomerisation.rxn, and put the SSC code into it:
To compile the code, run:
To start the simulation:
-e 10 - end the simulation after time 10
-t 0.1 - the time step of output equals 0.1
1200
1000 - -
0 
0 2 4 6 8 10 12
time
Fig.1 Smooth line - plot of master equation solution, oscillating line - stochastic solution
lb Parameter set 2: c = 0.5 S1 = 5000, time step = 0.1
Do the same procedure as in 1.1., but notice, that initial number of SI species is different.
SSC code:
region World
box width 1 height 1 depth 1
subvolume edge I
rxn x:Sl at 0.5 -> destroy x
new SI at 5000
record Si
400D
1000
0 1 2 3 4 5 6 7 8 9 10 11
time T
Fig.2 Simulation results for c=0.5, S10 = 5000
Ic Parameter set.3. c = 0.5 S1 10000, time step = 0.1
SSC code:
region World
box width 1 height I depth 1
subvolume edge 1
rxn x:S1 at 0.5 -> destroy x
new SI at 10000
record Si
0 1 2 3 4 5 6 7 8 9 10 11
tie
Fig.3 Simulation results for c = 0.5, S10 = 10000
The more initial number of S1 species is, the smoother line you have and it is similar to
master equation solution.
2. Autocatalytic reaction
Si + S2 -P 2S2 with reaction rate cl
2S2 -* Z with reaction rate c2
Create a file autocatalytic.rxn and put into it one of the described SSC codes.
2.1. c1*S1=5 , c2=0.005, S2=10 and S2=3000, time step=0.1. Deterministic steady state
S2=1000
SSC code:
SSC code S2=3000:
neSl at 1O
new S2 at 3000
record S2
To compile the code, run:
[zxc"zxc]$ ss autocatalytic.rxn
To start the simulation:
[zxcv 1zxcv]$ ./autocatalytic -e 20 -t 0.1
2500
20DD
O 2 4 6 8 10 12 14 1% 18 20 22
time T
Fig. 4 Simulation results for autocatalytic reaction: ciS1 = 5 , c2 0.005, S20 =
10 - line, S20 3000 - dashed line
To build a distribution in steady state:
[zxcv@zxcv]$ ./autocatalytic -e 50 -d 5
0.01
04
850 00 950 1o0w 1050
number of S2 molecules
1105 1150
Fig.5. S2 species distribution
3. Lotka reactions
S1-+S2 -- 2S2
A-6.2dt -
S2+S3 -2S3 c2
S3 -- + Z c3
Create the file lotka.rxn and put into it one of the following SSC codes.
Parameter Set: cl*S1=10, c2=0.01, c3=10, S2=1000, S3=1000, time step=0.1.
Deterministic steady state S2=S3=1000.
SSC code:
To compile the code, run:
To start the simulation:
0 5 10 15 20 25 30
time -
Fig.6. S2 - smooth line, S3 - dashed line. clSl=10, c2=0.01, c3=10, S2=1000, S3=1000
4000
3000
2000
time
20 2is 30
Fig.7. S2 time dependence. c1SI= 10, c2= 0.01, c3 = 10, S20 = 1000, S30 = 1000
6000
5000
4000
2 3000
2000
1000
3000
Fig.8. Phase diagram
To build a distribution in steady state:
[zxcv'.zxcy]$ ./lka -e 5C -d 151
0.00i2 0 i .c~rdti utSfag 1:2
0002-
00016
230 400 600 600 1000 1200 1400 1600 1800 2000
number of S2 molecules
Fig.9. S2 species distribution
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4. The Brusselator scheme
Create the file brusselator.rxn
400 600 600 1000 1200 1400 1600 1800 2000 2200 2400
number of S3 molecules
Fig.10. S3 species distribution
X1 --- Y1, cl
X2 + Y1 - Y2 + Z1, c2
2Y1+Y2--*3Y1, c3
Y1l--Z2, c4
and put into it one of the following SSC codes
Initial conditions: cl*X1=5000, c2*X2=50, c3=0.00005, c4=5, Y1=1000, Y2=2000
(deterministic steady state), time step=0.01.
SSC code:
To cornpile tecdrn
To start the simulation:
R *' --0 M-' iAi 0- 1**
I f II
UJ U.ULJL aj
0 2 4 a 8 10 12 14 16 18 2D 22 0 2 4 10 12 14 10 1s
tMe T time T
loom 
'g14..3.6
000 -
400-
0
0 1000 2000 3000 4000 5000 6000 7000
Yi
Fig.11. Results stochastic simulations run of the Brusselator reactions, with cl*X =
5000, c2*X2 = 50, c3 = 0.00005, c4 = 5, Y1 = 1000, Y2= 2000
0 1000 2DD 3000 4000
Y1
5000 6000 7000
Fig.12. Plot of four stochastic simulation runs, each having the same reaction parameters
as in fig.19, but different initial values of Y1 and Y2.
To build a distribution:
[zxcv@zxcv]$ ./brusselator -e 250 -4 50
IMM
o o 14.d*.,da 'J1Q14A.d.*. WV 13
00007
0.004
00002
00022 -10
2000 1000 2000 000 4000 o
number of YI molecules number of Y2 molecules
Fig.13. Yl,Y2 species distributions
5. The Oregonator scheme
X1 + Y2- Y1 cl
Y1 + Y2 -+Z1 c2
X2 + Y1 -- 2Y1 + Y3 c3
2Y1 -*Z2 c4
X3 + Y3 -0 Y2 c5
Create the file oregonator.rxn and put into it one of the following SSC codes
Initial conditions: c1 = 0.001, c2 = 0.1, c3 = 0.1, c4 = 0.016, c5 = 0.1, X1 = 2000, X2=
1040, X3 = 260, Y1 = 500, Y2 = 1000, Y3 = 2000.
SSC code:
To compile the code, run:
[zxcv@zxcv]$ ssc oregonator.rxn
To start the simulation:
[zxcv@zxcv]$ ./oregonator -e 25 -t 0.01
4=0
10 15 20 25 30 0 0.5 1 1.5
time time
i . e24.4.at - I
3500 500 1000 1500 2000 2500 3000 3500
Yi
Fig.14. The Oregonator scheme simulation results. cl = 0.001, c2 = 0.1, c3 = 0.1, c4 =
0.016, c5 = 0.1, Xl = 2000, X2 = 1040, X3 = 260, Yl = 500, Y2 = 1000, Y3 = 2000
1DDDD1
4000
2M0
0 500 100D 1500 2000 2500 3000
Y1
Y2
Fig.15. Plot of four simulations runs same as fig.24, but different initial values of
Y1,Y2,Y3
To build a distribution in steady state:
i~34.dsk.d.t" 504~9 2
C 300 400 000 000
C 20M 400 a00 Boo
number of y1 molecules
Fig.16. Y1 species distribution
a Ai 2i d.4 .~I3
I= 100 200 00 4M0 500 =0 7=0 00 9W
number of y2 molecules
Fig.17. Y2 species distribution
200 400 000
number of y3 molecules
Fig.18. Y3 species distribution = 10000, Y1 = 2000, Y2 = 4000, Y3 = 8000
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Chapter 5
Dissecting the role of CD4 and CD8 co-receptors in T
cell signaling: A puzzle resolved?
5.1 Introduction
CD4 and CD8 are membrane proteins expressed on T helper cells and cytotoxic T
lymphocytes, respectively, that are known to augment the sensitivity and response of T
cells to cognate pMHC ligands (Holler and Kranz, 2003; Li et al., 2004a). Textbooks
ascribe the ability of these co-receptors to enhance T cell responses to two main effects:
1] Binding of CD4 and CD8 to MHC class II and class I molecules helps stabilize weak
TCR-pMHC interactions. 2] The Src kinase, Lck, which is bound to the cytoplasmic tail
of co-receptors, is efficiently recruited to the TCR complex upon co-receptor binding to
the MHC, thereby enhancing the initiation of TCR signaling (Janeway et al., 2008).
Surface Plasmon resonance (SPR) experiments show that the half-life
characterizing co-receptor-MHC interactions is shorter than 35 milliseconds (off-rate
greater than 20 s-1, the resolution of SPR instruments) for both CD4 and CD8 (Gao et al.,
2002; Wyer et al., 1999; Xiong et al., 2001)). It is difficult to understand how the two
effects noted above can be potentiated by such fleeting interactions. For example,
consider the effect of co-receptor-MHC interactions in stabilizing the TCR-pMHC
complex. A typical good agonist pMHC ligand is bound to TCR for approximately 10
000 milliseconds (corresponding to an off-rate of 0.1 s-1) (Stone et al., 2009). This
implies that during the lifetime of the TCR-pMHC bond a co-receptor would disengage
from MHC approximately 1000 times, thereby making stabilization of TCR-pMHC
interactions via co-receptor-MHC binding unlikely.
Yet, expression of CD8 was found to stabilize pMHC binding to CD8+ T-cell
surfaces (Luescher et al., 1995; Wooldridge et al., 2005), and augment sensitivity (Holler
and Kranz, 2003). In contrast, past studies (Hamad et al., 1998) and recent in situ
measurements at intercellular junctions show that CD4 does not stabilize the interactions
of TCR with class 1I pMHC molecules (Huppa et al., Nature 2009). But, CD4 does
enhance the sensitivity of T helper cells (Huppa et al., Nature 2009; Li et al., 2004). As
the binding affinity of CD4 for the MHC ectodomain is just 2-4 times weaker than that
characterizing CD8-MHC interactions (Gao et al., 2002), and the half-lives of both co-
receptor MHC interactions are a 1000-fold shorter than the TCR-agonist pMHC bond,
these results are difficult to reconcile. To shed light on this puzzle and to understand the
potentially different ways in which CD4 and CD8 may augment TCR signaling, we
carried out computer simulations of the well-established earliest events in TCR signaling.
5.2 Simulation results
We carried out computer simulations of a T cell-APC interface of 1 pm2 area
contained 300 T-cell receptors, 100 co-receptors and 100 pMHC complexes (these
concentrations are typical for in vitro experiments, (Grakoui et al., 1999). The
biochemical reactions that could occur upon the appropriate proteins encountering each
other were (Scheme 1 in Fig. 5.1): TCR-pMHC binding and unbinding, co-receptor
binding to MHC and coreceptor binding to TCR via Lck (Fig. 5.1). TCR, co-receptors,
and pMHC were allowed to diffuse on the T cell and APC surface. In order to determine
the apparent dissociation rate of pMHC molecules off the T-cell surface we initialized the
simulation with 100 pMHC proteins bound to TCRs. We then simulated the biochemical
reactions noted above using the Stochastic Simulation Compiler (Lis et al., 2009) that
allows efficient implementation of the Gillespie algorithm (Gillespie, 1977) to study cell
signaling processes, including protein motion and stochastic effects (details in SI).
Several replicate simulations for each scenario were carried out, and average values of
the dissociation rate of pMHC proteins in the presence and absence of coreceptors were
obtained.
If a pMHC molecule dissociated from the T cell surface during the simulation, we
removed it, thereby preventing rebinding. This mimics experiments where antibodies are
used to achieve the same end. The parameters used to simulate situations with and
without co-receptors were identical (Table 1), and we studied the effects of varying the
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dissociation rate of the coreceptor-MHC bond (kog), keeping the on-rate the same. These
calculations aimed to explore whether the measured higher affinity of CD8 for MHC
class I proteins, compared to CD4-MHC class II interactions, could explain why CD8,
but not CD4, is observed to stabilize TCR-pMHC interactions (Hamad et al., 1998;
Huppa, 2009; Luescher et al., 1995; Wooldridge et al., 2005).
Based on arguments noted above, we expected differences in the half-life of co-
receptor-MHC interactions to have a minimal effect on the dissociation rate of pMHC
molecules from the T cell surface. However, our results (Fig. 5.2a) indicate that this is
not necessarily true. For co-receptor - MHC interactions with a kog value of the order of
20 s-, the effective half-life of pMHC molecules bound to the T cell surface is enhanced
by about a factor of 1.5. However, a 4-fold lower co-receptor-MHC affinity (kog ~ 80 s-
1), results in an effective dissociation rate from the T cell surface that is indistinguishable
from simulation results without the co-receptor. These results recapitulate the
experimental observation that CD4, which binds MHC class II proteins with a 2 to 4-fold
lower affinity compared to CD8 binding to MHC class I (Gao et al., 2002), does not
stabilize the TCR-pMHC bond, but CD8 does (Hamad et al., 1998; Huppa, 2009;
Luescher et al., 1995; Wooldridge et al., 2005). This is pleasing because it shows that
experimental results for CD4 and CD8 (Hamad et al., 1998; Huppa, 2009; Luescher et al.,
1995; Wooldridge et al., 2005) are not in conflict with each other.
However, what was wrong with the argument made earlier which suggested that
the fleeting interactions between MHC proteins and CD4 or CD8 could not stabilize
TCR-pMHC bonds? That argument did not account for the fact that co-receptor
associated Lck also interacts with TCR. Thus, the co-receptor's interactions with a TCR-
pMHC complex are bivalent, with one arm binding to MHC and the other to TCR
(cartoon on right in Fig.5.1). Thus, if the co-receptor dissociates from MHC, it is still
bound via Lck to the TCR-pMHC complex, and this enables rapid rebinding to MHC. A
similar effect is in play if Lck dissociates from the TCR. Our results show that such
cooperative interactions can cause co-receptor-mediated stabilization of the TCR-pMHC
bond only if co-receptor-MHC interactions have a half-life not much larger than 20 s-1
(fig. S5.3).
Although CD4 does not stabilize TCR-pMHC interactions (Hamad et al., 1998;
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Huppa, 2009), like CD8, it does enhance T cell responses (Huppa, 2009; Li et al., 2004a).
This raises the question of whether CD4 can enhance Lck recruitment to the TCR
complex, and more generally, whether CD4 and CD8 enhance T cell sensitivity to
antigen in different ways.
To examine these issues, we carried out computer simulations of the type used to
obtain the results in Fig. 5.2a except that the set of possible biochemical reactions was
augmented to include the earliest event in TCR signaling, phosphorylation of the TCR
ITAMs by Lck (scheme 2 in Fig.5.1). Multiple phosphorylation states of the ITAMs on
Q-chains of the TCR were represented by two phosphorylation states - partially and fully
phosphorylated TCRs (see, for example, (Wylie et al., 2007b)). To assess the role of the
co-receptor in TCR triggering, we studied two situations: 1] Lck is present as a free
membrane-associated molecule and there are no co-receptors; 2] Lck is associated with
the co-receptor. We carried out computer simulations for these two situations, with all
parameters being identical (Table 1), and compared the levels of TCR phosphorylation
(readout of signal strength). Varying the off-rate of coreceptor-MHC interactions did not
affect the qualitative results of these simulations (Fig. S5.2).
Fig. 5.2b shows simulation results of signal strength as a function of the off-rate
characterizing TCR-pMHC interactions. The simulations correctly recapitulate
experimental observations in that TCR phosphorylation discriminates between
stimulatory and non-stimulatory ligands. The border between stimulating and non-
stimulating peptides (~0.1-1 s 1 in the simulations carried out with co-receptors present,
black line in Fig. 5.2b) is dependent on the on-rate of the TCR-pMHC interaction. The
simulations correspond to this rate being 104 M~1s~1, as is experimentally measured for
typical good agonists. But, for higher value of the on-rate, pMHC ligands that bind TCR
with off-rates larger than 1 s-1 are stimulatory.
Importantly, co-receptors clearly enhance TCR phophorylation. As shown in Fig.
5.2b, if a threshold amount of TCR phosphorylation is required for downstream digital
signaling modules (Altan-Bonnet and Germain, 2005; Das et al., 2009; Reyes et al.,
2005) to be activated (resulting in T cell responses), peptides that bind to TCR with off-
rates in the range of 0.04-0.2 s-1 are stimulatory only when the co-receptor is present, but
barely stimulate TCR phosphorylation without the co-receptor. pMHC ligands that bind
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TCR with longer half-lives are stimulatory even withot the co-receptor. This is consistent
with reports of co-receptor-dependent and independent ligands in both CD4 and CD8
systems (Holler and Kranz, 2003; van Bergen et al., 2001). Dose-response curves
obtained from the simulations further support this point (Fig. S5.1).
We used the computational models to parse the relative contributions of TCR-
pMHC stabilization and Lck recruitment to coreceptor-mediated signal enhancement in a
way that is difficult to accomplish experimentally. We carried out computer simulations
where the only effect of co-receptors was to enhance Lck recruitment. This was achieved
by simulating systems where ITAM phosphorylation was allowed only if TCR and
pMHC were directly bonded, and not if they were a part of the TCR-pMHC-co-receptor
complex. These simulations showed results (Fig. 5.2c) similar to those in Fig. 5.2b. We
also carried out computer simulations where the only effect of the co-receptor was to
enhance the stability of the TCR-pMHC bond by a factor of 1.5 (as per results in Fig.
5.2a for kog = 20 s-, corresponds to CD8). This was accomplished by simulating
situations without the co-receptor (no enhancement of Lck recruitment), but with TCR-
pMHC half-lives enhanced to mimic co-receptor mediated stabilization. The results (blue
line, Fig. 5.2c) show that stabilization of the TCR-pMHC bond makes a minor
contribution to co-receptor-mediated enhancement of TCR signaling. Thus, even for
CD8, the main effect of the co-receptor is to enhance Lck recruitment to the TCR
complex, and for CD4 it is the only effect.
How can fleeting CD4-MHC interactions, which do not stabilize the TCR-pMHC
bond, enhance Lck recruitment? To answer this question, we analyzed the simulation
results using the following simple arguments and calculations.
When two membrane proteins capable of binding approach within the range of
interactions, there are two possible outcomes: the proteins associate and form a complex,
or they diffuse away from each other and leave the domain of interactions. This is
because there are two driving forces, attractive interactions pulling them together and
random diffusive forces pushing proteins apart from each other. As both processes are
stochastic, each possible outcome has a certain probability of occurrence. We calculated
the probability for Lck association with the TCR complex for the case when Lck is co-
receptor associated and when it is not. Differences in the probability with which Lck
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binds to the TCR and its mechanistic origin shed light on how the co-receptor enhances
Lck recruitment.
When Lck is not co-receptor-associated, vicinal TCR and Lck can either bind or
diffuse away. The on-rate of Lck-TCR association can be estimated in the following
way. It has to be large enough for the time required for TCR-Lck association to be longer
than the lifetime of strong agonist pMHC-TCR complexes, otherwise these ligands would
not trigger TCR in a co-receptor-independent way (Fig. 5.2b and (Holler and Kranz,
2003)). Also, the time required for TCR-Lck association must be shorter than the
lifetime of endogenous pMHC-TCR bonds in order to prevent frequent spurious
triggering of TCRs bound to endogenous ligands. These considerations imply
thatkoffAg <konLck < koffEn. Based on measurements of TCR-pMHC off-rates, we took
k onLck ~1 s- 1 molec' (area of interaction). Effects of variations in kon,Lck are detailed in
appendix to chapter 5 (see Fig. S5.4). The diffusion constant of membrane-associated
proteins is typically 0.01 tm2/s (Dushek et al., 2008). Assuming the range of interactions
to be of the order 100 angstroms (0.01 ptm)(Yachi et al., 2006), we can compute the rate
with which membrane proteins will leave the range of interactions due to diffusion to be
kmotion 100 s-1 . To find the probabilities escape versus binding, we compare the rates
of motion and binding to obtain:
kmotionLck + kmotionTCR 200
kmotionLck + kmotionTCR + konLck 201
P(binding) = konLck - 1 0.005 (2)
2kmotion+ kon,Lck 201
These estimates suggest that it is rather unlikely that Lck will form a bond with the TCR
when it is not associated with the co-receptor.
Now consider the situation when Lck is associated with the co-receptor. Once the
co-receptor is in the vicinity of a TCR-pMHC complex, it can either diffuse away or bind
to the MHC. Experimental measurements (Gao et al., 2002) estimate the on-rate for co-
receptor-MHC interactions to be very large - kon,MHC-CD4(8) > 105 M-'s-1 . This leads to the
following estimate for the 2-dimensional value of this rate parameter (appendix to
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(area of interaction)
chapter 5): kon,MHC-CD4(8) (2D) = 1670 . Notice that this is 16 times
molec x s
larger than the rate parameter corresponding to diffusive motion of proteins away from
each other (knoton ~ 100 s-1). This suggests that the large on-rate for co-receptor-MHC
interactions will combat diffusive forces effectively, enabling co-receptor binding to the
MHC with high probability. Also, once this bond between two proteins anchored to
apposed membranes is established, diffusion of the co-receptor and the MHC will be
severely slowed down compared to a protein on a single membrane. These effects allow
the co-receptor to effectively localize Lck to the TCR-pMHC complex.
To estimate the likelihood of successful Lck-TCR association given that the TCR-
MHC-coreceptor complex is assembled, we must consider the following possible events:
breaking TCR-MHC bond (koff 1 s-1), breaking MHC-coreceptor bond (kff ~ 20 s-1),
forming the TCR-Lck bond (kon 1 S1). Following the argument made earlier to
compute the probability of binding versus diffusion for free Lck, the probability of Lck
binding to the TCR complex is found to be:
P(binding) = kon,Lck 1 0.05 (3)
koffMHC-CD4(8) + koffTCR-MHC + konLck 20
Eqs. (2) and (3) show that Lck recruitment to the TCR complex is ten times more likely if
it is associated with the co-receptor compared to when it is present as free Lck.
We conclude that co-receptors CD4 and CD8 augment T cell signaling primarily
by enabling efficient recruitment of Lck to the TCR complex. The large on-rate of co-
receptor-MHC interactions enables efficient recruitment of Lck by combating the effects
of diffusive forces that tend to separate proteins within the range of interactions.
Although, for reasons we have discussed, CD4 and CD8 have differential ability to
stabilize TCR-pMHC interactions, the impact of this difference in triggering TCR
signaling appear to be minor.
5.3 Appendix to Chapter 5
5.3.1. Dose response curves for peptides of different strength
Another possible test of the model would be to study the dose-response curve that
follows form simulation of the model. We choose three different peptides: strong agonist
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(koff = 0.002), typical agonist (koff=0.02) and weak agonist (koff=0.1) to see how the
dose response curves change with for different peptide quality:
We see (Fig. S5.1) that although strong peptides are capable of signaling even without
coreceptor, ability of weak agonist to signal is critically dependent on the presence of
coreceptor. As mentioned in the main text, one might parallel this behavior to
experimentally determined classes of coreceptor-dependent and coreceptor-independent
peptides.
5.3.2. Cooperative binding is required for MHC stabilization on T-cell surface
Fig. S5.3 shows the enhancement of half-life of MHC bound to T-cell surface in
situation when Lck can not bind TCR' intracellular domain. In this situation MHC
interacts separately with TCR and coreceptor molecules present on the T-cell surface and
presence of coreceptor does not improve the half-life of MHC.
5.3.3. Parameter sensitivity studies
Parameter sensitivity studies were carried out for parameters that have no experimental
data available (typed in black font in Table 1):
* Fig. S5.4 illustrates that variations of kon, Lck-TCR (rate of Lck engagement
with TCR) within the range of 0.5 - 5 s-1 do not change the qualitative picture resulting
from simulations reported in the main text.
- Fig. S5.5 illustrates that variations of koff, Lck-TCR (rate of Lck disengagement
with TCR) within the range of 0.5 - 5 s-1 do not change the qualitative picture resulting
from simulations reported in the main text.
- Fig. S5.6 illustrates that variations of kp (rate of phosphorylation of TCR by
Lck) within the range of 0.02 - 0.2 s-1 do not change the qualitative picture resulting from
simulations reported in the main text.
- Fig. S5.7 illustrates that variations of kdp (rate of dephosphorylation of TCR)
within the range of 0.05 - 0.5 s-1 do not change the qualitative picture resulting from
simulations reported in the main text.
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5.3.4. SSC code for simulating dissociation of MHC off the T-cell surface
region World
box width 100 height 100 depth 1
subvolume edge 1
-MONOMER DISAPPEARANCE
rxn m:MHC(t#, c#) at 100000000 -> destroy m
-COMPLEXES FORMATION
- MHC/TCR bond
rxn m:MHC(t#, c#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#1) CD4(m#1, t#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#) t:TCR(m#, c#1) CD4(t#1, m#) at kon -> m.t # t.m
rxn m:MHC(c#2, t#) t:TCR(m#, c#1) CD4(t#1, m#2) at kon -> m.t # t.m
rxn TCR(m#1) MHC(t#1, p="ag") at koffAg -> break 1
rxn TCR(m#1) MHC(t#1, p="en") at koffEn -> break 1
-- TCR/CD4 bond
rxn t:TCR(c#, m#) c:CD4(t#, m#) at konLckl -> t.c # c.t
rxn t:TCR(c#, m#1) MHC(t#1, c#) c:CD4(t#, m#) at konLck -> t.c # c.t
rxn t:TCR(c#, m#) c:CD4(t#, m#1) MHC(c#1, t#) at konLck -> t.c # c.t
rxn t:TCR(m#2, c#) c:CD4(t#, m#1) MHC(c#1, t#2) at konLck -> t.c # c.t
rxn TCR(c#1, m#2) MHC(t#2) CD4(t#1) at koffLck -> break 1
rxn TCR(c#1, m#) CD4(t#1) at koffLck -> break 1
-- MHC/CD4 bond
rxn m:MHC(c#, t#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#1) TCR(m#1, c#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#) c:CD4(m#, t#1) TCR(c#1, m#) at konCD -> m.c # c.m
rxn m:MHC(t#2, c#) c:CD4(m#, t#1) TCR(c#1, m#2) at konCD -> m.c # c.m
rxn MHC(c#1) CD4(m#1) at koffCD -> break 1
--initial species
new MHC(p="ag", t#1) TCR(p="p0",m#1) at count-ag --start with MHC bound to T-cell surface through TCR
new MHC(p="en") at counten
new TCR(p="p0") at 200
new CD4(Ick="basal") at 100
diffusion at 0
diffusion MHC(t#, c#) at kdiff
diffusion TCR(m#, c#) at kdiff
diffusion CD4(m#, t#) at kdiffCD4
record MHC(p="ag",t#1) TCR(m#1)
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5.3.5. SSC code for simulation phosphorylation due to MHC-TCR interactions
--SPACE SETTINGS
region World
box width 100 height 100 depth 1
subvolume edge 1
--COMPLEXES FORMATION
- MHC/TCR bond
rxn m:MHC(t#, c#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#1) CD4(m#1, t#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#) t:TCR(m#, c#1) CD4(t#1, m#) at kon -> m.t # t.m
rxn m:MHC(c#2, t#) t:TCR(m#, c#1) CD4(t#1, m#2) at kon -> m.t # t.m
rxn TCR(m#1) MHC(t#1, p="ag") at koffAg -> break 1
-- TCR/CD4 bond
rxn t:TCR(c#, m#) c:CD4(t#, m#) at konLckl -> t.c # c.t
rxn t:TCR(c#, m#1) MHC(t#1, c#) c:CD4(t#, m#) at konLck-> t.c # c.t
rxn t:TCR(c#, m#) c:CD4(t#, m#1) MHC(c#1, t#) at konLck -> t.c # c.t
rxn t:TCR(m#2, c#) c:CD4(t#, m#1) MHC(c#1, t#2) at konLck -> t.c # c.t
rxn TCR(c#1, m#2) MHC(t#2) CD4(t#1) at koffLck -> break 1
rxn TCR(c#1, m#) CD4(t#1) at koffLck -> break 1
-- MHC/CD4 bond
rxn m:MHC(c#, t#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#1) TCR(m#1, c#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#) c:CD4(m#, t#1) TCR(c#1, m#) at konCD -> m.c # c.m
rxn m:MHC(t#2, c#) c:CD4(m#, t#1) TCR(c#1, m#2) at konCD -> m.c # c.m
rxn MHC(c#1) CD4(m#1) at koffCD -> break 1
-MODIFICATIONS TO SPECIES
- Phosphorylation/Dephosphorylation
rxn t:TCR(p="p0", c#1, m#2) MHC(t#2) CD4(Ick="basal", t#1) at 2*kp -> t.p "pl"
rxn t:TCR(p="pl", c#1, m#2) MHC(t#2) CD4(Ick="basal", t#1) at kp -> t.p = "p2"
rxn t:TCR(p="pl", m#) at 2*kdp -> t.p = "p0"
rxn t:TCR(p="p2", m#) at kdp -> t.p = "pl"
--initial species
new MHC(p="ag") at count ag
new TCR(p="pO") at 300
new CD4(Ick="basal") at 100
diffusion at 0
diffusion MHC(t#, c#) at kdiff
diffusion TCR(m#, c#) at kdiff
diffusion CD4(m#, t#) at kdiff
--OUTPUT
record TCR(p="p2")
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Tables:
Table 5.1. Rate parameters (in units s-.) used in simulations. Experimentally derived
parameters are shown in red (see review (Gao et al., 2002) for references), there are no
experimental data available for black entries. See appendix to chapter 5 showing that our
qualitative conclusions do not change upon varying these parameters, except if Lck does
not associate with TCR. Unit conversion rules can be found in chapter 4.
Rate parameter Reaction described
150 kon, TCR-MHC TCR-MHC on rate, (exp-104 M-Is-')
0.02 koffTCR-AgMHC TCR-MHC off rate for agonist peptide (exp-0.02 s-1)
1000 kon,CD4(8)-MHC MHC-coreceptor (CD4/CD8) on-rate(exp-10 5 M-'s 1 ')
20 koffCD4(8)-MHC MHC-coreceptor (CD4/CD8) off rate (exp-20 s-1)
50 kdiff, rate of diffusion of membrane surface proteins (exp-0.01 Ipm2/s)
20 koffTCR-EnMHC TCR-MHC off rate for endogenous peptide (exp-20 s-')
0.05 k,, rate of phosphorylation of TCR by Lck
0.2 kp,rate of dephosphorylation of TCR
1 ko, Lek-TCR, rate of Lck engagement with TCR
1 koff Lck-TCR, rate of Lck disengagement with TCR
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5.5 Figures for Chapter 5
5.5.1. Main Figures
Fig. 5.1. Pictorial representation of the computer simulations that were carried out. Three
kinds of proteins (MHC, coreceptor, TCR) were allowed to diffuse on the surface that
represents 1 [tm 2 of the T-cell/APC interface. Proteins were allowed to interact in accord
with the indicated biochemical reactions. In the first set of simulations, reactions from
scheme 1 were implemented; in the second set of simulations reactions from scheme 2
were implemented. Reaction rate parameters for these biochemical reactions are provided
in the Table 1. Cartoon of the Lck-TCR complex that leads to cooperative interactions
between the TCR, pMHC and coreceptor/Lck is shown on the right.
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Scheme 1 Scheme 2
CD4/8.m.w+MHC : CD4/8-MHC CD4/8...+MHC CD4/8-MHC
CD4/8..&a.. +TCR - CD4/8-TCR CD4/8M..w. +TCR - CD4/8-TCR
CD4/8-TCR - CD4/8-TCRp-+ CD4/8-TCRpp
TCRpp -+ TCRp -+ TCR
APC . jW_
JTCR
k,(coreceptor-MHC), s-
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/i threshold4----,-,-,- 
-
10 1 al 0.01 1 E-3 1
k,(TCR-MHC), s-
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Fig. 5.2 a) Effective half-life of MHC on the T-cell surface as a function of koffMHC-
coreceptor (which is proportional to affinity of the MHC-coreceptor interaction) as obtained
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in the first set of simulations (scheme 1 in Fig.1). At koff- 20 s- the half-life is enhanced
by -1.5 times in the presence of coreceptor, while at ko - 80 s-1 half-lives with and
without coreceptor are statistically indistinguishable.
b) Levels of TCR phosphorylation as a function of kff of the TCR-pMHC interaction.
The results are obtained from simulations of 1 tm2 of the T-cell/APC contact area with
the following protein concentrations: 300 TCR per pim 2, 100 co-receptors per pm 2 (black
curve), or no coreceptor present (red curve). Horizontal line indicates a threshold value of
TCR phosphorylation threshold required to potentiate downstream signaling and T cell
activation. Blue region represents the range of peptides that are coreceptor-dependent.
c) Signal enhancement measured by TCR phosphorylation. The red curve indicates
phosphorylation level in the absence of coreceptor (for peptides of different potency, as
measured by kog of TCR-pMHC complex). The blue curve represents phosphorylation
levels if coreceptor can only stabilize pMHC-TCR interactions, but not recruit Lck. The
black curve represents phosphorylation level when coreceptors can enhance Lck
recruitment but not stabilize the TCR-pMHC bond. How computer simulations could
separate these effects is described in the text.
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5.5.2 Supplementary Figures
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Fig. S5.1 Amount of fully phosphorylated TCR as a function of amount of peptides
presented in the contact area (Dose-Response curves) for strong agonist(a), typical
agonist(b), weak agonist(c)
-- 100 peptides, no coreceptor
- 100 peptides, with coreceptor
k0(coreceptor-MHC) = 20 s"
u-li
10 1
30 peptides, with coreceptor
k0 (coreceptor-MHC) = 80 s"
0.1 0.01
kff(TCR-MHC), s~
Fig. S5.2 Amount of fully phosphorylated TCR as a function of peptide quality (as
determined by kffTCR-pMHC) Coreceptor mediated enhancement does not change
qualitatively when varying stability of coreceptor-MHC interactions between 20 s~1
(black curve) and 80 s~1 (blue curve).
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Fig. S5.3 Effective half-life of MHC on the T-cell surface as a function of koffMHC-coreceptor
(which is proportional to affinity of the MHC-coreceptor interaction) as obtained in the
first set of simulations (scheme 1 in Fig. 1) with association between Lck and TCR set to
zero (kon(lck-TCR)=O). One sees that in the absence of cooperative binding (see fig. 2a of
main text) MHC is not stabilized on the surface.
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kff(TCR-MHC), s1
-180
-160
-140
120
100
80
60
40
20
1 E-4
Fig. S5.4 Parameter sensitivity studies for kon(Lck-TCR). Amount of fully
phosphorylated TCR is plotted a function of peptide quality (as determined by koffTCR-
pMHC). TCR phosphorylation with and without coreceptor is shown for 3 cases: kon(Lck-
TCR) = 0.5; 1; 5 s-1 (the rest of the parameters are the same as in Table 1). Coreceptor
mediated enhancement does not change qualitatively when varying koffTp
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Fig. S5.5 Parameter sensitivity studies for konf(Lck-TCR). Amount of fully
phosphorylated TCR is plotted a function of peptide quality (as determined by koffTCR
pMHC). TCR phosphorylation with and without coreceptor is shown for 3 cases: kof(Lck-
TCR) = 0.5; 1; 5 s-1 (the rest of the parameters are the same as in Table 1). Coreceptor
mediated enhancement does not change qualitatively when varying kofTCRpMHC
-... 0. etien. oecpo.....05..-.0
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Fig. S5.6 Parameter sensitivity studies for kp. Amount of fully phosphorylated TCR is
plotted a function of peptide quality (as determined by koffTCRpMHC). TCR
phosphorylation with and without coreceptor is shown for 3 cases: kp = 0.02; 0.05; 0.2 s-
(the rest of the parameters are the same as in Table 1). Coreceptor mediated enhancement
does not change qualitatively when varying kp.
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Fig. S5.7 Parameter sensitivity studies for kap. Amount of fully phosphorylated TCR is
plotted a function of peptide quality (as determined by kofTCR-pMHC) TCR
phosphorylation with and without coreceptor is shown for 3 cases: kap = 0.05; 0.2; 0.5 s-1
(the rest of the parameters are the same as in Table 1). Coreceptor mediated enhancement
does not change qualitatively when varying kap.
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Chapter 6
Mechanisms of signal enhancement by non-cognate
peptides in CD4 and CD8 T-cells
6.1 Introduction
Interactions between peptide-MHC complex and T-cell receptor (TCR) play
major role in shaping response of the T-cell to its environment allowing for pathogen
recognition and proper T-cell homeostasis. Normally, during the immune response, T-cell
activates only upon TCR stimulation with peptide-MHC complexes containing peptides
derived from pathogenic proteins. Although peptides derived from self-proteins are not
able to stimulate naive T-cell by themselves, they actively participate in the action of the
immune system. Firstly, thymocytes are tested in thymus against the pool of self-peptides
to ensure appropriate sensitivity of the T-cell receptor (through positive and negative
selection) (Palmer and Naeher, 2009). Secondly, it was reported that peripheral presence
of weak ligands, such as self peptides, is required for proper homeostasis of the naYve T-
cell population (Surh and Sprent, 2008). Thirdly, some self-derived peptides can enhance
signals that were initiated by the pathogenic-peptides (Krogsgaard et al., 2007a;
Krogsgaard et al., 2005). Interestingly, the manner of enhancement was found to be quite
different in the CD4 and CD8 T-cells (Ebert et al., 2009; Lo et al., 2009; Yachi et al.,
2005a; Yachi et al., 2007). Our paper focuses on the last phenomenon and provides
computational insight into the possible differences between the CD4 and CD8 systems
that could be responsible for the observed difference in the co-enhancement quality of the
self-peptides in the mixtures of self- and non-self peptides.
From the biophysical point of view, difference between self- and nonself-derived
peptides is manifested through the different affinities of interactions between TCR and
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peptide-MHC complex (Holler and Kranz, 2003; Stone et al., 2009). Mature T-cell
receptors that have undergone thymic selection are generally expected to interact very
weakly with self-peptides (although exceptions do exist (Rosette et al., 2001)). Typically,
self-peptides have kof (TCR-pepMHC) > 10 s-1 while pathogenic peptides capable of
activating T-cell have kort (TCR-pepMHC) < 1 s-1 as measured by BiaCore experiments
(Stone et al., 2009). Thus, one can view the value of korr 1 s-1 as a kind of threshold in
koff values that ensures recognition of the peptide.
It should be noted, however, that T-cell sensitivity (for example, as determined by
the threshold value of korr) to TCR stimulation is not set in stone and varies whilst T-cell
progresses through different developmental periods. It is achieved through different
"rheostat"-like mechanisms with most notable being miR181a regulations (Li et al.,
2007). For instance, thymocytes are more responsive than mature T-cells and can respond
to self peptides due to the change of the activating threshold as regulated by miR181a
(Ebert et al., 2009).
Mature T-cells, on the other side, have a reasonably high threshold of activation
such that self-derived peptides presented to T-cells on the lipid bilayer or APCs do not
provoke T-cell activation. Yet, mature T-cells are able to sense the presence of self-
peptides in the mixture with cognate peptides as indicated by signal augmentation
compared to the situation when only cognate peptides are presented to the T-cell (Ebert et
al., 2009; Lo et al., 2009; Yachi et al., 2005a; Yachi et al., 2007). This indicates that
mechanism of enhancement is different from sensitivity modulation. The exact molecular
mechanism remains the subject of the debates particularly because of the contrasting
results obtained with CD4 and CD8 T-cells (Ebert et al., 2009; Lo et al., 2009; Yachi et
al., 2005a; Yachi et al., 2007).
In CD8 T-cells it has been found that all tested non-activating-peptides are able to
synergize the effect of cognate peptides, while in CD4 cells only some of the null-
peptides are capable of enhancing the signal provided by agonist (Li et al., 2007; Yachi et
al., 2007). In this paper we show that these results are, in fact, consistent with each other
and can arise from a single mechanism.
Involvement of non-cognate peptides along with agonist peptides presents an
interesting puzzle because of the dramatic difference in the time scales associated with
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stability of different pepMHC-TCR complex. For the activating peptides lifetime of the
bound TCR-pepMHC complex is about 10-100 seconds (kog ~ 0.1-0.01 s-1), while self-
derived peptides that are always present on the APC surface in complex with MHC form
extremely unstable bond with TCR with lifetime about 50 milliseconds (kog >20 s-1).
Three orders of magnitude in difference between koff's suggest that different mechanisms
may operate in each situation.
First step to reconciling these rate differences was due to Wylie et al who
hypothesized that Lck might have two states capable of carrying out the phosphorylation,
basally active and fully active states (Wylie et al., 2007a). While the former has limited
kinase activity, the latter is active enough to phosphorylate even short lived complexes
such as self-peptide-MHC-TCR. This assumption was recently confirmed in experiments
studying the properties of membrane bound phosphotase CD45 that actively maintains
the balance between three forms of Lck (inactive, basally active, fully active) (McNeill et
al., 2007; Zamoyska, 2007). Particularly, CD45 promotes transformation of the inactive
form of Lck to the basally active, but also inactivates fully active form down to the
basally active one. In other words, it is CD45 who assures that Lck is in the basally active
state.
This function of CD45 protein, together with its peculiar physical dimensions,
plays the crucial role in the spatial coordination of the kinase activity of Lck. Namely, the
length of the extracellular domain of CD45 is approximately 40 A, which is considerably
larger compared to approximately 15 A of the total length of the TCR-pepMHC
connection. The dimensional mismatch makes it impossible for phosphotase CD45 to be
localized in close proximity to the bound TCR-pepMHC complex (Burroughs and van
der Merwe, 2007). So, Lck can be securely promoted to the fully active state while in
contact with TCR-pepMHC complex, but it will be deactivated shortly upon departure
from the safe zone around TCR-pepMHC. This, as one will see in more details below,
creates a potential for the signal enhancement: if fully activated Lck encounters TCR
engaged with the self-pepMHC before it gets deactivated, it might as well phosphorylate
its C-chains, thus, increasing the total TCR phosphorylation level.
As one can see from the above considerations, the mechanism behind the self-
peptide co-enhancement includes profound contribution of the spatial component.
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Although there have been conceptual studies dealing with the principles behind the self-
peptide enhancement (Li et al., 2004a; Wylie et al., 2007a), coherent consideration that
takes into account both protein-protein interactions and spatial localization and
incorporates all available biophysical measurements is still lacking. Here, we report the
first study that meets these criteria and, thus, allows us to analyze different possible
enhancement mechanisms in details.
We consider the situation when antigen presenting cell (APC) presents the
mixture of cognate and non-cognate peptides on its surface. We analyze three different
explicit models that describe signal enhancement due to the presence of non-signaling
peptides on the APC surface. Each model represents distinct mechanism that is
characterized by a certain parameter regime of validity and specific assumptions about
the molecular interactions. We find in all cases that interplay between spatial motion of
membrane proteins and protein-protein interactions are critical to the signal enhancement
mechanism.
This explicit description of synergism due to non-cognate peptide-MHCs allows
us to address the important debate regarding the differences in the signal enhancement in
CD4 and CD8 T-cells (Ebert et al., 2009; Lo et al., 2009; Yachi et al., 2005a; Yachi et al.,
2007). We search for the possibility that differences in CD4 vs CD8 experiments arise
from a common mechanism due to differences in the strength of molecular interactions.
For example, it is well known that CD8 has larger affinity for MHC molecules than CD4
(Gao et al., 2002). We, therefore, examine the models with respect to parameters that
describe structural and molecular differences between CD4 and CD8 coreceptors, such as
interactions with MHC receptor, interactions between TCR and Lck bound to
intracellular domain of the coreceptor and efficacy of (-chain phosphorylation by Lck. In
all three models we, indeed, are able to identify the critical properties that are responsible
for the observed experimental distinction between CD4 and CD8 self-peptide co-
stimulation.
Finally, the prospective taken in this work, namely, a heavy emphasis on spatial
movement of proteins in the membrane in early T-cell signaling, allows us to comment
on the importance and function of the heterogeneteities existing in the T-cell membrane
before any TCR signaling. Important example is microclustering of T-cell receptors on
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the surface (Campi et al., 2005; DeMond et al., 2008; Dustin, 2009). Our work offers the
way of thinking for more detailed studies of spatial effects in T-cell signaling that will
address the questions like what is optimal spatial distribution of TCR leading to the
optimal signaling (i.e. what is optimal size and pattern of microclusters) etc.
6.2 Model 1 of self-peptide enhancement
Model 1 is described by the following general picture. At rest, T-cell surface
contains a mixture of T-cell receptors and coreceptors (Lck is assumed to be constantly
associasted with coreceptor, at least on the time scale of the early signaling events). Large
amounts of CD45 ensure that Lck, both free and coreceptor associated one, is in the
basally active state, thus, at the initial point we assume that all of the Lck is at the basally
active state. The activity of Lck is defined through its ability to phosphorylate engaged T-
cell receptor, reflected by the C-chain phosphorylation rate (k, and kp,act - see Table 1)
(Kersh et al., 1998). We define the level of basal activity of Lck (kp) as the one that is
consistent with kinetic proofreading requirements sufficient to deliver TCR
phosphorylation by an agonist (koff, TCR-AgMHC <0.l s), but not by the self-peptide. Upon
engagement with the antigen-presenting cell, coreceptor-associated Lck is recruited to the
engaged TCR-pepMHC complex. This process is regulated by two interactions:
coreceptor-MHC binding (on-rate kon,CD4(8)-MHC and off-rate koffCD4(8)-MHC) and Lck
association with intracellular domain of TCR (on-rate kofn,Lck-TCR and off-rate koffLck-TCR).
In this model we assume that Lck can carry out c-chains phosphorylation only if it is
associated with TCR that is engaged with MHC at the same moment. Note that peptide
identity does not play direct role, the likelihood of TCR phosphorylation is very different
for self and non-self-peptides due to different lifetimes of the pepMHC-TCR complex.
Only upon complete C-chain phosphorylation, adapter proteins associated with T-
cell receptor can upgrade Lck to the fully active state provided that Lck remains
associated with TCR sufficiently long. This process is coarse-grained into one activation
reaction described by the rate kact. Fully active state of Lck is characterized by increased
-chain phosphorylation rate (kp,act) and can carry out phosphorylation even before
engagement with TCR, rather, spatial proximity is sufficient condition for kinase action.
Deactivation under the action of CD45 is also described through single reaction
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characterized by the rate kdeact; it is assumed that deactivation can only take place when
coreceptor is not associated with either TCR or MHC and, thus, approach of oversized
CD45 protein is possible.
Ultimately, coreceptor bearing fully active Lck can disassemble from MHC-TCR
complex after which it diffuses freely around the T-cell surface. During this period, fully
active form of Lck survives for a limited amount of time until CD45 downgrades Lck to
basaly active form (this timescale is set by the choice of kdeact to be approximately
1/kdeact). If, during this time, it encounters TCR that is transiently associated with the self-
derived pepMHC, Lck can phosphorylate new TCR provided that fully active Lck is
sufficiently active. The sufficient condition is that kp,act 2 koffTCR-EnMHC, i.e. endogenous
peptide-MHC comlpex is engaged with TCR long enough for the fully active Lck to
phosphorylate its C-chains. This mode of action is local with respect to the initial agonist-
MHC engagement position because fully active Lck can only go so far before it becomes
deactivated to the basal level. This mechanism is summarized pictorially on the Fig. 6.1.
We see therefore, that self peptides involvement in the signaling process is
critically dependent on the spatial component and mutual locations of cognate pepMHC,
non-cognate MHC and coreceptor. We can deduce the most sensitive parameters
controlling enhancement by self peptides to be diffusion rate of the coreceptor, rate of
deactivation of the fully active form of Lck, and, of course, concentration of the self-
peptides. It comes as no surprise in this model that artificially co-localized self- and
agonist peptides are capable of the strong enhancement of the signal, e.g. when put
together on the quantum dot or bound by a molecular tether (Anikeeva et al., 2006;
Krogsgaard et al., 2007b).
In order to study the behavior of the model in details we have performed spatially
resolved stochastic simulations mimicking 1 tm 2 interface between T-cell and antigen-
presenting cell. We assume that there are 300 T-cell receptors, 100 coreceptors engaged
with Lck and 100 MHC-peptide complexes freely diffusing in this area. The read-out of
the simulation was the amount of fully phosphorylated TCRs at steady-state. For
simplicity, multitude of phosphorylation site on -chain of TCR was modeled by
introducing two states - partially phosphorylated TCR and fully phosphorylated TCR
(Kersh et al., 1998; Wylie et al., 2007a). The presence of the phosphotases that
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constitutively dephosphorylate c-chains was modeled by the dephosphorylation reaction
characterized by the rate kap.
Table 1 presents parameters used in the simulations, and lists the basic set of
reactions. The red entries indicate parameters available from biophysical measurements.
These table entries were recomputed from available experimental information (all the
numbers are in units of s4 in accord with the discussion in methods section,
experimentally measured values corresponding to the simulation parameter are also
provided). Black entries had to be estimated theoretically. In fact, in many cases
experimental data provide indirect, yet very strict bounds on the experimentally
unavailable parameters.
For instance, the phosphorylation and dephosphorylation by basal Lck rates are
readily estimated from the fact that kinetic proofreading scheme leading to fully
phosphorylated TCR must separate peptide-MHC complexes into two classes in accord
with their koffTCR-pepMHC. Particularly, peptide-MHC complexes with korr >1 s4 should
never be able to stimulate the T-cell (i.e., fully phosphorylate TCR in this model) while
peptide-MHCs with korr<l s 1 deliver different levels of TCR phosphorylation (see Fig.
6.1). Rate of Lck association with internal part of TCR and Lck activation rate are
estimated following the same reasoning. There is, however, no reliable argument to
anticipate the value of two parameters.
Firstly, phosphorylation rate by fully activated Lck is free parameter of the model
that has been varied extensively. As one will see below, it is varying this rate parameter
we find that the model exhibits regimes reminiscent of CD4 and CD8 behavior with
respect to self-peptides for different values of phosphorylation rate by fully activated
Lck.
Secondly, Lck deactivation rate from fully active to the basal state is completely
free parameter. As mentioned above, this parameter regulates the lifetime of the freely
diffusing fully active Lck. Thus, two extreme scenarios are possible: one, when Lck has
lifetime sufficient to encounter other TCR-MHC complexes, and second, when Lck is
deactivated immediately upon coreceptor disengagement from TCR-MHC. This, in fact,
leads to two very different mechanism of signal enhancement that are considered in
models 1 and 2. Here, in first model, we set deactivation rate to a sufficiently small
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value. Physically this means that coreceptor with activated Lck will have a reasonable
lifetime after disengagement from the original TCR-pepMHC. During this lifetime,
activated Lck will phosphorylate TCRs transiently complexed with self-peptides-MHC.
Next, we see how the levels of phosphorylation delivered by agonist alone
compare with the phosphorylation triggered by the mixture of agonist and null-peptide
(k, =20 s 1). According to experimental data, mixtures perform better due to synergistic
effects of the non-cognate peptides. Indeed, as one can see on the Fig. 6.3 addition of
non-cognate peptides dramatically increases the signal. Moreover, for small
concentrations of agonist, we see that 10 agonist peptides presented in the sea of the self-
peptides perform as good as ~30 agonist peptides alone.
What is the parameter, responsible for the amount of enhancement delivered by
self-peptides? Rate of deactivation of coreceptor associated Lck, which, basically,
represents the activity of the CD45 and diffusion rate of the free coreceptor both
determine how far away can receptor with fully active Lck diffuse from the agonistMHC-
TCR complex which initially activated Lck. The bigger is the area covered by diffusion
of fully active Lck, the bigger is the harvest of TCRs bound to endogenous pepMHC that
Lck can phosphorylate. As one can see from Fig. 6.3 (red open circles), increasing
deactivation rate leads to the smaller signal enhancement levels.
Molecular and structural differences between the CD4 and CD8 coreceptors can
be ascribed to several parameters in this model. Firstly, these are parameters
corresponding to the interaction of coreceptor with MHC. It is generally accepted that
CD8 affinity to the MHC class I molecules is 2-3 times higher than CD4 affinity to MHC
class II molecules (Gao et al., 2002). Secondly, the rate of Lck binding to TCR can be
different due to different structure of intracellular and transmembrane domains of CD4
and CD8 proteins. Finally, the rate of phosphorylation by the fully active Lck could also
be different for CD4 and CD8 proteins as a consequence of different spatial organization
of coreceptor-Lck-TCR complex.
Experiments show that enhancement effect depends on the self-peptides identity,
which in kinetic reaction-diffusion scheme translates into stability of self-pepMHC-TCR
(kog), for tested pool of peptides in case of CD4 T-cells, while all tested null-peptides
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enhance the signal equally well in CD8 T-cells. Can we describe these experimental
differences varying parameters distinguishing CD4 and CD8 T-cells?
In our simulations behavior of CD8 cells would be manifested in that all the self-
peptides in the wide range of koffTCR-EnMHC (e.g. 10 s 1 to 300 s-) would be able to
enhance the signal initiated by the agonist. On the other side, experimentally observed
CD4-like behavior would correspond to the situation when only limited range of self-
peptides could co-enhance agonist-MHC (e.g. only 10 s4 to 50 s-1).
We find in our simulations that varying parameters related to coreceptor
association with MHC or Lck binding to TCR does not change the range of self-peptides
that are able to enhance the agonist-derived signal. Rather these parameters affect the
magnitude of enhancement for all the self-peptides equally. However, when the
effectiveness of TCR phosphorylation by fully activated Lck is perturbed, one sees that
range of co-enhancing self-peptides changes. If the phosphorylation rate by fully active
Lck is high, then practically all the self peptides can synergize the signaling with equal
efficiency (see Fig. 6.4a), which correspond to the observations made on CD8 T-cells. If,
however, phosphorylation by fully active Lck is moderately stronger then by basal Lck,
the quality (koff) of the self-peptide plays a crucial role (see Fig. 6.4b), like it was
observed in case of CD4 T-cells. Biologically this would mean that CD8 coreceptor
associates Lck with TCR more tightly and carries out phosphorylation more effectively
then CD4.
Also, note that in CD4-like regime (Fig. 6.4b) only strong agonist can be
synergized by sufficiently good peptides, whereas in CD8-like case (Fig. 6.4a) this effect
is independent of quality of the agonist.
Summing up, in the described mechanism, the difference in behavior of the CD4
and CD8 T-cell is due to the distinct ways of coordinating Lck nearby intracellular part of
the TCR, which leads to the higher efficiency of phosphorylation in CD8 T-cells
compared to CD4 cells. Indeed, the recent experiments (Mallaun et al., 2008) indicate
that the potency of coreceptor associated kinase is critically dependent on the close
proximity between coreceptor and T-cell receptor. This difference in CD4 versus CD8
Lck proximity to intracellular domain of TCR can be a consequence of the difference in
affinities of the coreceptors to MHC or simply follow from the different structures of
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these proteins. We identify it as a critical, parameters, but the cause of variation lies
actually in the physical differences for CD4 and CD8 coreceptors ((association with
MHC, structure of the intracellular domain).
6.3 Model 2 of self-peptide enhancement
In this model we explore a different set of assumptions that describe the self-
peptide involvement in the signaling process. Here, we consider the regime when
deactivating ability of CD45 is very high (kdeact is large) and lifetime of fully active Lek
is very small, i.e. it becomes deactivated almost immediately upon disengagement from
TCR-pepMHC complex. Thus, the only the possibility to extend action of fully active
Lek is through stable association with intracellular domains of TCR for as long as TCR is
engaged to peptide-MHC complex (i.e., koff,Lck-TCR is very small). Because of the stable
binding, activated Lek is always localized within the original, successful TCR-pepMHC
interaction. Thus, signal enhancement can only occur when other MHCs that bear self-
peptides occasionally engage with TCR in the region nearby the initial TCR-MHC
complex (as shown pictorially on Fig. 6.5).
If, in order to reflect the above biological picture, we merely change koff, Lck-TCR in
the model 1 to the smaller value, it leads to the constitutive signaling even with non-
signaling peptides, thus, losing the distinction between agonist and non-agonist peptides.
Such a behavior is due to stochastic activating of Lek: once every while, even self-
peptides are capable of activating one or few fully active Lek molecules. Such rare events
play no role in model 1 because Lek is deactivated shortly after it disengages from TCR.
If Lek binds to TCR very stably then single fully active Lek has a lifetime determined not
by deactivating ability of CD45 but rather by dissociation rate of Lck-TCR connection.
Presence of active Lck allows for phosphorylation of bystander-TCR-pepMHC which, in
turn, activates more Lek leading to global TCR phosphorylation. In this manner rare
events trigger uncontrolled activation of T-cells. The only difference between weak and
strong peptides in this situation is in average waiting time until such rare event occurs.
Biologically this would imply that every T-cell could get activated by non-cognate
peptide if we observe it for sufficiently long time, which is obviously non-realistic.
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Hence, model 2 requires that, unlike in previous model, we use two different
parameters describing the stability of Lck-TCR complex. As one can see from table 1,
rate of Lck dissociation from TCR, koff, Lck-TCR, takes two different values: very large,
when TCR is not bound to pepMHC (i.e. Lck-TCR bond is very unstable without
pepMHC), or small value, when TCR is bound to pepMHC (i.e., Lck-TCR bond is
stable). As detailed above, additional discrimination between the rates of TCR binding
with free Lck or MHC-coreceptor mediated Lck binding is necessary in this model,
because otherwise free Lck could trigger unstimulated T-cell due to single stochastic
engagement leading to long stable binding.
As one can see from Table 1, reaction network in this model is almost identical to
the previous model with the only difference in rate constants and possibility to cross-
phosphorylate bystander TCR by Lck engaged with the other TCR. In order to study this
mechanism and do not mix it with model 1, deactivation rate of Lck was set to the very
large value. This means that Lck will be deactivated almost instantaneously upon
disengaging from TCR, hence, only proximal mode of cross-phosphorylation is possible.
Two mechanisms described by models 1 and 2 are, therefore, not mutually exclusive,
and, in reality, signal enhancement is likely to be the consequence of both of the
mechanisms.
Since no changes are made in the basic signal initiation module, model 2 is
equally capable of discriminating between agonist and non-agonist peptides (see Fig. 6.6)
in the same manner as model 1. One finds, however, that enhancement mechanism of
model 2 is less efficient compared to the model 1 (see below). It is because the
mechanism of signal enhancement in Model 2 requires that 5 proteins ultimately appear
in the very close proximity to each other (see Fig. 6.5) as opposed to just 3 proteins
"colliding" productively in the Model 1.
In terms of models simulations the difference in enhancement strength is seen
when varying TCR dephosphorylation rates in each model, which represent activity of
generic phosphotases. To recognize the effect of dephosphorylation rate one should note
that in both models TCR phosphorylation is arising from two sources: direct
phosphorylation due to engaging with agonist-MHC, which provides the signal, and
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phosphorylation due to non-agonist pepMHCs, which provides signal enhancement.
Changing the dephosphorylation rate affects differentially each of the mechanisms.
Direct phosphorylation mechanisms and rate parameters are identical in both
models. Since in both models dephosphorylation is possible only after disengagement of
TCR from MHC (i.e. when phosphotase can approach it), then, even in the limit of the
very strong dephosphorylation rate, TCRs bound to the agonist MHCs will get
phosphorylated. In this limit, upon disengagement TCRs will get dephosphorylated
almost instantaneously and thus phosphorylation levels (i.e. signal levels) are defined by
the number of TCR bound to agonist-MHC at each instant of time. Note, that signal
enhancement decreases to zero when phosphotases are very active because those TCRs
are regularly exposed to phosphotases due to shortness of binding time with non-cognate
peptide-MHC. Hence, we see that rate of dephosphorylation affects phosphorylation
levels due to signal initiation less dramatically then signal enhancement. As one
decreases kdph, TCR (i.e. reduces level of phosphotases activity), signal enhancement
becomes more and more pronounced. By comparing the level of signal enhancement for
equal values of kdph,TCR in both models we can judge the efficiency of each enhancement
mechanism.
In simulations of model 2, kdph,TCR must be decreased compared to model 1 in
order to observe similar levels of signal enhancement (see table 1 and Fig. 6.7). Indeed,
when keeping dephosphorylation rate in Model 2 exactly the same as in Model 1, one
observes no signal enhancement when comparing agonist-null-peptide mixture against.
the agonist alone. Even though this comparison allows us to judge the relative "strength"
of signal enhancement in each mechanism, it does not provide the basis for
discriminating between two models, because one can not say which value of the
dephosphorylation rate corresponds to the level of phosphotases activity inside the real
cell since kdph,TCR actually coarse-grains a number of processes into a single step
In spite of the different enhancement mechanism, model 2 exhibits features
similar to model 1 with respect to the discrimination between CD4-like and CD8-like
behavior. Similar to model 1, in model 2 there are several relevant parameters: rates of
coreceptor-MHC association and dissociation, rate of Lck associating with, and
132
dissociating from, the internal domain of TCR, and, finally, the rate of phosphorylation
by fully active Lck.
Varying relevant parameters we should be able to reproduce both CD4- and CD8-
like behavior of T-cell activation module with respect to self-peptides. Namely, for
different values of the parameter we should be able to see that the self-peptides of broad
range contribute approximately equally to the signal enhancement, independent of their
quality (CD8-like), or that self-peptides of restricted range are capable of co-enhancing
(CD4-like behavior).
Decreasing coreceptor-MHC association rate or increasing their dissociation rates
decreases levels of TCR phosphorylation due to signal enhancement, but does so equally
for all self-peptides. Same results are obtained when varying parameters of TCR and Lck
interactions. Therefore, it is impossible to reproduces both CD4 and CD8 behavior only
changing these parameters. The discrimination of the self-peptides based on their quality
can, however, be explained when varying the rate of TCR-phosphorylation by fully active
Lck with CD8-like regime observed for more efficient phosphorylation by fully active
Lck, and CD4-like regime for less efficient phosphorylation (Fig. 6.8). Biologically, this
can be the consequence of the bigger stability of CD8-MHC interactions and differenes in
structure between CD4 and CD8 coreceptors.
6.4 Model 3 of self-peptide enhancement
In this part we study spatial behavior of the model that can be considered as a
modification of the "pseudodimer" model (Krogsgaard et al., 2007a). Note that in models
1 and 2 coreceptor could bind to the engaged pepMHC-TCR complex at the same time
through both its extracellular domain (CD4/CD8+MHC interactions) and its intracellular
domain (Lck associated with coreceptor + TCR interaction). This arrangement plays
important role in the described mechanism of Lck recruitment to the engaged TCR. In
this, a la "pseudodimer", model, it is assumed that due to steric reasons (Krogsgaard et
al., 2007a) such an arrangement is not possible. Instead, receptor bound to engaged TCR
through intracellular domain can attach to another MHC molecule forming
"pseudodimer" structure with two different MHCs in the close proximity of a single
coreceptor and its Lck kinase (Fig. 6.9).
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As one can see from Table 1, the basic parameters of the model are the same as
for model 2 with the exception of the dephosphorylation rate constant and rate of Lck
association with TCR. Due to this similarity, we see that discrimination of the agonist and
null peptides is preserved in this model (Fig. 6.10). However, since model 3 does not
provide efficient Lck recruitment through coreceptor, rate of direct association between
Lck and intracellular domain of engaged TCR has to be increased compared to the
models 1 and 2 in order to achieve reasonable levels of signaling. At the same time, we
find that enhancement strength, as understood in previous section, is about the same for
model 3 as for model 1. This is reflected in that similar enhancement levels (Fig. 6.11)
are achieved with same rate of dephosphorylation (Table 1). Improved enhancement in
model 3 compared to model 2 is due to strong interactions (see kon,coreceptor-MHC, Table 1)
of the extracellular domain of coreceptor with bypassing MHCs, effectively recruiting
them to the engagement site while in model 2 it was passive process of random
occurrence of MHC nearby the site of initial engagement.
We do not find, however, that "pseudodimer" behaves like catalytic center
phosphorylating multiple TCRs transiently engaging with non-cognate pepMHC part of
pseudodimer (Krogsgaard et al., 2007a). Rather, because of the short-lived coreceptor
MHC association, we find that multiple engagements of MHC-TCR lead to the signal
enhancement
Finally, we study how in this model the differences between CD4 and CD8
receptors can be accommodated. Following the same procedure as for the previous two
models, we find that in model 3 it is also effectiveness of phosphorylation by fully active
Lck that is responsible for observed experimental disparity between CD4 and CD8 T-
cells. The Fig. 6.12 indicates that for smaller value of kp.act one can observe the difference
between the different non-cognate peptides enhancing the signal, while for larger value of
kp,act all natural non-cognate peptides will deliver approximately similar level of signal
enhancement.
6.5 Discussion
We have described three models detailing possible mechanisms of signal
enhancement by non-cognate peptides. Each model is characterized by different set of
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assumptions and employs parameters consistent with available direct biophysical
measurements. Model 1 requires the smallest number of assumptions and parameters
about the molecular interactions. Models 2 and 3, however, require additional assumption
about ability of fully active Lck to cross phosphorylate bystander TCR while still bound
to initial TCR. Also supplementary distinction of Lck binding with engaged/free TCR
should be introduced to models 2 and 3. Note that models 1 and 2 are compatible with
described mechanism (Chapter 5) of the Lck recruitment, while model 3 does not have a
mechanism for coreceptor recruiting Lck to the engaged TCR. It must be also
additionally stressed that models 1 and 2 are not mutually exclusive and actual
enhancement process can employ both mechanisms at the same time.
Importance of the spatial coordination of T-cell receptors and MHC proteins is a
feature common to all the models. The locality of the action of fully activated Lck
restricts the region of active signaling to the proximity of the initial TCR-MHC
productive encounter. This correlates well with recent experiments indicating that
additional co-localization of TCRs (e.g. through the actin skeleton actions) improves
signaling in T-cells (Anikeeva et al., 2006; DeMond et al., 2008; Krogsgaard et al.,
2005). On the same basis, the experiments where peptide-MHC proteins are artificially
co-localized with a biotin link (Krogsgaard et al., 2005) are also explained by either of
three models.
Analysis of all models reveals that one of the important differences between CD4
and CD8 T-cells is the efficiency of TCR phosphorylation by fully activated TCR. This
efficiency determines the ultimate level of sensitivity accessible by T-cells, because no
pepMHC-TCR interaction can be "felt" by T-cell if lifetime of pepMHC-TCR complex is
smaller than time required by fully active Lck to phosphorylate engaged TCR. All the
considered models predict that fully active Lck is more efficient in CD8 T-cells (i.e.
kp,actCD8>kp,actCD4). This fact has to be of special importance in the situation when T-cell
operates on the edge of its sensitivity threshold, e.g. when it has to be positively selected
during the thymic selection process. In accord with the considered models, it would be
reasonable to predict that CD8 T-cells could be positively selected on the broader set of
peptides than CD4 T-cells (as measured by koff, pepMHC-TCR)- This prediction is
corroborated by recent experiments by Mark M. Davis group (Ebert et al., 2009) and
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Allen's group (Lo et al., 2009) where endogeneous positively selecting peptides were
identified for the first time and it was found that only these peptides are capable of co-
enhancing activation signal derived from agonist.
We conclude by considering the possibilities of experimental discrimination
between three models. Model 3 does not allow coreceptor to be simultaneously bound to
the engaged TCR-MHC complex with both its intracellular domain bound to TCR and
extracellular domain bound to MHC. FRET or similar structural studies could be of help
when judging the reliability of this assumption. Models 1 and 2 are different in more
subtle manner and are not mutually exclusive. Model 1 requires coreceptor to diffuse
away from the site of original engagement, while model 2 provides very local mode of
signal enhancement. Note, that Model 2 would be very insensitive to the variations in the
phosphotase maintaining Lck in its basal state (CD45), while large increase of the CD45
levels will shut down any signal enhancement in Model 1. So, varying CD45 levels and
measuring the change in signal enhancement, one can estimate experimentally the
contribution of each of the model. Alternative experiment would be to physically co-
localize coreceptor with TCR with some kind of covalent linker and determine the level
of signal enhancement. With physical co-localization, only model 2 that can be realized
and, hence, measured change in enhancement levels will describe the contribution of
enhancement in accord to the model 1.
Finally, it follows from all of the considered mechanisms that colocalization of T-
cell receptors on the surface will drastically improve signaling and sensitivity. This is
particularly important because according to recent experiments (Campi et al., 2005;
Dustin, 2009) T-cell receptors are not randomly distributed across the T-cell surface but
rather are organized in the pre-formed microcluters. The formation of microclusters can
be very important part of the spatial organization critical for the early T-cell signaling
which we plan to assess in future work.
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6.6 Appendix to Chapter 6
SSC code Model 1:
--COMPLEXES FORMATION
-- MHC/TCR bond
rxn m:MHC(t#, c#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#1) CD4(m#1, t#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#) t:TCR(m#, c#1) CD4(t#1, m#) at kon -> m.t # t.m
rxn m:MHC(c#2, t#) t:TCR(m#, c#1) CD4(t#1, m#2) at kon -> m.t # t.m
rxn TCR(m#1) MHC(t#1, p="ag") at koffAg -> break 1
rxn TCR(m#1) MHC(t#1, p="en") at koffEn -> break 1
- TCR/CD4 bond
rxn t:TCR(c#, m#) c:CD4(t#, m#) at konLck1 -> t.c # c.t
rxn t:TCR(c#, m#1) MHC(t#1, c#) c:CD4(t#, m#) at konLckl -> t.c # c.t
rxn t:TCR(c#, m#) c:CD4(t#, m#1) MHC(c#1, t#) at konLckl -> t.c # c.t
rxn t:TCR(m#2, c#) c:CD4(t#, m#1) MHC(c#1, t#2) at konLck2 -> t.c # c.t
rxn TCR(c#1, m#2) MHC(t#2) CD4(t#1) at koffLck -> break 1
rxn TCR(c#1, m#) CD4(t#1) at koffLck2 -> break 1
- MHC/CD4 bond
rxn m:MHC(c#, t#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#1) TCR(m#1, c#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#) c:CD4(m#, t#1) TCR(c#1, m#) at konCD -> m.c # c.m
rxn m:MHC(t#2, c#) c:CD4(m#, t#1) TCR(c#1, m#2) at konCD -> m.c # c.m
rxn MHC(c#1) CD4(m#1) at koffCD -> break 1
- MODIFICATIONS
- Phosphorylation/Dephosphorylation
rxn t:TCR(p="p0", c#1, m#2) MHC(t#2) CD4(Ick="basal", t#1) at kpl -> t.p = "p1"
rxn t:TCR(p="pl", c#1, m#2) MHC(t#2) CD4(Ick="basal", t#1) at kp2 -> t.p = "p2"
rxn t:TCR(p="p0", c#1, m#2) MHC(t#2) CD4(Ick="active", t#1) at kpactl -> t.p = "p1"
rxn t:TCR(p="pl", c#1, m#2) MHC(t#2) CD4(Ick="active", t#1) at kpact2 -> t.p = "p2"
rxn t:TCR(p="p0", m#2) MHC(t#2, c#1) CD4(Ick="active", m#1) at kpactl -> t.p = "p1"
rxn t:TCR(p="pl", m#2) MHC(t#2, c#1) CD4(Ick="active", m#1) at kpact2 -> t.p = "p2"
rxn t:TCR(p="p1", m#) at kdpl -> t.p = "p0"
rxn t:TCR(p="p2", m#) at kdp2 -> t.p = "p1"
- Lck activation/deactivation
rxn c:CD4(lck="basal", t#1) TCR(c#1, p="p2", m#2) MHC(t#2) at kact -> c.Ick = "active"
rxn c:CD4(lck="basal", m#1) TCR(p="p2", m#2) MHC(c#1, t#2) at kact -> c.Ick = "active"
rxn c:CD4(Ick="active", t#, m#) at kdeact -> c.Ick = "basal"
--initial species
new MHC(p="ag") at count ag
new MHC(p="en") at counten
new TCR(p="pO") at 300
new CD4(Ick="basal") at 100
diffusion at 0
diffusion MHC(t#, c#) at kdiff
diffusion TCR(m#, c#) at kdiff
diffusion CD4(m#, t#) at kdiff
record TCR(p="p2")
Rate parameters
'kon': 150, 'koffAg': 0.02, 'konCD': 1000, 'koffCD': 20.0,
'kpl': 0.1, 'kp2': 0.05, 'kdpl': 0.4, 'kdp2': 0.2, 'kdiff: 50, 'kact': 1,
'kdeact': 0.3, 'koffEn': 20, 'konLckl': 1, 'konLck2': 1, 'koffLck': 1,
'koffLck2': 1, 'kpactl': 10000, 'kpact2': 10000, 'countag': 0, 'count en': 0,
137
SSC code Model 2
--COMPLEXES FORMATION
- MHC/TCR bond
rxn m:MHC(t#, c#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#1) CD4(m#1, t#) t:TCR(m#, c#) at kon -> m.t # t.m
rxn m:MHC(t#, c#) t:TCR(m#, c#1) CD4(t#1, m#) at kon -> m.t # t.m
rxn m:MHC(c#2, t#) t:TCR(m#, c#1) CD4(t#1, m#2) at kon -> m.t # t.m
rxn TCR(m#1) MHC(t#1, p="ag") at koffAg -> break 1
rxn TCR(m#1) MHC(t#1, p="en") at koffEn - break 1
-- TCR/CD4 bond
rxn t:TCR(c#, m#) c:CD4(t#, m#) at konLckl -> t.c # c.t
rxn t:TCR(c#, m#1) MHC(t#1, c#) c:CD4(t#, m#) at konLckl -> t.c # c.t
rxn t:TCR(c#, m#) c:CD4(t#, m#1) MHC(c#1, t#) at konLckl -> t.c # c.t
rxn t:TCR(m#2, c#) c:CD4(t#, m#1) MHC(c#1, t#2) at konLck2 -> t.c # c.t
rxn TCR(c#1, m#2) MHC(t#2) CD4(t#1) at koffLck -> break 1
rxn TCR(c#1, m#) CD4(t#1) at koffLck2 -> break 1
- MHC/CD4 bond
rxn m:MHC(c#, t#) c:CD4(m#, t#) at konCD -> m.c # c.m
rxn m:MHC(c#, t#1) TCR(m#1, c#) c:CD4(m#, t#) at konCD - m.c # c.m
rxn m:MHC(c#, t#) c:CD4(m#, t#1) TCR(c#1, m#) at konCD -> m.c # c.m
rxn m:MHC(t#2, c#) c:CD4(m#, t#1) TCR(c#1, m#2) at konCD -> m.c # c.m
rxn MHC(c#1) CD4(m#1) at koffCD -> break 1
-MODIFICATIONS
- Phosphorylation/Dephosphorylation
rxn t:TCR(p="p0", c#1, m#2) MHC(t#2) CD4(Ick="basa", t#1) at kpl -> t.p = "p1"
rxn t:TCR(p="p1", c#1, m#2) MHC(t#2) CD4(Ick="basa", t#1) at kp2 -> t.p = "p2"
rxn t:TCR(p="pO", c#1, m#2) MHC(t#2) CD4(Ick="active", t#1) at kpactl -> t.p = "p1"
rxn t:TCR(p="p1", c#1, m#2) MHC(t#2) CD4(Ick="active", t#1) at kpact2 - t.p = "p2"
rxn t:TCR(p="pO", m#2) MHC(t#2, c#1) CD4(Ick="active", m#1) at kpactl - t.p = "p1"
rxn t:TCR(p="pl", m#2) MHC(t#2, c#1) CD4(Ick="active", m#1) at kpact2 -> t.p = "p2"
rxn t:TCR(p="p0", m#1, c#) MHC(t#1) CD4(Ick="active") at kpactlcross -> t.p = "p1"
rxn t:TCR(p="p1", m#1, c#) MHC(t#1) CD4(Ick="active") at kpact2cross -> t.p = "p2"
rxn t:TCR(p="p1", m#) at kdpl -> t.p = "p0"
rxn t:TCR(p="p2", m#) at kdp2 -> t.p = "p1"
- Lck activation/deactivation
rxn c:CD4(Ick="basal", t#1) TCR(c#1, p="p2", m#2) MHC(t#2) at kact -> c.Ick = "active"
rxn c:CD4(Ick="basal", m#1) TCR(p="p2", m#2) MHC(c#1, t#2) at kact - c.Ick "active"
rxn c:CD4(Ick="active", t#, m#) at kdeact -> c.Ick = "basal"
--initial species
new MHC(p="ag") at count ag
new MHC(p="en") at count en
new TCR(p="pO") at 300
new CD4(Ick="basal") at 100
diffusion at 0
diffusion MHC(t#, c#) at kdiff
diffusion TCR(m#, c#) at kdiff
diffusion CD4(m#, t#) at kdiff
layout grid 100 *100
record TCR(p="p2")
record MHC(p="ag", c#, t#)
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SSC code Model 3:
limit TCR at 5
--COMPLEXES FORMATION
- MHC/TCR bond
rxn m:MHC(t#) t:TCR(m#) at kon -> m.t # t.m
rxn TCR(m#1) MHC(t#1, p="ag") at koffAg -> break 1
rxn TCR(m#1) MHC(t#1, p="en") at koffEn -> break 1
-- TCR/CD4 bond
rxn t:TCR(c#) c:CD4(t#) at konLck -> t.c # c.t
rxn TCR(c#1) CD4(t#1) at koffLck -> break 1
rxn TCR(c#1,m#) CD4(t#1,m#) at koffLck2 -> break 1
-- MHC/CD4 bond
rxn m:MHC(c#) c:CD4(m#) at konCD -> m.c # c.m
rxn MHC(c#1) CD4(m#1) at koffCD -> break 1
- MODIFICATIONS
- Phosphorylation/Dephosphorylation
rxn t:TCR(p="pO", c#1, m#2) MHC(t#2) CD4(Ick="basal", t#1) at kpl -> t.p = "p1"
rxn t:TCR(p="p1", c#1, m#2) MHC(t#2) CD4(lck="basal", t#1) at kp2 -> t.p = "p2"
rxn t:TCR(p="pO", c#1, m#2) MHC(t#2) CD4(Ick="active", t#1) at kpactl -> t.p = "p1"
rxn t:TCR(p="p1", c#1, m#2) MHC(t#2) CD4(Ick="active", t#1) at kpact2 -> t.p = "p2"
rxn t:TCR(p="pO", m#2) MHC(t#2, c#1) CD4(Ick="active", m#1) at kpactl -> t.p = "p1"
rxn t:TCR(p="p1", m#2) MHC(t#2, c#1) CD4(Ick="active", m#1) at kpact2 -> t.p = "p2"
rxn t:TCR(p="pl", m#) at kdpl - t.p = "p0"
rxn t:TCR(p="p2", m#) at kdp2 -> t.p = "p1"
-- Lck activation/deactivation
rxn c:CD4(lck="basal", t#1) TCR(c#1, p="p2", m#2) MHC(t#2) at kact -> c.ick = "active"
rxn c:CD4(Ick="basal", m#1) TCR(p="p2", m#2) MHC(c#1, t#2) at kact -> c.ick = "active"
rxn c:CD4(Ick="active", t#, m#) at kdeact -> c.ick = "basal"
--initial species
new MHC(p="ag") at count ag
new MHC(p="en") at count en
new TCR(p="pO") at 300
new CD4(Ick="basal") at 100
diffusion at 0
diffusion MHC(t#, c#) at kdiff
diffusion TCR(m#, c#) at kdiff
diffusion CD4(m#, t#) at kdiff
layout grid 100 * 100
record TCR(p="p2")
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Table 6.1 Rate parameters used in simulations of Models 1-3, studying signal
enhancement by non-cognate peptides. (Experimentally derived parameters are shown in
red, fitted parameters are shown in black - there are no experimental data available for
black entries)
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Model #
Reaction described
1 2 3
150 150 150 kon, TCR-MHC. TCR-MHC on rate (exp~ 104 Ms-1)
0.02 0.02 0.02 koffTCR-AgMHC TCR-MHC off rate for agonist peptide (exp~0.02 s-1)
1000 1000 1000 kOn,CD4(8)-MHC MHC-coreceptor (CD4/CD8) on-rate (exp~ 105 M's-1)
20 20 20 koffCD4(8)-MHC MHC-coreceptor (CD4/CD8) off rate (exp~20 s-1)
50 50 50 kiff, rate of diffusion of membrane surface proteins (~0.01 pm2/s)
20 20 20 koffTCR-EnMHC TCR-MHC off rate for endogenous peptide (exp~20 s~1)
0.05 0.05 0.05 kp, rate of phosphorylation of TCR by basal Lck
0.2 0.02 0.2 kdp,rate of dephosphorylation of TCR
1 1 100 kon, Lck-TCR, rate of Lck engagement with TCR
0.0002 0.02
1 20 20 koff, Lck-TcR, rate of Lck disengagement with 
TCR
300 300 300 kp,actve,, rate of phosphorylation by fully active Lck
1 1 1 kact rate of Lck activation
0.3 101 101 kdeact, rate of Lck deactivation when away from TCR-pepMHC
complex
N/A 300 kpcross rate of phosphorylation of the bystander TCR by the fully
active Lck bound to another TCR
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6.8 Figures for Chapter 6
Fig. 6.1 Pictorial description of Model 1. The grey surface represents interface between
T-cell (underneath the surface) and APC (above the surface). MHC proteins (brownish)
at APC present two types of peptides: agonist peptides (red star) and non-cognate
peptides (yellow star). Coreceptor (rainbow color) that spans through the interface is
constitutively associated with Lck (red oval) associates with MHC and TCR and after full
activation of Lck disengages, diffuses around and occasionally encounters TCR engaged
with non-cognate pepMHC and phosphorylate it.
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Fig. 6.2 Peptide potency as a function of koff of the peptidesMHC-TCR for the model
where Lck can be basally active or fully active. Simulation of 1 pim 2 of the T-cell/APC
contact area. Concentration of TCR is 300 per pm2, concentration of coreceptor is 100
per pm2.
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Fig. 6.3 Signaling levels of the agonist peptide alone (closed squares) compared to the
mixture of agonist and non-cognate peptide (open circles). The curve in red describes the
behaviour of the mixture of agonist and non-agonist peptides with the rate of Lck
deactivation twice larger than that for the black curve (Table 1). Increasing deactivation
reduces the lifetime of fully activated Lck and hence reduces the signal enhancement
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Fig. 6.4 The TCR phosphorylation stimulated by agonist of indicated kog (three types of
Ag are presented: strong with ko = 0.02 in black, intermediate with kon=0.06 in red and
weak with koff=O.1 in green) or mixture of agonist together with non-stimulating peptide
(denoted as En, endogenous). x-Axis shows the kog for EnMHC-TCR interaction. Panel
(a) corresponds to the high value of the rate of phosphorylation by fully active Lck (kph,act
= 300), while panel (b) has low rate of phosphorylation by fully active Lck (kph,act 100).
As on can see from panel (a) non-cognate peptides of all kinds synergize equally well
when kph,act is large, which is reminiscent of CD8 T-cells behavior. On panel (b)
enhancement level differs for different non-cognate peptides, which is similar to observed
CD4 behavior.
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Fig. 6.5 Pictorial description of Model 2. Coreceptor binds stably to the assembled TCR-
agonistMHC complex and associated Lck gets fully activated. Fully activated Lck is
capable of phosphorylating bypassing TCRs that engage with any pepMHC in the close
vicinity of the original complex. Upon disassembly from original complex fully activated
Lck is deactivated almost instantaneously, which ensures the proximal mode of signal
enhancement.
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Fig. 6.6 Peptide potency as a function of koff of the peptidesMHC-TCR for the model 2.
Simulation of 1 pm2 of the T-cell/APC contact area. Concentration of TCR is 300 per
2 of 12tmconcentration ofcoreceptor is 100 per M.
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Fig. 6.7 Signaling levels of the agonist peptide alone (closed squares) compared to the
mixture of agonist and non-cognate peptide (open circles). A mixture delivers biger
phosphorylation due to non-cognate peptides enhancement.
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Fig. 6.8 The TCR phosphorylation stimulated by agonist of indicated kff or mixture of
agonist together with non-stimulating peptide (denoted as En, endogenous). x-Axis shows
the kof for EnMHC-TCR interaction. Panel (a) corresponds to the high value of the rate
of phosphorylation by fully active Lck (kph,act = 300), while panel (b) has low rate of
phosphorylation by fully active Lck (kph,act 100)-
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Fig. 6.9 Pictorial description of Model 3. Coreceptor associated Lek binds to the
intracellular domain of TCR that is engaged with pepMHC. Due to steric reasons,
extracellular domain of coreceptor can not bind to the engaged MHC, and so it binds to
the bypassing pepMHC, forming "pseudodimer" like structure. When Lek is fully
activated, it can cross-phosphorylated any TCR transiently engaging with the second
pepMHC, leading to signal enhancement.
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Fig. 6.10 Peptide potency as a function of kort of the peptidesMHC-TCR for the model 3.
Simulation of 1 ptm 2 of the T-cell/APC contact area. Concentration of TCR is 300 per
pm2, concentration of coreceptor is 100 per pm2.
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Fig. 6.11 Signaling levels of the agonist peptide alone (closed squares) compared to the
mixture of agonist and non-cognate peptide (open circles) for simulation of model 3. A
mixture delivers biger phosphorylation due to non-cognate peptides enhancement.
Enhancement curves for two different agonist peptides are shown: strong agonist
(kof=0.02 s~) and weak agonist (kof= 0.1 s-)
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Fig. 6.12 The TCR phosphorylation in Model 3 when stimulated by mixture of agonist of
indicated k,,f and non-stimulating peptide (denoted as En, endogenous) or agonist alone.
x-Axis shows the kof for EnMHC-TCR interaction. Panel (a) corresponds to the high
value of the rate of phosphorylation by fully active Lck (kph,act 300), while panel (b) has
low rate of phosphorylation by fully active Lck (kph,actlO10).
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PART III
Chapter 7
A model for genetic and epigenetic regulatory
networks identifies rare pathways for transcription
factor induced pluripotency
7.1 Introduction
Cellular states are plastic, and even terminally differentiated cells (e.g., B-cells)
can be reprogrammed to pluripotency by ectopic expression of selected transcription
factors (Aoi et al., 2008; Jaenisch and Young, 2008; Meissner et al., 2007; Park et al.,
2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Wemig et al., 2007). This
finding raises the possibility of creating patient-specific stem cells for regenerative
medicine (Nishikawa et al., 2008). However, reprogramming efficiencies range from
0.0001 % to 29 % (Huangfu et al., 2008; Takahashi et al., 2007; Takahashi and
Yamanaka, 2006; Yu et al., 2007), with most reports showing that successful induction of
the pluripotent state is rare even if all required factors are present (Brambrink et al., 2008;
Hanna et al., 2008). The genetic and epigenetic regulatory mechanisms that make
reprogramming possible, and determine its efficiency, are poorly understood (Jaenisch
and Young, 2008). Elucidating these mechanistic principles can help define optimal
strategies for reprogramming differentiated cells, and answer fundamental questions
regarding how cellular identity is maintained and transformed.
In spite of recent progress, our knowledge of the identities and functions of the
genes and proteins involved in regulating the transformation of cellular identity is grossly
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incomplete (Jaenisch and Young, 2008; Sridharan and Plath, 2008; Stadtfeld et al., 2008).
Thus, it is not yet possible to construct a detailed molecular mechanistic description of
how epigenetic modifications and expression of master regulatory genes are controlled.
However, ectopic expression of the same transcription factors can reprogram different
cell types (Aoi et al., 2008; Hanna et al., 2008; Takahashi and Yamanaka, 2006), and the
genetic and epigenetic transformations observed during reprogramming of diverse
differentiated cells share many common features (Brambrink et al., 2008; Egli et al.,
2008; Jaenisch and Young, 2008; Maherali et al., 2007; Meissner et al., 2008; Mikkelsen
et al., 2008; Mikkelsen et al., 2007). These common observations can be the basis for
developing a conceptual understanding of the architecture of the genetic and epigenetic
networks that regulate transcription factor induced reprogramming and establish cellular
identity during differentiation.
We have taken a step toward this goal by developing a computational model that
is consistent with, and suggests general mechanistic explanations for, empirical
observations of transcription factor induced reprogramming. The model makes
experimentally-testable predictions. If validated, descendents of this model could also
provide insights into the aberrant de-differentiation events which characterize some of the
most malignant cancers.
7.2 Model Development
Elegant theoretical models for the molecular regulatory networks responsible for
stem cell renewal and differentiation and the population dynamics of these processes
have been created (Cinquin and Demongeot, 2005; Jones and Simons, 2008; Jones et al.,
2007; Qu and Ortoleva, 2008; Winkler et al., 2007). Our goal is different. We aim to
develop a model for the architecture of coupled epigenetic and genetic networks which
describes large changes in cellular identity (e.g., induction of pluripotency by
reprogramming factors). Although the general principles of interactions between genetic
and epigenetic layers of regulation have been described (Goldberg et al., 2007; Loeffler
and Roeder, 2002), no computational model has been developed to study the outcomes of
such interactions and their biological consequences. Such a computational model would
be a useful complement to experiments in understanding the processes that occur during
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reprogramming of differentiated cells, and why reprogramming is rare. Here, we
propose, to our knowledge, the first computational model that describes how cellular
identity changes by creating a mathematical description of interactions between
epigenetic and genetic networks. Our goal is not to describe the details of how specific
regulatory proteins interact, but rather, to understand general principles underlying how
cellular states evolve upon ectopic expression of certain types of genes. The concise
model we have developed explains why reprogramming probability is low, and makes
experimentally testable predictions.
Almost all cells in a multi-cellular organism share the same DNA sequence. Yet,
different cell types express distinct genes and perform different functions. Epigenetic
modifications are major regulators of cell-type specific gene expression. They function
by packaging DNA into configurations that allow only some genes to be expressed, while
other genes are tightly packed into heterochromatin structures that hinder access of most
transcription factors (Henikoff, 2008). Changes in cellular identity during developmental
differentiation or transcription factor induced reprogramming require modification of the
epigenetic state of the cell. The maintenance and alteration of cellular identity is
regulated by a complex set of interactions between developmentally important genes,
chromatin modifiers, transcription factors etc., the details of which remain unknown.
Toward developing a model for the architecture of these complex regulatory networks we
consider only the developmentally important genes. For simplicity, each ensemble of
genes responsible for maintenance of a particular cellular identity (e.g., Oct4, Sox2, etc.,
for pluripotency) is described as a single module (Fig. 7.1 a). Theoretical justification for
treating genes that control the embryonic stem (ES) cell state as a collective unit exists
(Chickarmane et al., 2006). We also carried out some studies with each module
consisting of a small number of genes (see Fig. 7.6 and corresponding discussion below).
ES cells can differentiate in to various lineages. Upon further differentiation,
cells become more restricted. For example, hematopoetic stem cells can differentiate in
to T and B-lymphocytes, but not neural cells. Therefore, in our model, we arrange gene
modules in a hierarchy (Fig. 7.1 a). Although each cell state can potentially differentiate
in to many branches, without loss of generality, we consider two branches to emanate
from each cell state. Thus, the cellular states are arranged on a Cayley tree. In our
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model, a cell state (Fig. 7. 1b) is specified by: i] the state of the epigenome, and ii] the
expression levels of master regulatory genes.
Specification and regulation of the epigenome: The epigenome is specified by chromatin
states. Histones with positive marks (e.g. H3K4me3) promote transcription, and histones
with negative marks (e.g. H3K27me3) repress transcription (Kouzarides, 2007; Orford et
al., 2008). Hypermethylated genes are also silent (Fouse et al., 2008; Meissner et al.,
2008). Genes associated with both H3K4me3 and H3K27me3 simultaneously (bivalent
marks) can recruit promoters, but transcription is suppressed (Bernstein et al., 2006;
Efroni et al., 2008; Guenther et al., 2007). Based on these observations, in our model,
each developmentally important gene module can adopt one of three possible epigenetic
states. It can be silent either due to negative histone marks or DNA methylation (denoted
as the "-1" state), marked positively by histone marks (denoted as the "+1" state), and
marked bivalently (denoted as the "0" state). From the standpoint of gene expression,
each module can be either actively transcribing (denoted as the "+1" state) or not
(denoted as the "0" state).
During interphase, DNA with genes packaged in a way characteristic of the cell's
identity manages gene transcription and protein synthesis. Before cell division, the
chromosomes condense. During telophase at the end of mitosis, the prevailing protein
environment could alter the chromatin states of decondensing chromosomes in a daughter
cell, thereby modifying the epigenetic state of its DNA (Egli et al., 2008; Orford and
Scadden, 2008). We divide the cell cycle in to two parts (Fig. 7.2). During phase one
(termed interphase, for ease of reference), the epigenetic state cannot be modified and
gene expression is subject to this constraint. In phase two (termed telophase, for ease of
reference), the epigenetic state can potentially be altered by the protein environment
established during the preceding interphase.
Chromatin state maps show that the ES state is characterized by an unusually
large proportion of bivalent chromatin marks on developmentally important genes
(Bernstein et al., 2006; Mikkelsen et al., 2007; Pan et al., 2007). Therefore, we define the
ES state as one where the gene module controlling this state (expressing Sox2, Oct4, etc.)
is in the open chromatin state and all other master regulator genes are bivalently marked
(Fig. 7.1b, left panel). Since the identities of all master-regulatory genes are not yet
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experimentally available, it should be noted that bivalency of all master-regulatory
modules in the ES state is an assumption that extrapolates available knowledge to yet
unidentified modules.
It is known that, as cells differentiate from the ES state, bivalently marked genes
remain bivalent, acquire a positive mark, or are silenced by negatively marked histones or
methylation (Bernstein et al., 2006; Mikkelsen et al., 2007; Pan et al., 2007). Other than
pluripotent ES cells, upon receiving appropriate cues, a cell state can only differentiate in
to other states in the same lineage. Upon differentiation from the ES state positive
histone marks are removed at an earlier stage compared to silencing of genes by DNA
methylation, and reactivation of DNA methylated genes is more difficult than those with
negative histone marks. These facts are encapsulated in our model by the following rules
regarding how proteins expressed by a particular gene module can modify epigenetic
states during telophase (Fig. 7.3b): 1] They favor putting positive marks on the module
that expresses them, which enables stable maintenance of cellular identity. 2] They favor
putting negative histone marks on the modules regulating the immediate progenitor or an
immediate "sibling" in the hierarchy; this hinders differentiation in to cells in competing
lineages and accidental de-differentiation to the progenitor. 3] They favor putting
bivalent histone marks on the modules that regulate immediate progeny, which keeps
cells poised to differentiate. 4] They favor methylation of all modules that regulate cell
states in competing lineages or less differentiated states in the same lineage. This has a
similar effect as the marking of histones in rule 2.
Rules 1-3 are based on experimental facts, and concern how proteins expressed by
a gene module can affect the histone marks of only modules that regulate its immediate
precursor, immediate progeny (see Fig. 7.3b), or other states to which its precursor can
differentiate (i.e., "nearest neighbors" on the hierarchy of gene modules shown in Fig.
7.1 a).
Rule 4 states that proteins expressed by a gene module favor silenced chromatin
state of gene modules that are distal from it in the hierarchy by DNA methylation (Fig.
7.3b). Although there are no experimental measurements showing that methylation of
unrelated lineages is directly caused by master-regulatory genes of current cell state, this
rule is motivated by the global DNA methylation of genes of unrelated lineages observed
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upon cell differentiation (Maherali et al., 2007; Meissner et al., 2008) and the fact that
global DNA hypomethylation blocks differentiation (Jackson et al., 2004). To further
investigate the effect of such long-range interactions, we have perturbed the formulation
of rule 4 in different ways. We find that unless long-ranged nature of rule 4 is included,
the in silico reprogramming trajectories exhibit features which are inconsistent with
experimental observations. In particular, stable expression of protein products of the ES
master-regulatory module becomes possible within the first reprogramming cycle, in
contradiction with the observation that endogenous Oct4 is expressed shortly before
completion of reprogramming after at least 12 days of action of reprogramming factors
(see, for example Fig. 2 in (Jaenisch and Young, 2008) and references therein). Our
computational results are also inconsistent with this observation if we allow proteins
expressed by a module to put bivalent marks on all modules that regulate states in the
lineage that are below it, rather than just the immediate progeny (rule 3 above).
Specification and regulation of gene expression: In our model, gene expression during
interphase is subject to constraints imposed by the epigenetic marks as follows: 1'] if a
gene module is positively marked, its expression is favored. Expression of bivalently
marked gene modules is not favored, but it is not as strongly suppressed as modules that
are negatively marked or DNA methylated (see Eq. 3 in Methods). 2'] Diverse
experimental data (Briscoe et al., 2000; Rekhtman et al., 1999) show that, due to effects
such as feedback regulation, etc., expression of genes from competing lineages is
mutually repressed. For example, GATA-1, erythroid lineage specific gene, and PU-1,
transcription factor for genes of myeloid lineage are among the most studied master-
regulatory genes. They posses typical properties attributed to the master-regulators in this
manuscript: they enhance their own expression (Nishimura et al., 2000; Okuno et al.,
2005) and mutually antagonize each others' activity (Cinquin and Demongeot, 2005;
Rekhtman et al., 1999; Roeder and Glauche, 2006). We thus impose such mutually
repressive interactions to gene modules that regulate directly competing cellular states
(i.e., nearest neighbors in the hierarchy in Fig. 7.3a).
Rules 1-4 noted above are meant to describe how the epigenetic state is
maintained and how it could evolve due to protein products of signaling events or ectopic
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expression of transcription factors. During telophase, there could be a "tug of war"
between the epigenetic state preferred by newly expressed proteins and that preferred by
proteins expressed in accord with the preceding epigenetic state (Orford and Scadden,
2008). Similarly, rules 1' and 2' could lead to a tug of war between expression of
different genes. Our computations reveal possible outcomes of these battles.
The epigenetic modifications during telophase or gene expression patterns during
interphase are simulated on a computer using a Monte-Carlo algorithm, with rules 1-4
and l'-2' represented as effective Hamiltonians (Eqs. 2-3, Methods). We specify the
initial epigenetic state of the cell or the proteins that have been expressed in the previous
interphase (including signaling products and ectopic expression of transcription factors).
If the gene expression pattern is specified, simulation of telophase results in an epigenetic
state that becomes the input for simulation of the next interphase, and so on (see
Methods).
7.3 Results: Differentiation
ES cells are cultured in specific media (e.g., containing LIF/BMP4 for mouse ES
cells) to prevent differentiation (Ying et al., 2008). The medium inhibits a self-induced
differentiation pathway. We represent this feature by assuming that proteins expressed
by the module regulating the ES state favor putting positive chromatin marks on gene
modules regulating immediate progenies if LIF, etc. are absent. Simulations of this
situation show (Fig. 7.4) that, as in experiments (Jaenisch and Young, 2008), ES cells
differentiate randomly to one of their progeny.
Our model exhibits robust differentiation (forward programming) to specific cell
states when the appropriate cues are delivered. Appropriate cues are expression of
proteins (e.g., signaling products) that become available during interphase. In the next
telophase, these proteins favor putting positive histone marks on the gene module
regulating the appropriate progeny of the current cellular state (rule 1). Results from our
computer simulations demonstrate that our model exhibits high-fidelity responses to such
differentiation cues. This is consistent with the experimental observation that
overexression of the master-regulatory genes of desired lineage leads to predominant
differentiation in that direction (David et al., 2008; David et al., 2009). This result is
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relevant because practical use of induced pluripotent cells will involve differentiating
them to desired cell types. We also find an exponential decay of the number of
progenitor cells (with a signal strength-dependent lifetime), as has been noted before
(Johnston et al., 2007).
7.4 Results: Reprogramming
We simulate reprogramming experiments by starting with a terminally
differentiated cell state where genes from other lineages, etc., have been epigenetically
silenced. Our basic premise is that terminally differentiated cells can reprogram because
protein products of the ectopically expressed genes can potentially alter the epigenetic
state of the cell as a cell progresses through the telophase. In our low resolution model,
we identify genes not by names, but rather by their functional properties. We presume
that Klf4 and c-Myc are important ingredients of the reprogramming "cocktail" because
they promote progression through the cell cycle, and this provides more opportunities for
the other reprogramming factors to perturb the epigenome during telophase. This
functional identification of Klf4 and c-Myc makes our model general, and is validated by
experiments showing that shutting down p53 abrogates the need for Klf4 and c-Myc for
reprogramming (only Oct4 and Sox2 required) precisely because this also allows faster
progression through the cell cycle (Banito et al., 2009; Hong et al., 2009; Kawamura et
al., 2009; Marion et al., 2009; Utikal et al., 2009). Oct4 and Sox2 have an enormous
number of binding targets on the DNA, and are responsible for maintenance of the ES
state which likely implies multiple interactions with master-regulatory genes. We
therefore identify the ectopic expression of these genes with the function of being highly
likely to perturb the epigenome during telophase.
Each gene module in our model corresponds to an ensemble of carefully tuned
mutually interacting master-regulatory genes that govern a particular cellular identity. At
the moment, not all of the master-regulatory genes of cellular states are experimentally
identified, thus we use gene modules to represent these ensembles in a general way. Even
though products of ectopically expressed Oct4 and Sox2 have numerous targets (Wilson
and Koopman, 2002), it is unlikely that the epigenetic state of many such sets of genes
will be simultaneously altered. Thus, in order to mimic the effect of reprogramming
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factors, we randomly pick one epigenetically silenced gene module and change its state to
correspond to open chromatin. To examine the effects of overexpression of ectopic
genes, we also study the consequences of multiple epigenetic transformations at a time
(see Fig. 7.6 and discussions below).
Starting with a terminally differentiated state we perturb the epigenome as
described above, and then simulate the next gene expression phase where both the
module regulating the terminally differentiated state and the one which was transformed
to open chromatin status can express proteins according to rules 1'-2' (or Eq. 3). The
protein atmosphere thus generated becomes the input to simulation of the next telophase
according to rules 1-4 (or Eq. 2). This can then potentially establish a new epigenetic
state which becomes input to simulation of the next gene expression phase; i.e., the
genetic and epigenetic states are allowed to come to a new balance. Then, the epigenetic
state of another randomly picked silent gene module is changed to open chromatin
because of the effects of reprogramming factors. This procedure is continued.
We carried out 10, 000 independent replicate simulations of the effects of ectopic
expression of reprogramming factors on a differentiated cell in a model with four levels
in the hierarchy of cellular states. Results from each simulation describe the fate of a
single cell in a population. Only 3 out of 10, 000 "cells" successfully reprogrammed; i.e,
as in experiments, reprogramming is rare. The percentage of cells that reprogram
depends upon the number of levels in the hierarchy (0.0001 % and 2 % of the cells
reprogram successfully for a five-level and three-level hierarchy, respectively). This
suggests that reprogramming efficiency should improve for less differentiated cells. This
remains to be demonstrated directly in a well-defined lineage such as the hematopoietic
system. However, some support for this idea exists. Hanna et al. demonstrated a notable
increase in the efficiency of reprogramming B cells upon Pax5 knockdown (17). Loss of
Pax5 had been previously shown to cause dedifferentiation of B cells to a common
progenitor that upon transplantation allowed T cell development (Nutt, 2008).
We report results for models consisting of 3-, 4- and 5-levels in the hierarchy of
gene modules, but in real organisms the depth of the differentiation tree could be as large
as tens of levels (Matthew and Brian, 2006). Since our results indicate that
reprogramming efficiency decreases quickly with the increase in the depth of the
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hierarchy, it is natural to ask why reprogramming is at all feasible. The reason is that
master-regulatory genes that regulate closely related states are not mutually exclusive sets
of genes. The difference between genes that regulate closely related cellular states can be
as small as one or two genes (Nutt, 2008). However, genes that regulate cellular states
distal in the hierarchy are not correlated in this way. As our model does not treat
correlations between genes that regulate closely related states, in effect, each gene
module in our model represents master regulatory genes that control the identity of a
number of cellular states that have many master regulatory genes in common. Thus, a 5-
level hierarchy in our model might represent a 50-level depth of differentiation in a real
organism.
The results reported above were obtained for specific values of parameters (Table
1) which represent rules 1-4 and l'-2' (Eqs., 2-3 in Methods). Our simulation results are
consistent with diverse experimental observations (see Table 2 and discussion below)
only if the methylation constraints (rule 4) and mutual repression of expression of gene
modules (rule 2') are relatively strong effects (i.e. H>G and J>F, see Table 1 and
parameter sensitivity in SI for further details). As long as these two conditions are met,
the specific choice of parameter values only alters the quantitative value of the number of
successfully reprogrammed cells, but reprogramming to the ES state remains rare.
Our simulation results suggest a mechanistic explanation for why reprogramming
is so rare. When reprogramming factors attempt to change cellular identity by altering
the epigenetic state of a previously silenced gene module, the probability of success
depends upon the position of this module relative to the one that regulates the terminally
differentiated state. We find that the position of the module whose epigenetic state is
altered can belong to one of three categories (Fig. 7.5a).
Suppose this gene module regulates a cellular identity in a different lineage from
the terminally differentiated state. In the next interphase, both modules can express
proteins as there are no mutually repressive interactions between them. In the subsequent
telophase, proteins expressed by each module would favor epigenetic silencing of the
other (rule 4). Expression of proteins characteristic of a cell type from a different lineage
does not favor reprogramming because it leads to cell death or arrest in our model. Cell
death could be mediated by various mechanisms including genetic instabilities if the two
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open gene modules send conflicting instructions to housekeeping genes. Of course, there
is also the chance that the cell will be rescued by stochastic expression of some master-
regulatory gene, or that the cell will assume an "intermediate" cell state without master
regulation that could be viable, but does not reprogram, such as some arrested
states(Mikkelsen et al., 2008); finally, there is a possibility that two master regulators will
not repress each other in full, but some minuscule amount of expression of both will
remain thus, arresting the cell. Within the framework of our model we do not distinguish
between these possibilities, and classify cells in all these unusual, dead, or arrested states
to be dead/arrested.
The gene module whose epigenetic state is altered by reprogramming factors
could be in the same lineage as the differentiated cell, but not be its sibling or progenitor.
In the following interphase, this module and the one that regulates the terminally
differentiated state can both express proteins. In the subsequent telophase, according to
our model, protein products of the gene module regulating the terminally differentiated
state will favor epigenetic silencing of the module that was turned on by the action of
reprogramming factors (rule 4). But, the opposite is not true because the cellular state
regulated by the gene module whose epigenetic state was altered by reprogramming
factors could potentially differentiate to the terminally differentiated cell type. Thus, the
altered gene module will be silenced again, and the cell remains terminally differentiated.
Reprogramming factors could also change the epigenetic state of a previously
silenced gene module which regulates an immediate sibling or the progenitor of the
terminally differentiated state. In the subsequent interphase, these two gene modules with
open chromatin status will not simultaneously express proteins at high levels. This is
because gene modules that are "nearest neighbors" in the hierarchy mutually repress each
other (rule 2'). If the dominantly expressed gene module (determined stochastically) is
the one which regulates a sibling or the progenitor of the terminally differentiated state,
then during the next telophase its products will establish epigenetic marks consistent with
a new identity (rule 1). Thus, with a probability determined by stochastic effects, a step
toward reprogramming can occur via trans-differentiation or de-differentiation.
These arguments suggest that a step toward reprogramming occurs with
significant probability only if the epigenetic state of a gene module regulating a sibling or
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progenitor of the differentiated cell is. changed to open chromatin status by
reprogramming factors. This is a rare event in our simulations where the set of master
regulator genes that determine a cellular identity are considered to be one gene module.
In reality, this is even less likely because it requires reprogramming factors to orchestrate
changes to a set of master regulator genes synchronously. For successful reprogramming
to the ES state, a sequence of such rare events must occur in a particular cell. This is
because after a step toward reprogramming occurs, the partially reprogrammed cell is
subject to all the constraints discussed above. Therefore, although cellular identity is
plastic, reprogramming a terminally differentiated cell to the ES state is rare and requires
many cell cycles.
Two examples of how states evolve under the influence of reprogramming factors
in our simulations are shown in Fig. 7.5b. The first example shows a "cell" that does not
successfully reprogram, as after a successful trans-differentiation, ultimately the cell is
arrested/dead. In the second example reprogramming to the ES state occurs successfully,
and it shows an interesting feature. At an intermediate time point, before the ES state is
realized, reprogramming factors have turned on expression of the endogenous gene
module that regulates the ES state. But this is transient, as this module is quickly
silenced. We find that, unless proteins expressed by each gene module can DNA
methylate genes that are distal in the hierarchy of states (rule 4), expression of
endogenous genes that regulate the ES state can occur early and prior to the temporal
increase in the number of bivalently marked genes observed during reprogramming. In
other words, our model recapitulates the observation that endogenous expression of Oct4
and Sox2 is the last step toward reprogramming only if the DNA methylation constraint
is "long-ranged". Thus, the model suggests that transient blocking of de novo
methyltransferases might allow endogenous expression of Oct 4, Sox2, etc., at
intermediate time points. This is consistent with the observation that DNA
methyltransferase and histone deacetylase (HDAC) inhibitors, such as valproic acid
(VPA), an HDAC inhibitor, improve reprogramming efficiency (Huangfu et al., 2008).
Our model predicts that reprogramming occurs via a sequence of trans-
differentiations to immediate siblings or de-differentiations to immediate progenitors in
the hierarchy of cellular states. Note, however, that our results do not imply that pure
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differentiated states will be observed as reprogramming occurs. Oct4, Sox2, etc., have
numerous targets, and so genes from unrelated lineages will transiently be expressed
during reprogramming to the ES state (22). But, the entire set of master regulatory genes
for a cellular state from a different lineage will not be expressed.
We illustrate this point by showing computer simulation results from a model
where we consider each gene module to be comprised of three individual genes (Fig.
7.6). Reprogramming factors can attempt to change the epigenetic state of the individual
genes randomly as before. However, in this more complex model, if we allow only one
gene's epigenetic state to be modified in every telophase, reprogramming becomes so
rare that we cannot observe it in a realistic computer simulation time. So, we allowed a
larger number of transformations per cycle. Choosing this number to be too large
corresponds to overexpression of reprogramming factors, and this severely hinders
reprogramming (supplementary information, section 3). For the results shown in Fig.
7.6, we randomly pick 12 genes and change their epigenetic states during each simulated
telophase. We assume that the entire set of genes comprising a module must be
expressed for its products to regulate the epigenetic or genetic network. This is
consistent with combinatorial control of regulation.
Fig. 7.6a shows two examples of in silico cells that successfully reprogram to the
ES state. Reprogramming takes place via a sequence of trans-differentiation and de-
differentiation events wherein the entire set of genes that regulate a progenitor or sibling
of the previous cellular state is expressed. But, the intermediate states are not pure
differentiated states as some genes from unrelated lineages are also turned on at the same
time (as observed in experiments (Mikkelsen et al., 2008)). If the terminally
differentiated state in our simulations is analogous to a B cell, our simulations predict that
all successfully reprogrammed cells must transit through an impure state where all the
genes regulating the hematopoetic stem cell state are turned on (as in Fig. 7.6a).
Although beyond the scope of this work, it would be reasonable to test this
prediction by applying a cre-lox based lineage-tracing approach. Using one or more
stem/progenitor specific promoters that are inactive in the terminal state (e.g., B cell), in
combination with a lox-STOP-lox reporter, one could retrospectively determine whether
all the resulting iPS cells are labeled and hence have transiently expressed markers of
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earlier stages within the same lineage. An unrelated cell type, such as fibroblasts, should
generate unlabeled iPS cells because it would not be expected to transition through
hematopoietic progenitor stages and hence serve as an appropriate control.
The results depicted in Fig. 7.6 could also potentially be assessed quantitatively in
experiments where the temporal evolution of the gene expression patterns of a number of
successfully reprogrammed cells is observed. Consider a state where the master regulator
genes corresponding to a particular cellular identity are all expressed. One could then
ask: when these genes are subsequently silenced during reprogramming, which complete
set of master regulatory genes start expressing proteins? One could ask this question at
various times during reprogramming and in various successfully reprogrammed cells.
This would enable calculation of the following four point correlation function (C):
CQi, j; t, t + At) = (5si,o (t + At),5su(t + At).osa~ (t)oso (t)) (1)
where 6 is the Kroenecker delta, t is time, t+At is a later instant in time during
reprogramming (a cycle in our simulations), i and j are labels of two genes, and Si is
either 1 or 0 depending upon whether the ith gene is expressing proteins or turned off.
Our computer simulations predict (Fig. 7.6b) that, at each stage of
reprogramming, the correlation function would have high values for genes from lineages
related to the terminally differentiated starting point and low values for genes of
unrelated lineages. We hope that this prediction can also be assessed in future
experiments. This could involve permanent labeling as mentioned above, or possibly, in
the long-term, real-time monitoring of cell state transitions.
7.5 Discussion
To the best of our knowledge, we have developed the first computational model
that describes how terminally differentiated cells may be reprogrammed by expression of
ectopic genes. This is achieved by a mathematical description of interactions between
epigenetic and genetic networks of master-regulatory genes that govern specific cell
states. The model also describes differentiation in accord with experiments. Our model
describes cellular states as attractors on a generalized landscape of all possible
genetic/epigenetic configurations. Cellular states are stable, self-renewing states unless a
perturbing signal (either differentiation cue or reprogramming factors are introduced).
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As summarized in the table 2, major features of the reprogramming process are
explained by our results and the mechanism of reprogramming it suggests. For instance,
different cell types can be reprogrammed with the help of the same set of factors(Aoi et
al., 2008; Hanna et al., 2008; Maherali et al., 2007) because ectopic expression of genes
that have many targets (e.g., Oct4 and Sox2) can perturb the epigenetic state regardless of
the identity of the starting differentiated cell type. The importance of fast progression
through the cell cycle (due to cMyc, Klf4, or p53 knockdown) is because this offers more
opportunities for epigenetic transformations during telophase. The important
experimental observation that endogenous Oct4 and Nanog expression (Jaenisch and
Young, 2008) occurs just prior to complete reprogramming is also recapitulated by our
model. The stochastic nature of the reprogramming process(Hanna et al., 2009) and its
low yield (Jaenisch and Young, 2008) are because only a few types of trajectories can
lead to successful reprogramming, and they are realized rarely by stochastic perturbation
of the epigenome by the reprogramming factors. Our model predicts the nature of these
rare trajectories to be those that progress through reprogramming via de-differentiation to
closely related cell types (immediate progenitors or siblings in the hierarchy). Ways to
directly test this prediction are suggested. However, any feature that involves a specific
molecular interaction between specific molecules is not described by our model.
In our current model, we consider states with genes that express proteins with
conflicting demands to die/arrest. In reality, some of these situations can give rise to
steady states that do not arrest or reprogram (such as the recently studied BIV1, MCV8,
etc., cell lines) (Mikkelsen et al., 2008). The ideas emerging from our model are
consistent with observations made by manipulating these trapped states.
For example, consider the observation that removing reprogramming factors
allows cells from the BIVI cell line (isolated during reprogramming of B lymphocytes)
(Mikkelsen et al., 2008) to reprogram to the ES state. This suggests that overexpression
of reprogramming factors prevents these cells from reprogramming to the ES state. Our
model suggests that this could be due to two reasons. First, over expression of
reprogramming factors (which have many targets) could simultaneously change the
epigenetic states of a number of silenced genes to permissive chromatin status. Our
simulations of the model shown in Fig. 7.6 with a large number of such simultaneous
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transformations (e.g., 22 at a time, rather than 12 at a time used for Fig. 7.5) prevents
successful reprogramming because of the large probability of obtaining dead or arrested
states. As noted above, one of these states that cannot reprogram could correspond to the
BIVI cells.
Secondly, our model describes how lowering expression of reprogramming
factors in BIVI cells could enable reprogramming. In our simulations, we consider
proteins expressed during each interphase to act on the epigenome to reach a new balance
which then leads to a corresponding protein expression pattern before another epigenetic
transformation can occur due to the action of reprogramming factors. This is analogous
to assuming that the reprogramming factors can act to change the epigenetic state of a set
of master regulator genes rarely. If reprogramming factors are grossly overexpressed,
this would not be true. So, before a new protein expression pattern could be expressed
consistent with a newly acquired epigenome (say, de-differentiation to a progenitor),
another epigenetic transformation would occur, and the whole cycle would start again.
Simulation results showing this effect upon overexpression of reprogramming factors are
depicted in Fig. S7.4b. Removing reprogramming factors could potentially allow
reprogramming of cells trapped in such an infinite loop.
Our low-resolution model for the architecture of genetic and epigenetic regulatory
networks that determine how cellular identities change is consistent with diverse
observations (Table 2). In formulating this model, we ruled out many models that were
inconsistent with known experimental results, but we cannot rule out all other possible
models. Therefore, the predictions of the model (noted earlier) need to be experimentally
tested (perhaps in ways that we have suggested) to either falsify it or encourage studying
it further. If tested positively, the suggestions emerging from our model regarding ways
to enhance reprogramming yields should be further explored. It would also be interesting
to study other transcription factor induced cell state conversions (Davis et al., 1987; Xie
et al., 2004) within the conceptual and computational framework we have developed for
how cellular identity is transformed. In particular, recent results of direct conversion
between exocrine and endocrine cells through ectopic expression of three alternative
transcription factors (Zhou et al., 2008) should be examined.
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It would be interesting to further investigate several assumptions adopted in the
model for the lack of specific information about individual master-regulatory modules.
For example, maximum expression levels of different master-proteins within different
modules could differ, as well as coupling between genetic and epigenetic networks could
be different for different modules. Also, we assumed that every simulated cell (as
represented by a simulated trajectory) has the same level of expression of reprogramming
factors while in reality cells can be transfected in a heterogeneous fashion. Also, the
difference in viral integration sites in different cells could lead to the different expression
levels of exogeneous genes thus making effect of reprogramming factors heterogeneous
across the population. In a sense then, we have studied those cells which have expressed
reprogramming factors at levels above a threshold. It would be interesting to further
explore the consequences of such heterogeneity. Another avenue for further exploration
lies in defining the notion of time during the reprogramming process, in this work cell
cycling has been adopted as a measure of time required for reprogramming while in
reality cells cycle with non-equal rates determined from some form of cell division rate
distribution (simplest form would be an exponential distribution). It would be interesting
to see applicability of the 4-point correlation function based analysis for the situation
when cell cycling rates are not identical. Finally, de-silencing action of reprogramming
factors is assumed to be distributed randomly. It would be interesting to consider
situations when de-silencing distribution is not uniform across the hierarchy. It is possible
that non-uniform distributions can improve the reprogramming efficiency.
From the standpoint of statistical physics, our model couples a Potts model with
short and long-ranged interactions in external fields (Eq. 2) with an Ising model with
short-ranged interactions in an external field (Eq. 3). It may be fruitful to develop a
deeper field-theoretic understanding of such models.
7.6 Simulation Methods
All simulations are carried out with the help of two hierarchical lattices because
two lattices are required to properly describe the cell state as shown in Fig. 7.1b. In the
simulation code provided in supplement, we consider 4 levels in the hierarchy (such as
the one in Fig. 7. 1b). Other possibilities (3 and 5 levels) have been considered also.
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The epigenetic lattice has a discrete epigenetic state associated with each node (-
1,O,+1). SePigen - _1 corresponds to closed chromatin, SePien = 0 corresponds to bivalent
chromatin and Sepie = +1 corresponds to open chromatin. Genetic lattice describes
expression of proteins from master-regulatory modules. It has discrete gene expression
states associated with each node (0, +1). Sen = 0 corresponds to the absence of any
protein expression from the given gene, Sgen = + 1 corresponds to the maximum protein
expression from the gene.
In order to initialize simulations one has to specify either the epigenetic or genetic
state of the lattice (see Fig. 7.7). If we start by specifying the protein expression pattern,
computer simulations are carried out to determine the epigenetic state that is realized in
telophase. A Monte-Carlo simulation algorithm is used in accord with the following
Hamiltonian, with its four terms representing rules 1-4 (see Model development),
respectively:
H[{S|'}]=-G <Si" >S,'+G ><S" >.Sj +G j<S >| Se '|
ij Esibling ,progeny of i 1, jeparent of i
+H (< Sj "" > -a)Siep (2)
j,ioprogeny of j
and i j
Si"P denotes the epigenetic spin state of the ith module, and Sigen specifies the protein
expression level of the ith module. The angular brackets denote the average expression
level of the jth module obtained during the preceding interphase, and could include
protein products of ectopic genes or signaling events. ISj*PI represents the absolute value
of Siep. The quantity G is a positive parameter that represents the strength with which the
protein atmosphere can modify the epigenetic state by altering histone marks. H is a
positive parameter that represents the strength of the DNA methylation constraint. The
quantity, a, is a positive constant that favors values of Siep < a if proteins expressed by
gene, j, are present. As detailed in the supplementary information (section 2), the results
of our simulations are inconsistent with experimental results if H is not greater than G.
As long as H > G, our qualitative results do not depend upon the specific values of these
parameters. The specific value of a does not affect qualitative results. Results presented
in the main text are for a = 0, and G = 25, H = 40 (in units described below).
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During simulation of the telophase, the epigenetic state S*Pep" of each module
fluctuates. The output of the telophase simulation is < SePige>, an average of these
fluctuating values for each node of the lattice (i.e. for each module). Because we have a
discrete representation for the epigenetic marks (+1, 0, or -1) while actually each gene
bears multiple marks, using the average allows us to reflect intermediate levels of
positive and negative histone marks on a gene. For example, an average value near zero
for the epigenetic state of a gene module implies that both positive and negative marks
are present on histones associated with it, a value close to one represents an open
chromatin state, etc.
Average values of epigenetic state serve as input for simulation of interphase. If
<epign> ~1 (gene is epigenetically available), than it will favor protein expression during
the interphase in accord with the rules depicted on Fig. 7.3a. Similarly, if two
neighboring states are epigenetically available, only one protein will be expressed due to
mutual repression of neighboring master-regulators. Separate Monte Carlo simulations
are carried out to establish gene expression patterns during interphase. The following
Hamiltonian, with the two terms in it corresponding to rules 1' and 2' (see Model
development), respectively, is used:
H ({S'en }] = -Fj (< Sep > -b)Sen + j S,"en S "en (3)
SitjEnearest neighbors
The angular brackets denote the average value of epigenetic state of the ith module
obtained during the preceding telophase. F is a positive constant that represents how
strongly a protein is expressed or repressed if it is in open chromatin state or in
heterochromatin, respectively. The parameter, b, is a positive constant; protein
expression is favored if <Siep> > b. Note that the form of the first term in Eq. 3 implies
that protein expression is more strongly repressed if a gene is packaged in
heterochromatin compared to if it is bivalently marked. J represents the strength of
mutual repression by other proteins. As detailed in the supplementary information
(section 2), our results are inconsistent with experiments if J is not greater than F. As
long as J >F, the specific values do not affect qualitative results. As long as the
parameter b is larger than the typical size of fluctuations in <Si*P> (- 0.1), the specific
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value of b does not affect qualitative results. Results presented in the main text
correspond to b = 0.3, and F = 2000, J = 3000 (for units, see below).
Values of Sigen fluctuate during this Monte-Carlo procedure. The output of the
simulation of the interphase is <Sien>, which represents the average expression level of
the regulatory protein in the interphase. These averages are further used in the next
telophase simulation, thus, completing the cycle.
The Monte-Carlo algorithm is standard (Frenkel, 2002): the lattice spins (+1/0/-i
on epigenetic lattice; +1/0 on genetic lattice) are initialized randomly. The move consists
of 1) randomly choosing the node on the lattice; 2) randomly deciding on the choice of
new value of Si for this node (i.e. if Si*pigen was 0 then it can become -1 or +1 with equal
probability; 3) energy for this configuration is computed according to the appropriate
Hamiltonian; 4) attempted changes in state are accepted with probability equal to min [1,
exp {[- /AH{S,}] ]. The parameter, p, is analogous to inverse temperature used in
simulation of thermal systems, and sets the scale for the parameters, F, G, H and J. If we
pick this effective temperature to be too high (P << F, G, H, J), the system is disordered;
specific cellular identities are not established and the model has no biological
significance. We use P 1 for results reported in the main text.
A computer code written using the C++ language is provided in the supplement
allows calculation of all the results we report. For details regarding the output and input
formats see the supplementary information.
Acknowledgments: We thank Dr. C. Bock for many helpful comments on a draft of this
paper. We thank the referees for comments and suggestions that significantly improved
the manuscript. AKC thanks Prof. Phillip Sharp for introducing him to this problem, and
AKC and MA are grateful to Prof. Rudy Jaenisch for educational discussions. This
research was supported by a NIH Director's Pioneer award to AKC.
176
Table 7.1: Parameters used to obtain the simulation results reported in the main text.
Results do not change qualitatively as long as the parameters lie in the following ranges:
H>G, J>F, 0.1<b<O.5 and O<a<0.6
Value of the
Parameter of the model
parameter
Protein action on epigenetic lattice G=25
Mutual suppression by two proteins J=3000
Action from epigenetic to genetic lattice F=2000
Methylation strength H=40
Minimal protein expression level required to actively a=0
affect epigenetic state of the gene
Minimal epigenetic availability of the gene required b=0.3
to allow protein expression
Table 7.2: Experimental features of reprogramming explained by the proposed model
Experimental reprogramming features explained by the model
Reprogramming takes at least 12 days of continuous cell
transformation (Brambrink et al., 2008)
Low yield of reprogramming process(Jaenisch and Young, 2008)
Stochastic nature of reprogramming(Hanna et al., 2009)
The fact that the same gene cocktail can reprogram different
terminal cell types(Aoi et al., 2008; Hanna et al., 2008)
The fact that immortalizing the cells should improve
reprogramming, e.g. by knock-down of p53 gene(Hong et al., 2009;
Kawamura et al., 2009; Marion et al., 2009)
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7.6 Appendix to Chapter 7
7.6.1. Parameter sensitivity studies
Here we discuss how changes in the six parameters in our model (Eqs. 2 and 3 in
the main text) affect the results of our computer simulations. The results shown in the
main text correspond to the following parameter values: F=2000; J=3000; G=25; H=40;
a=0; b=0.3
The effective temperature used in the simulations is T=1. For any other choice of
the temperature, T"**, the parameters F,J,G,H have to be linearly scaled; i.e.,
Fnew=F*Tnew , etc, for the simulation results to be invariant.
The simulations results reported in the main text do not change qualitatively as
long as the parameters lie in the following ranges: H>G>>T & J>F>>T, b lies between
0.1 and 0.5, and a between 0 and 0.6. Below, we provide a detailed description of why
these parameter ranges are appropriate.
la. Parameters involved in simulation of the epigenetic network (Eq. 2). H, G, and a.
The parameters, G and H, describe the coupling between genetic and epigenetic
networks. For example, G is the strength with which a value of <Sigen> = 1 (i.e., high
protein expression by the ith gene module) favors a value of + 1 for <Sieggen> (i.e., open
chromatin) during simulation of the epigenetic network. H is the strength of the
methylation constraint. It determines the strength with which proteins expressed by a
gene module favor methylation of another gene module according to rule 4 in the main
text. We have carried out simulations with H>G, H~G, and H<G. The simulation
results reported in the main text correspond to H>G. The other two parameter regimes
lead to results that are inconsistent with experimental findings as described below.
Consider situations where G and H are approximately of the same magnitude, H -
G. Now, when proteins expressed by two distal gene modules are expressed
simultaneously (for example, as a result of reprogramming factors' action), this leads to a
tug-of-war which is resolved in several (typically, 2-3) cell cycles. Because H~G,
stochastically, only one of the modules will be silenced when cell will achieve
epigenetically/genetically balanced state. When H=G and two proteins are expressed at
exactly the same level, the methylation (H) and self-support (G) will exactly cancel each
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other and in the next cycle two protein will be expressed at exactly the same levels as in
the previous cycle. However, due fluctuations, proteins never have exactly same
expression levels. And the slightest differences in protein levels is amplified in the next
cycle because H-G is positive for one protein (hence, this protein is more suppressed) and
negative for the other protein (hence, it will be epigenetically more available in the next
cycle).Thus, in several cycles balanced epigenetic/genetic state with only one master-
protein expressed is achieved. (in the simulations reported in fig. S7.2a we perform
epigenetic perturbation every 4 cycles in order to allow for cell state equilibration time).
If we allow epigenetic perturbations to be more frequent, in this circumstance, each
expressing gene module experiences methylation constraint from multiple other modules
which results in silencing of all genes (death/arrest).
Therefore, in this parameter regime, random lineage switches occur during
reprogramming and no specific path for reprogramming trajectories can be identified (see
Fig. S7.2a). For example, lineage switches can occur from a fully differentiated state to a
state in a different lineage that is almost fully reprogrammed. This corresponds to sudden
changes in epigenetic patterns of the cell, rather than a continuous evolution of the
number of bivalent domains. For G=H, we find that such cross-lineage jumps are
dominant in our simulations, occurring 21 times more frequently than gradual evolution
of epigenetic patterns in successfully reprogrammed trajectories. Thus, when H-G,
"shortcuts" are dominant during simulations of reprogramming, leading to large and rapid
"jumps" from a differentiated state to a nearly reprogrammed state. This is inconsistent
with experimental observation of timelines of reprogramming with distinct changes in
cell appearance and cell markers (Jaenisch and Young, 2008). Note that sudden jumps of
the sort we see in our simulations with G-H have been observed upon treating fibroblasts
with a drug called AZA (Meissner et al., 2008), which causes global demethylation (i.e.,
removes the methylation constraint). These large jumps do not lead to reprogramming.
Based on these considerations, we believe that our simulation results for G-H are not
consistent with experimental observations.
If H<G, because the methylation constraints are weak, we often see stable
expression of the endogenous gene module regulating the ES state after one or two
cycles, and without transitioning through intermediate states. For example, even if H is
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only 3 times smaller than G, 8% of trajectories exhibit stable induction of the gene
module regulating the ES state after the very first cycle of epigenetic perturbations. This
is inconsistent with experimental results showing that endogenous expression of Oct4,
Sox2, etc., never appears before at least day twelve, and that reprogramming is associated
with a gradual evolution of cell appearance and markers (1). For these reasons, we
focused on the parameter regime H>G, for which the results reported in the main text are
qualitatively robust. For example, if H = 60 and G = 35, rather than H = 40 and G = 25
as in the main text's figures, the reprogramming efficiency for a 4-level hierarchy is -5
out of 104 cells and the qualitative pathways followed by successfully reprogrammed
cells remains the same as discussed in the main text.
The parameter, a, describes the minimal level of gene expression that allows a
particular gene module to exert methylation constraints on other genes. In our
simulations, a=O, which means that, as long as protein is expressed, it can methylate
other gene modules with a strength related to its expression level. Changing the
parameter a between 0 and 0.6 does not alter qualitative results. For example, if a = 0.5,
rather than 0 as in the main text, the reprogramming efficiency for a 4-level hierarchy of
states is -6 out of 104 cells, and the qualitative pathways followed by successfully
reprogrammed cells remain the same as discussed in the main text.
1b. Parameters involved in the simulation of the genetic network: F, Jand b.
Parameters F and J describe the coupling between the epigenetic and genetic
network. Parameter F is the strength with which open chromatin (positive <SiePi'e">)
favors gene expression (positive Si*gn) during the simulation of the genetic network.
Parameter J describes the strength with which proteins expressed by two neighboring
gene modules in open epigenetic states mutually repress each other. The choice of F and J
is dictated by our assumption that two neighboring genes with open chromatin should
with high probability express only one out of two proteins. This is to be consistent with
experimental evidence that genes modules responsible for the competing lineages are
mutually repressive (Cinquin and Demongeot, 2005). For this to be true, the parameter J
needs to be larger than F.
Stochastically, during simulation of the genetic network, transitions can occur
from a state where one of two mutually repressive gene modules is expressed to one
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where the other is expressed. F and J must be much larger than the effective temperature
of the simulations (T) in order to minimize such transitions during the simulation time as
this would result in both proteins being simultaneously expressed. If the two gene
modules thus expressing proteins are immediate siblings in the hierarchy of states, then
rules 3 and 4 in the main text would result in silencing of both gene modules, leading to
cell death/arrest. If the two gene modules were progenitor and immediate progeny, then
the cell would remain in a terminally differentiated state because of the asymmetry of the
methylation constraint for states in the same lineage. Fig. S7.3 shows an example of the
latter situation for simulations carried out with values of F and J that are too small. Thus,
if F and J are not sufficiently large, reprogramming is not possible. For intermediate
values of F and J we find that reprogramming probability decreases (for F= 1000 and
J=2000 only about 4 cells out of 105 cells reprogram successfully), but the qualitative
nature of the temporal pathways followed by successfully reprogrammed cells remain the
same.
Protein expression by gene module i is favored when the value of <SePigen>
representing the chromatin state of this gene is greater then b. The value of b has to be
more than zero to ensure stability of the stem cell state in the absence of self-induced
differentiation (e.g., when LIF, etc., are present in the medium). Typical simulations
show that, in the ES state, <SePien(ES gene module)> -1 and <SPien(all other gene
modules)> fluctuates between -0.1 and +0.1. The parameter, b, must be larger than the
size of these typical fluctuations in order to prevent spontaneous differentiation. Our
qualitative results do not change if b lies between 0.1 and 0.5. For example, if b = 0.4,
rather than 0.3 as in the main text, the reprogramming efficiency for a 4-level hierarchy
of states is -6 out of 104 cells, and the qualitative pathways followed by successfully
reprogrammed cells remain the same as discussed in the main text.
7.6.2. Effect of increasing the frequency of action by reprogramming factors
Fig. S7.4a details the events that occur during one-level de-differentiation in our
simulations with parameters that are consistent with experimental observations (see
above). In our simulations, it takes two cell cycles to complete a successful de-
differentiation or trans-differentiation. During the first cycle, reprogramming factors
cause a new perturbation to the epigenome in the telophase and the perturbed epigenome
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controls protein expression in the subsequent interphase. The resulting protein
expression profile may not be in balance with underlying epigenetic state. During the
subsequent telophase (which begins the second cycle), a new balance between the
epigenetic and genetic states of the cell is established. Hence, in the subsequent
interphase, the protein expression reaches accord with the prevailing epigenetic state.
Note that in experiments, it is likely that more time (cell cycles) is required in order to
balance the genetic and epigenetic states. For example, in nuclear transfer experiments it
takes 12 to 20 cycles to achieve global demethylation of somatic DNA (Jaenisch and
Young, 2008; Simonsson and Gurdon, 2004).
If the reprogramming factors are overexpressed, they will have a higher
probability of altering the epigenetic states of gene modules more frequently than once in
two cell cycles. In this situation, our simulations predict that reprogramming is not
possible because cells will never be able to balance their genetic and epigenetic networks,
as is shown on Fig. S7.4b. Any endogenous expression of Oct-4 or Nanog will only be
observed transiently, because further epigenetic perturbations occur before the ES state
can be stably established.
Overexpression of reprogramming factors should also lead to an increase in the
number of genes that can be epigenetically altered in every cell cycle. In our simulations,
this means that a greater number of genes would be epigenetically modified during each
perturbation of the epigenome. The effects of this can be evaluated in a model where
each module consists of three individual genes (Fig. 7.6 in main text). If only 12 genes
are altered in a cycle (as in main text), 15 out of 100, 000 "cells" reprogram. But if 15,
20, or 22 genes are altered per cycle, out of 100, 000 "cells", only 5, 2, and 0 cells
reprogram. Thus, overexpression of reprogramming factors hinders reprogramming.
7.6.3. C++ code that illustrates reprogramming process
C++ code is provided as supplementary file "reprog.cpp". The code allows one
observe reprogramming trajectories. (Simply compile and then run the code after
compiling).
Simulation shows progression of the cell states starting from terminally
differentiated state under the action of reprogramming factors (they are turned on in the
second cell cycle after stability of the terminal state by itself is illustrated).
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The simulation outputs the average values of the genetic and epigenetic variable
at each cycle in accord with the simulation flow chart.
So, for fully differentiated state genetic and epigenetic networks will look like:
GENETIC
1 0 0 0 0 0 0 0
EPIGENETIC
+1 -1 -1 -1 -1 -1 -1 -1
Terminally differentiated state
The GENETIC diagram indicates that only proteins of "bottom left corner" master-
regulatory gene module are expressed. And EPIGENETIC diagram indicates that
chromatin open only for "bottom left corner" master-gene, while the rest of master genes
are in the closed chromatin state.
Note that this state is stable state of the cell, "attractor" in the space of the cellular states,
because it will renew itself, provided that cell is forced to proliferate.
Fully differentiated state will be recognized in the program output as having the
following genetic/epigenetic structure:
GENETIC
1
0 0 0 0 0 0 0 0
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EPIGENETIC
0 0 0 0 0 0 0 0
ES state
Simulation begins in the fully differentiated state of the 4 levels hierarchy of cell states.
Beginning from the second cell cycle reprogramming factors start acting. They randomly
perturb epigenetic structure of the terminally differentiated cell. In the output one can see
that randomly chosen epigenetic module will have its "-1" state flipped to "+1" state.
Then, during the next cell cycle epigenetic and genetic will find assume balanced state,
which in the majority of cases results in the completely silenced, unviable state such as
follows:
GENETIC
0 0 0 0 0 0 0 0
Dead/arrested
EPIGENETIC
-1 -1 -1 -1 -1 -1 -1 -1
This is indicative of cell arrest/cell death situation.
In order to start new reprogramming trajectory, one can simply restart the compiled code.
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In the few cases one will observe one-level de-differentiation and in about 5-10 out of
10,000 cases one will see the complete reprogramming from terminal fully differentiated
state to the ES cell state.
7.6.4. Population behavior of the cells
On Fig. S7.5 the diagram depicting transitions between stable cell populations
under the action of reprogramming factors is presented. The starting point is terminally
differentiated state depicted on the bottom of the picture. Possible transitions from this
state are indicated by arrows. Probability to experience a particular transition is indicated
by the % value on top of the corresponding arrow. For example, starting from the
population of terminally differentiated cells, only -7 % of cells successfully de-
differentiate one level, while 67 % of cells either die or get arrested in the intermediate
state. Further, one sees that out of one level de-differentiated cells only -7%
dedifferentiate one level further etc, thus giving very low total yield of reprogrammed
cells at about 0.04%.
Table S1. Summary of efficiency of reprogramming in different parameter regimes.
G<H G~H G>H
Efficiency of reprogramming 4 84 0
(out of 104 cells)
Table S2. Dependence of reprogramming efficiency on number of genes perturbed
during action of reprogramming factors for the model where each master-regulatory
module consists of 3 genes.
Number of genes perturbed during action
8 10 12 15 20 22
of reprogramming factors
Efficiency of reprogramming 6 10 15 5 2 0
(out of 105 cells)
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7.8 Figures for Chapter 7
Fig.1b l 6
ES cell state
Genetic Network (protein expression)
0 Protein expressed fully
0 Protein not expressed at all
Epigenetic Network (genes availability)
* Open chromatin
o Bivalent chromatin
P HeterochromatinPluripotent progenitor
Fig. 7.1 Specification of the genetic and epigenetic states that describe cellular states
(a) Only the master-regulatory genes that govern cell state are arranged in a hierarchy
(house keeping, stress-response and many other genes are not considered). Each node of
the hierarchy represents an ensemble of master-regulatory genes that govern a particular
cellular state. For example, genes in the top node are known master-regulators of the
embryonic stem cell state (e.g. Oct4, Sox2, Nanog). When a cell is in the ES state, only
these three genes will be expressed while other genes will not. Similarly, when a cell is
fully differentiated, genes in one of the bottom modules will be expressed but not any
other gene in the network. Each master-regulatory ensemble can contain many genes,
only three are shown in each node.
(b) Fig. la has been coarse-grained such that only master-regulatory modules (nodes
in fig. I a) are shown. Cellular identity is determined by both epigenetic (chromatin
marks, DNA methylation) and genetic (expression profile) states. Examples of two states
(ES state and "left" pluripotent progenitor) are shown. For each example, two lattices are
needed to describe the state of gene expression and the epigenome: top lattice reflects the
expression levels of master-regulatory proteins in the ES/progenitor state and bottom
lattice reflects the epigenetic state of master-regulatory genes in the ES/progenitor state.
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Fig. 7.2 Simplified model for progression through the cell cycle. The cell cycle is
divided into two generalized phases: called interphase and telophase for simplicity. Gene
expression occurs during the interphase, while cell division and associated processes
occur in the telophase. In the interphase gene expression profile is governed by the stable
epigenetic marks on the master-regulatory genes. In the telophase, however, protein
environment can change the epigenetic marks of the master-regulaory genes, particularly
when DNA is decondensing after cell division. Differentiation signals (newly expressed
proteins) determine future epigenetic marks created during telophase due to the action of
the new protein environment. The color code representing genetic and epigenetic states is
the same as in Fig.1.
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Fig. 7.3 (a) During interphase, gene expression profiles of master-regulatory modules are
established. Gene expression is influenced by epigenetic marking of the corresponding
gene and interactions between expressed proteins. Two rules reflect this in our
simulation: 1) when master-regulatory gene is in epigenetically marked positively, it
favors expression of the corresponding protein; 2) when two (three) neighboring genes
are in epigenetically open states, they all favor expression of corresponding proteins, but
due to their mutually repressive action (see text) only one of two(three) genes are
expressed. Which gene is expressed is chosen stochastically. The color code representing
genetic and epigenetic states is the same as in Fig. 1
(b) During the telophase, the protein environment can alter the epigenetic marks on the
master-regulatory genes. Epigenetic marks on both neighboring and distant genes in the
hierarchy can be altered. Long-range effect is typically mediated through DNA
methylation which epigenetically silences all of the master-regulatory genes of unrelated
lineages and also ancestral states (see text). Short-range interactions affect nearest-
neighbors differentially: progenies master-regulatory genes are preferentially put into
bivalent states while progenitor and competing lineage modules are epigenetically
silenced. The color code representing genetic and epigenetic states is the same as in Fig. 1
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Fig. 7.4: Changing cellular identity during self-initiated differentiation of the ES cell-
state is shown in detail. Process begins with cell division where regulatory modules of
progenies are put into epigenetically open states. In phase 2 only one of the three
neighboring proteins can be actually expressed in accord with Fig. 3a. Thus, one of three
possibilities is realized: self-renewal, and differentiation to the "left" or "right" lineages.
In the absence of external stimuli, in our simulations, there is an equal chance to observe
each outcome. Simulations are performed with parameter values F=2000; J=3000; G=25;
H=40; a=O; b=0.3. The color code representing genetic and epigenetic states is the same
as in Fig.1.
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Fig. 7.5: Reprogramming is a consequence of random perturbation of epigenetic state of
the cell. In our model, reprogramming factors can change the epigenetic state of
randomly chosen regulatory modules (for reasons, see text).
(a) Starting from a fully differentiated state, reprogramming factors can perturb any
of the remaining 14 positions (for the case of a 4-level hierarchy). Four outcomes
are possible depending on the perturbation site: death/arrest, trans-differentiation,
de-differentiation or return to the initial cellular state. These outcomes are
determined by simulating the system in accord with the rules described in the text
and Figs. 2 - 3. The color code representing genetic and epigenetic states is the
same as in Fig. 1
(b) Examples of real trajectories observed in simulations illustrating different
temporal evolution of epigenetic and genetic states. Complete cell reprogramming
appears as a consequence of several successful de-differentiation events as seen in
the second example trajectory. Simulations are performed with parameter values
F=2000; J=3000; G=25; H=40; a=O; b=0.3. The color code representing genetic
and epigenetic states is the same as in Fig. 1
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Fig.7.6 (a) Simulations of a model where each gene module regulating a cellular identity
consists of three different genes. In this (similar to the previous) model, individual genes
do not interact with each other. Rather modules interact with each other when all of the
proteins in a module are expressed. Since reprogramming factors change the epigenetic
state of randomly chosen individual genes, several (here: at least three) genes have to be
changed to open chromatin status at the same time in order to allow a whole module to be
able to express proteins. Examples of simulated trajectories show activation of genes of
unrelated lineages during successful reprogramming. Simulations are performed with
parameter values F=2000; J=3000; G=25; H=40; a=O; b=0.3.
(b) If population averaged expressions of genes during reprogramming can be measured,
one can compute a 4-point correlation function (see Eq. 1). This correlation function
describes the probability of activation of a given gene after the master regulatory gene
module, i, was silenced. Then all the genes can be grouped in three groups as our
simulation indicates. Thus, the genes defining the most likely paths to reprogramming
can be identified as the ones with the highest magnitude of this correlation function. The
correlation function was computed by averaging over all successfully reprogrammed
trajectories. The colors correspond to the magnitude of the correlation function (as shown
on the left)
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Fig.7.7:Flow chart of the simulation procedure. The simulation essentially mimics
progression through the cell cycle in accord with Fig. 2. In each phase of the cell cycle,
interactions within and between genetic and epigenetic lattices are enforced through the
Hamiltonians of Eq. 2 and 3. Mathematical structure and choice of parameters are such
that rules depicted in Fig.3 are obeyed. For analysis of sensitivity to parameter variations
see supplementary information.
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Supplementary figures
epigenetic perturbation
by reprogr. factors
Fig. S7.1a: Example of a part of a simulation trajectory for H=G illustrating large and
fast cross-lineage jumps from a terminally differentiated to an almost reprogrammed
state. As noted in section 2.a, such jumps are dominant when H-G. (This simulation was
carried out with F=2000; J=3000; G=25; H=25; a=O; b=0.3). The color code
representing genetic and epigenetic states is the same as in Fig. 7.1.
epigenetic perturbation action of methylation
by reprogr. factors constraint
Fig. S7.1b: Example of a part of a simulation trajectory for G>H (in this case G>3H).
The gene module regulating the ES state is turned on stably during the first epigenetic
perturbation. This simulation was carried out with F=2000; J=3000; G=25; H=8; a=O;
b=0.3. The color code representing genetic and epigenetic states is the same as in Fig. 7.1
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No reprogramming
possible
epigenetic perturbation action of methylation
by reprogr. factors constraint
Fig. S7.2: Example of a part of a simulation trajectory with small values of F and J. The
simulation was carried out with F=200, J=300, G=25; H=40; a=O; b=0.3. The color code
representing genetic and epigenetic states is the same as in Fig. 7.1.
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Fig. S7.3a: Example of a typical
trajectory obtained from our
simulations showing that it takes
several cell cycles (in our simulations,
2 cycles) to achieve one level of
reprogramming in a stable manner.
This simulation was performed with
parameter values: F=2000; J=3000;
G=25; H=40; a=O; b=0.3. The color
code representing genetic and
epigenetic states is the same as in
Fig.7.1.
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Fig. S7.3b: Example of a typical
trajectory from our simulations
where, because reprogramming
factors are overexpressed, they
can act at every cycle, as opposed
to the every two cycles (as in
panel (a)). This renders
reprogramming impossible for
reasons described in the main
text. This simulation was
performed with parameter values:
F=2000; J=3000; G=25; H=40;
a=O; b=0.3.
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Fig.S7.4:Dynamics of cell differentiation upon receiving cues of different strength. Our
simulations show that the progenitor cells differentiate in accord with first order
kinetics, with the lifetime of progenitor cells depending on the signal strength.
The blue curve describes the behavior of a cell population which received a signal
that is twice as weak as the population represents by the black line. Simulations
are performed with parameter values F=2000; J=3000; G=25; H=40; a=O; b=0.3.
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Fig.S7.5: The diagram depicting transitions between stable cell populations under the
action of reprogramming factors. The starting point is terminally differentiated state
depicted on the bottom of the picture. Possible transitions from this state are indicated by
arrows. Probability to experience a particular transition is indicated by the % value on top
of the corresponding arrow.
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Chapter 8
Concluding remarks
In conclusion, I would like to reiterate the premise of this thesis that was stated in
Chapter 1. Biology offers a broad spectrum of problems ranging from fundamental
studies of chemical networks and application of stochastic chemical networks to signal
processing all the way to the application of coarse-grained statistical mechanical model
for phenomenological description of cellular behavior. Some of the problems have been
explored in this thesis.
Innumerable amount of problems was not covered in this thesis and it is my hope
as a future professional scientist to explore connections between post-translational
modifications and changes in transcriptional program of the cell in more details. Novel
chip-based experimental technics allow one to trace expression of thousands of genes at a
time. The wealth of connections and interdependences in the transcriptional networks
create enormous problem when trying to recover underlying network structure based on
the expression data alone. Additional level of complexity is put in due to non-linearity of
"interactions" between different genes since these interactions are mediated by post-
translational networks such as the ones studied in this thesis.
Unified view of transcriptional and post-translational networks, even on the crude
coarse-grained level could provide a new paradigm for looking at the biological network.
The need for such a novel paradigm is nicely referred to as "Need for a New Mechanics"
by Bill Hlavacek and Jim Faeder (Hlavacek and Faeder, 2009)*
*Hlavacek, W.S., and Faeder, J.R. (2009). The complexity of cell signaling and the need
for a new mechanics. Sci Signal 2, pe46.
215
216
Curriculum Vitae
Maksym Artomov
please note professional name spelling: Maxim N. Artyomov
born May 30, 1982
Massachusetts Institute of Technology
Room E19-538
77 Massachusetts Ave
Cambridge, MA 02139 USA
Work phone:1-617-252-1744
e-mail: maxart@mit.edu
PhD Thesis Title: Stochastic Processes in Biological Systems: Selected Problems
Education:
2009 (Dec.1)
2005-2009
2004-2005
1999-2004
... post-doctoral researcher at Broad Institute
graduate student at Massachusetts Institute of Technology,
Chemistry Department.
University of Chicago, M.Sc.
Moscow State University, B.Sc. with honorary Gold Medal
* 2006 Teaching Award: for excellence in teaching (as teaching assistant in
undergraduate Thermodynamics and Kinetics class)
* 1999 Silver Medal in International Chemistry Olympiad among high-school
students (Bangkok, Thailand)
Teaching and Work Experience:
* Summer 2009
* Fall'07
e Spring'06
* Fall'05
e Fall'04/Spr'05
- Internship in Vertex Pharmaceuticals (Cambridge, MA)
Target identification in signalling pathways affected by IBD
- TA in the Statistical Mechanics with Biological Applications
(5.70, graduate course, MIT, Chemistry Dep)
- TA in the Chemical Thermodynamics and Kinetics course
(5.60, advanced undergraduate course, MIT, Chemistry Dep)
- TA in the Chemical Thermodynamics and Kinetics course
(5.60, advanced undergraduate course, MIT, Chemistry Dep)
- TA in the General Chemistry course
(first-year undergraduate course, U.Chicago)
Awards:
217
Research interests:
Computational biologys and systems biology: stochastic modeling of signaling pathways, modeling of
biophysical measurements (biacore/SPR) in complex systems: heterogeneous binding of
multimeric ligands.
Biological Applications of the Statistical Mechanics: molecular motors, statistical models in
immunology, stochastic fluctuations in chemical networks.
Non-Equilibrium Statistical Mechanics: Non-Equilibrium Steady States, Stochastic Processes,
Transport Phenomena, Stochastic Fluctuations in Chemical Networks.
Equilibrium Statistical Mechanics: Polymers, Systems with longe-range interactions.
Publications:
1. Stone J., Artyomov M.N., Eisen H.N., Chakraborty A.K., Kranz D.
MHC Tetramer staining and activation assay revisited
Manuscript in preparation (2009)
2. Artyomov M.N., Lis M., Devadas S., Chakraborty A.K.
Mechanusms ofself-peptide mediated signal enhancement during early T-cell activation
To be submitted to Journal of Immunology (2009)
3. Mouquet H., Scheid J.F., Zoller M., Ott R., Shukair S., Artyomov M.N., John Pietzsch J.,
Connors M., Pereyra F., Walker B.D., HolD., Wyatt R.T., Mascola J.R., Wilson1 P.C.,
Seaman1 M.S., Eisen H.N., Chakraborty A.K., Hope T., Ravetch J.V., Wardemann L,
Nussenzweig M.C.
Polyreactivity increases the affinity of anti-HIV antibodies by heteroligation
Submitted to Nature (2009)
4. Artyomov M.N., Eisen H.N., Chakraborty A.K.
Method for determining the effect of heteroligation on the stability of multivalent interactions:
application to neutralizing antibodies to HIVantigens
Submitted to Journal of Immunological Methods (2009)
5. Artyomov M.N., Morozov A.Yu., Kolomeisky A.B.
Dynamics of Reversible Burnt-Bridge Models of Molecular Motors
Submitted to Condensed Matter Physcis (2009)
6. Artyomov M.N., Lis M., Devadas S., Chakraborty A.K.
Role of coreceptor in early T-cell signaling events
Submitted to Immunity (2009)
7. Artyomov M.N., Meissner A., Chakraborty A.K.
A model for genetic and epigenetic regulatory networks identifies rare pathways for transctiption factor
induced pluripotency
Submitted to Plos Comp Biology (2009)
8. Artyomov M.N., Mathur M.S., Samoilov M., Chakraborty A.K.
Bimodality in monostable reversible chemical networks
Journal of Chemical Physics, 131, 195103 (2009)
218
9. Lis M., Artyomov M.N., Devadas S., Chakraborty A.K.
Efficient Stochastic Simulation of Reaction-Diffusion Processes via Direct Compilation
Bioinformatics 25(17), 2289-91(2009)
10. Artyomov M.N.
On the higher order Onsager Reciprocity relations
Physical Review Letters (C), 102, 149701 (2009)
11. Artyomov M.N., Morozov A.Yu., Kolomeisky A.B.
Molecular Motors Interacing with their own tracks
Physical Review E, 77, 040901(R) (2008)
12. Henrickson S.E., Mempel T.R., Mazo I.B., Liu B., Artyomov M.N., Zheng H, Peixoto A,
Flynn M.P., Senman B, Junt T., Wong H.C., Chakraborty A.K., von Andrian U.H.
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T
cell activation
Nature Immunology, 9(3), 282-291 (2008)
13. Artyomov M.N., Das J., Kardar M., Chakraborty A.K.
Purely stochastic binary decisions in cell signaling models without underlying deterministic bistabilities
Proceedings of the National Academy of Sciences of USA, 104, 18958-18963 (2007)
0 See coverage of this work in Physics Today, July 2008, page 28.
14. Artyomov M.N., Morozov A.Yu., Pronina E., Kolomeisky A.B.
Dynamic properties of molecular motors in Burnt-Bridge Motors
Journal of Statistical Mechanics - Theory and Experiment, P08002 (2007)
15. Morozov A.Yu., Pronina E., Kolomeisky A.B., Artyomov M.N.
Solution of burnt-bridge models for molecular motor transport
Physical Review E, 75(3) 031910 (2007)
16. Artyomov M.N., Freed K.F.
Actin polymerization under pressure: A theoretical study
Journal of Chemical Physics, 126(2) 024908 (2007)
17. Artyomov M.N., Freed K.F.
Compressible models of equilibrium polymerization
Journal of Chemical Physics, 123(19) 194906 (2005)
18. Artyomov M.N., Kolomeisky A.B.
Thermodynamics and phase transitions of electrolytes on lattices with different discretization parameters
Molecular Physics, 103(21-23) 2863-2872 (2005)
19. Artyomov M.N., Kobelev V., Kolomeisky A.B.
Lattice models of ionic systems with charge asymmetry
Journal of Chemical Physics, 118(14) 6394-6402 (2003)
20. Durov V.A., Artemov M.N., Shilov I.Y. (name spelled incorrectly in the translated version)
Molecular structure and dielectric properties of associated liquids: Models of comblike associates with
branches of arbitrary length
Russian Journal of Physical Chemistry, 79(12) 1955-1966 (2005)
21. Durov V.A., Artemov M.N. (name spelled incorrectly in the translated version)
Molecular structure and dielectric properties of associated liquids. The simplest model of comb association
Russian Journal of Physical Chemistry, 79(2) 207-214 (2005)
219
Presentations:
* May 10, 2009
* Mar 19, 2009
* Mar 16, 2009
* Jan 11, 2009
* Aug 20, 2008
* Augl,2008
* Jul 8, 2007
- Oral Presentation at AAI 2009 (imunology) Meeting in Seattle:
Role of the Coreceptor in Early T-cell Signaling
- Oral Presentation at APS March Meeting in Pittsburgh:
Reaction-Diffiusion vs Reactions in cell signalling
- Oral Presentation at APS March Meeting in Pittsburgh:
Stochastic bimodality without underlying bistability
- Poster Presentation at Mini-Stat-Mech Meeting, UC Berkeley:
Mechanism of somatic cells reprogramming to induced embryonic cells
- Oral Presentation at ACS Fall Meeting in Philadelphia:
Molecular Motors Interacting with Their own Tracks
- Oral Presentation at Les Houches Summer School Seminar:
Molecular Motors Interacting with Their own Tracks
- Poster Presentation at IUPAP StatPhys23 Conference, Genova, Italy:
Purely stochastic binary decisions in cell signaling models without underlying
deterministic bistabilities
Professional Activities:
e Jun-Aug 2009
* Aug 2008
* Sep 2007
* Jan 2007
e Jul 2006
- Internship in Vertex Pharmaceuticals (Cambridge, MA)
study of signalling pathways affected by IBD
- Les Houches Theoretical Physics Summer School
on Long-Range Interactions and Non-Equilibrium Phenomena
- Institute Poincare' Trimester on Non-Equilibrium Statistical Physics,
attended Month I: Non-Equilibrium Steady States, IHP, Paris, France
- D.Frenkel' &B.Smit' Understanding Molecular Simulations Tutorial
University of Amsterdam, Netherlands
- Boulder Summer School in Condensed Matter and Materials
Physics: Physics of Soft Matter, Complex Fluids and Biological Materials.
Boulder, CO, USA
220
References:
Arup K. Chakraborty
Robert T. Haslam Professor of Chemical Engineering
Professor of Chemistry, Professor of Biological Engineering
Department of Chemical Engineering
Massachusetts Institute of Technology
Room E19-502C
77 Massachusetts Ave
Cambridge MA 02139 USA
Phone: 617.253.3890
Fax: 617-258-5766
Email: arupcomit.edu
Web: http://web.mit.edu/akcgroup
Mehran Kardar
Professor of Physics
Department of Physics
Massachusetts Institute of Technology
Room 6C-315
77 Massachusetts Ave
Cambridge MA 02139 USA
Phone: (617) 253-3259
Fax: (617) 253-2562
Email: kardarsmit.edu
Web: http://web.mit.edu/kardar/www/
Anatoly B. Kolomeisky
Associate Professor
Rice University
Department of Chemistry, Department of Chemical and Biomolecular Engineering
6100 Main Street
Houston, TX 77005-1892
Office: Biology 306
tel. (713) 348-5672
fax. (713) 348-5155
E-mail: tolyaorice.edu
http://python.rice.edu/-kolomeisky/
221
